
<html lang="en"     class="pb-page"  data-request-id="beb909cb-6b10-4f31-809b-73233d8eecc9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.7b01186;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)" /></meta><meta name="dc.Creator" content="Douglas S.  Williamson" /></meta><meta name="dc.Creator" content="Garrick P.  Smith" /></meta><meta name="dc.Creator" content="Pamela  Acheson-Dossang" /></meta><meta name="dc.Creator" content="Simon T.  Bedford" /></meta><meta name="dc.Creator" content="Victoria  Chell" /></meta><meta name="dc.Creator" content="I-Jen  Chen" /></meta><meta name="dc.Creator" content="Justus C. A.  Daechsel" /></meta><meta name="dc.Creator" content="Zoe  Daniels" /></meta><meta name="dc.Creator" content="Laurent  David" /></meta><meta name="dc.Creator" content="Pawel  Dokurno" /></meta><meta name="dc.Creator" content="Morten  Hentzer" /></meta><meta name="dc.Creator" content="Martin C.  Herzig" /></meta><meta name="dc.Creator" content="Roderick E.  Hubbard" /></meta><meta name="dc.Creator" content="Jonathan D.  Moore" /></meta><meta name="dc.Creator" content="James B.  Murray" /></meta><meta name="dc.Creator" content="Samantha  Newland" /></meta><meta name="dc.Creator" content="Stuart C.  Ray" /></meta><meta name="dc.Creator" content="Terry  Shaw" /></meta><meta name="dc.Creator" content="Allan E.  Surgenor" /></meta><meta name="dc.Creator" content="Lindsey  Terry" /></meta><meta name="dc.Creator" content="Kenneth  Thirstrup" /></meta><meta name="dc.Creator" content="Yikang  Wang" /></meta><meta name="dc.Creator" content="Kenneth V.  Christensen" /></meta><meta name="dc.Description" content="Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, are associated with an increased risk of developing Parkinson’s disease. Surrogates for the LRRK2 kinase domain based on checkpoin..." /></meta><meta name="Description" content="Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, are associated with an increased risk of developing Parkinson’s disease. Surrogates for the LRRK2 kinase domain based on checkpoin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 27, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01186" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01186" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01186" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01186" /></link>
        
    
    

<title>Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01186" /></meta><meta property="og:title" content="Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0019.jpeg" /></meta><meta property="og:description" content="Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, are associated with an increased risk of developing Parkinson’s disease. Surrogates for the LRRK2 kinase domain based on checkpoint kinase 1 (CHK1) mutants were designed, expressed in insect cells infected with baculovirus, purified, and crystallized. X-ray structures of the surrogates complexed with known LRRK2 inhibitors rationalized compound potency and selectivity. The CHK1 10-point mutant was preferred, following assessment of surrogate binding affinity with LRRK2 inhibitors. Fragment hit-derived arylpyrrolo[2,3-b]pyridine LRRK2 inhibitors underwent structure-guided optimization using this crystallographic surrogate. LRRK2-pSer935 HEK293 IC50 data for 22 were consistent with binding to Ala2016 in LRRK2 (equivalent to Ala147 in CHK1 10-point mutant structure). Compound 22 was shown to be potent, moderately selective, orally available, and brain-penetrant in wild-type mice, and confirmation of target engagement was demonstrated, with LRRK2-pSer935 IC50 values for 22 in mouse brain and kidney being 1.3 and 5 nM, respectively." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01186"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01186">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01186&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01186&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01186&amp;href=/doi/10.1021/acs.jmedchem.7b01186" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8945-8962</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01164" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01210" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+S.++Williamson">Douglas S. Williamson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5094-5200" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Garrick+P.++Smith">Garrick P. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pamela++Acheson-Dossang">Pamela Acheson-Dossang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+T.++Bedford">Simon T. Bedford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0531-8096" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victoria++Chell">Victoria Chell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=I-Jen++Chen">I-Jen Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justus+C.+A.++Daechsel">Justus C. A. Daechsel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zoe++Daniels">Zoe Daniels</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++David">Laurent David</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawel++Dokurno">Pawel Dokurno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7332-8889" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Morten++Hentzer">Morten Hentzer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+C.++Herzig">Martin C. Herzig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roderick+E.++Hubbard">Roderick E. Hubbard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+D.++Moore">Jonathan D. Moore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+B.++Murray">James B. Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1007-8218" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Newland">Samantha Newland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+C.++Ray">Stuart C. Ray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry++Shaw">Terry Shaw</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+E.++Surgenor">Allan E. Surgenor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9869-1430" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lindsey++Terry">Lindsey Terry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0373-2090" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Thirstrup">Kenneth Thirstrup</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yikang++Wang">Yikang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+V.++Christensen">Kenneth V. Christensen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1759-8988" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Vernalis (R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#99fdb7eef0f5f5f0f8f4eaf6f7d9effcebf7f8f5f0eab7faf6f4"><span class="__cf_email__" data-cfemail="ceaae0b9a7a2a2a7afa3bda1a08eb8abbca0afa2a7bde0ada1a3">[email protected]</span></a>. Phone: +44 (0) 1223 895555.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01186&amp;href=/doi/10.1021%2Facs.jmedchem.7b01186" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8945–8962</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 12, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 August 2017</li><li><span class="item_label"><b>Published</b> online</span>27 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01186" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01186</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8945%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDouglas%2BS.%2BWilliamson%252C%2BGarrick%2BP.%2BSmith%252C%2BPamela%2BAcheson-Dossang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D21%26contentID%3Dacs.jmedchem.7b01186%26title%3DDesign%2Bof%2BLeucine-Rich%2BRepeat%2BKinase%2B2%2B%2528LRRK2%2529%2BInhibitors%2BUsing%2Ba%2BCrystallographic%2BSurrogate%2BDerived%2Bfrom%2BCheckpoint%2BKinase%2B1%2B%2528CHK1%2529%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8962%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01186"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3249</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01186" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;S. Williamson&quot;},{&quot;first_name&quot;:&quot;Garrick&quot;,&quot;last_name&quot;:&quot;P. Smith&quot;},{&quot;first_name&quot;:&quot;Pamela&quot;,&quot;last_name&quot;:&quot;Acheson-Dossang&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;T. Bedford&quot;},{&quot;first_name&quot;:&quot;Victoria&quot;,&quot;last_name&quot;:&quot;Chell&quot;},{&quot;first_name&quot;:&quot;I-Jen&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Justus&quot;,&quot;last_name&quot;:&quot;C. A. Daechsel&quot;},{&quot;first_name&quot;:&quot;Zoe&quot;,&quot;last_name&quot;:&quot;Daniels&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;David&quot;},{&quot;first_name&quot;:&quot;Pawel&quot;,&quot;last_name&quot;:&quot;Dokurno&quot;},{&quot;first_name&quot;:&quot;Morten&quot;,&quot;last_name&quot;:&quot;Hentzer&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;C. Herzig&quot;},{&quot;first_name&quot;:&quot;Roderick&quot;,&quot;last_name&quot;:&quot;E. Hubbard&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;D. Moore&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;B. Murray&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Newland&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;C. Ray&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;Shaw&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;E. Surgenor&quot;},{&quot;first_name&quot;:&quot;Lindsey&quot;,&quot;last_name&quot;:&quot;Terry&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Thirstrup&quot;},{&quot;first_name&quot;:&quot;Yikang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;V. Christensen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8945-8962&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01186&quot;},&quot;abstract&quot;:&quot;Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, are associated with an increased risk of developing Parkinson’s disease. Surrogates for the LRRK2 kinase domain based on checkpoint kinase 1 (CHK1) mutants were designed, expressed in insect cells infected with baculovirus, purified, and crystallized. X-ray structures of the surrogates complexed with known LRRK2 inhibitors rationalized compound potency and selectivity. The CHK1 10-point mutant was preferred, following assessment of surrogate binding affinity with LRRK2 inhibitors. Fragment hit-derived arylpyrrolo[2,3-b]pyridine LRRK2 inhibitors underwent structure-guided optimization using this crystallographic surrogate. LRRK2-pSer935 HEK293 IC50 data for 22 were consistent with binding to Ala2016 in LRRK2 (equivalent to Ala147 in CHK1 10-point mutant structure). Compound 22 was shown to be potent, moderately selective, orally available, and brain-penetrant in wild-type mice, and confirmation of target engagement was demonstrated, with LRRK2-&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01186&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01186" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01186&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01186" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01186&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01186" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01186&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01186&amp;href=/doi/10.1021/acs.jmedchem.7b01186" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01186" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01186" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01186%26sid%3Dliteratum%253Aachs%26pmid%3D29023112%26genre%3Darticle%26aulast%3DWilliamson%26date%3D2017%26atitle%3DDesign%2Bof%2BLeucine-Rich%2BRepeat%2BKinase%2B2%2B%2528LRRK2%2529%2BInhibitors%2BUsing%2Ba%2BCrystallographic%2BSurrogate%2BDerived%2Bfrom%2BCheckpoint%2BKinase%2B1%2B%2528CHK1%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D21%26spage%3D8945%26epage%3D8962%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/jmcmar.2017.60.issue-21/20171109/jmcmar.2017.60.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mutations in leucine-rich repeat kinase 2 (LRRK2), such as G2019S, are associated with an increased risk of developing Parkinson’s disease. Surrogates for the LRRK2 kinase domain based on checkpoint kinase 1 (CHK1) mutants were designed, expressed in insect cells infected with baculovirus, purified, and crystallized. X-ray structures of the surrogates complexed with known LRRK2 inhibitors rationalized compound potency and selectivity. The CHK1 10-point mutant was preferred, following assessment of surrogate binding affinity with LRRK2 inhibitors. Fragment hit-derived arylpyrrolo[2,3-<i>b</i>]pyridine LRRK2 inhibitors underwent structure-guided optimization using this crystallographic surrogate. LRRK2-pSer935 HEK293 IC<sub>50</sub> data for <b>22</b> were consistent with binding to Ala2016 in LRRK2 (equivalent to Ala147 in CHK1 10-point mutant structure). Compound <b>22</b> was shown to be potent, moderately selective, orally available, and brain-penetrant in wild-type mice, and confirmation of target engagement was demonstrated, with LRRK2-pSer935 IC<sub>50</sub> values for <b>22</b> in mouse brain and kidney being 1.3 and 5 nM, respectively.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is a neurodegenerative disorder typically characterized by motor symptoms of resting tremor, slowness of movement and muscular rigidity, as well as nonmotor symptoms such as pain and depression.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Pathologically, the disease is identified by the loss of dopaminergic neurons, with a consequent decrease in dopamine levels in the brain, and by aggregation of the protein α-synuclein in the dopaminergic neurons. These aggregations, known as Lewy bodies, are composed of insoluble α-synuclein, associated with other proteins such as ubiquitin.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Current PD therapies aim at increasing the dopamine levels in areas innervated by dopaminergic neurons in the brain; none, however, address the underlying disease-causing problem. Many alternative approaches to treating PD are therefore under investigation,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> one of which is inhibition of leucine-rich repeat kinase 2 (LRRK2).</div><div class="NLM_p">LRRK2 is a 2527 amino acid, multidomain protein involved in catalyzing phosphorylation and GTP-GDP hydrolysis,<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> and its downstream substrates include a subset of Rab GTPases.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Evidence showing a relationship between LRRK2 and the pathogenesis of PD is mounting.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Single nucleotide polymorphisms in the functional domains of LRRK2 have been associated with familial and sporadic PD,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and importantly, the clinical features of PD associated with LRRK2 mutations cannot be distinguished from those featuring in idiopathic PD.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This strongly suggests a common pathogenic mechanism and that LRRK2 activity is a rate-limiting factor in PD progression.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Several LRRK2 pathogenic variants have been identified in PD patients,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> most commonly the G2019S substitution in the activation loop of the kinase domain of the protein.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> G2019S PD is inherited in an autosomal dominant fashion, suggesting a gain-of-function mutation of the LRRK2 protein.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In support of this hypothesis, biochemical studies on G2019S, as well as I2020T mutants, showed increased kinase activity of LRRK2.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This suggests a causal involvement of overactive LRRK2 in the pathogenesis of familial forms of PD. Thus, inhibitors of LRRK2, including the G2019S mutant, could be used as disease modifying treatment in familial PD.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26">(19-26)</a></div><div class="NLM_p">LRRK2 kinase domain inhibitors previously reported (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) range from broad spectrum kinase inhibitors such as staurosporine <b>1</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> to more selective inhibitors such as aminopyrimidobenzodiazepinone <b>2</b> (LRRK2-IN-1),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> which have poor CNS penetration. Further efforts have led to the discovery of CNS penetrant, selective inhibitors such as arylbenzamide <b>3a</b> (GSK2578215A),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> aminopyrimidine <b>4a</b> (GNE-7915),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> pyrrolopyrimidines <b>5</b> (PF-06447475)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and <b>6</b> (JH-II-127),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> indazole <b>7</b> (MLi-2),<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> and aminopyridine <b>8</b>.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> There has not yet, however, been a report on the progression of a compound into the clinic, which would require sufficient target engagement and an acceptable pharmacokinetic and safety profile.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative set of reported LRRK2 inhibitors <b>1</b>–<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The design of LRRK2 inhibitors has been impeded in part by the complexity of this large multidomain protein such that stable, soluble, crystallizable kinase domain constructs have not yet been obtained.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Discovery efforts have primarily used homology models based on other kinases with similar sequence identity in the ATP binding site of LRRK2, such as ALK,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> B-Raf,<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(41-44)</a> ERK2,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> JAK2,<a onclick="showRef(event, 'ref30 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref30 ref45 ref46 ref47">(30, 45-47)</a> IRAK4,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Lck,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> MLK1,<a onclick="showRef(event, 'ref35 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref35 ref50 ref51 ref52">(35, 50-52)</a> ROCK1<a onclick="showRef(event, 'ref29 ref53'); return false;" href="javascript:void(0);" class="ref ref29 ref53">(29, 53)</a> or TAK1,<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> or analysis of ligand-bound X-ray crystal structures with off-target kinases such as TTK,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> MST3,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> or Tyk2<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> to rationalize selectivity. Roco4, a LRRK2 homolog from amoeba, has been used to approximate some aspects of the human LRRK2 ATP binding site.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> More recently, ligand bound crystal structures of selective LRRK2 inhibitors in complex with a humanized form of Roco4 have been described, in which two point mutations give the surrogate increased resemblance to LRRK2.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">We report herein the design of a LRRK2 kinase domain surrogate obtained by introduction of point mutations into checkpoint kinase 1 (CHK1). The resulting X-ray crystal structures of the proteins in complex with known literature inhibitors of LRRK2 rationalized compound potency and selectivity. Further validation of the surrogates was undertaken by comparing the binding affinity of LRRK2 inhibitors with the mutant proteins and their LRRK2 activity. The utility of the crystallographic surrogate approach was then demonstrated in the optimization of a series of arylpyrrolo[2,3-<i>b</i>]pyridine LRRK2 inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The search for a suitable template for a LRRK2 surrogate was initiated by aligning the LRRK2 kinase domain sequence (residues 1873–2141) to all kinase structures in the RCSB Protein Data Bank (PDB).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Only kinases with X-ray structures determined at a resolution of 2.6 Å or better were analyzed further. The kinase affording the highest sequence identity was mixed-lineage kinase 1 (MLK1), which was 33.8% identical to the LRRK2 kinase domain; indeed, MLK1 has formed the basis of several LRRK2 homology models previously described.<a onclick="showRef(event, 'ref35 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref35 ref50 ref51 ref52">(35, 50-52)</a> To ensure sufficient kinase family coverage in the template search, a minimum sequence identity of 20% was used to select kinases for ATP binding site similarity assessment. Similarity was estimated by identifying all residues within 5 Å of staurosporine <b>1</b> binding (obtained via X-ray or docking) and comparing those to the LRRK2 kinase domain. The list of potential surrogate templates was further prioritized if kinases showed >50% ATP binding site similarity to LRRK2 and have a nonaromatic gatekeeper residue. This led to a final selection of 10 kinases as potential starting points for a LRRK2 surrogate (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Template Selection for LRRK2 Kinase Domain Surrogate</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">sequence identity (%)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">binding site similarity (%)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">gatekeeper residue<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MLK1</td><td class="colsep0 rowsep0" align="char" char=".">33.8</td><td class="colsep0 rowsep0" align="char" char=".">57.1</td><td class="colsep0 rowsep0" align="left">Met</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMPKa2</td><td class="colsep0 rowsep0" align="char" char=".">32.3</td><td class="colsep0 rowsep0" align="char" char=".">71.4</td><td class="colsep0 rowsep0" align="left">Met</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMK4</td><td class="colsep0 rowsep0" align="char" char=".">32.2</td><td class="colsep0 rowsep0" align="char" char=".">57.1</td><td class="colsep0 rowsep0" align="left">Ile</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLK4</td><td class="colsep0 rowsep0" align="char" char=".">32.0</td><td class="colsep0 rowsep0" align="char" char=".">52.4</td><td class="colsep0 rowsep0" align="left">Leu</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aurora A</td><td class="colsep0 rowsep0" align="char" char=".">31.3</td><td class="colsep0 rowsep0" align="char" char=".">52.4</td><td class="colsep0 rowsep0" align="left">Leu</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MST1</td><td class="colsep0 rowsep0" align="char" char=".">30.8</td><td class="colsep0 rowsep0" align="char" char=".">61.9</td><td class="colsep0 rowsep0" align="left">Met</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MARK3</td><td class="colsep0 rowsep0" align="char" char=".">30.4</td><td class="colsep0 rowsep0" align="char" char=".">57.1</td><td class="colsep0 rowsep0" align="left">Met</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHK1</td><td class="colsep0 rowsep0" align="char" char=".">29.1</td><td class="colsep0 rowsep0" align="char" char=".">52.4</td><td class="colsep0 rowsep0" align="left">Leu</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK3</td><td class="colsep0 rowsep0" align="char" char=".">28.4</td><td class="colsep0 rowsep0" align="char" char=".">57.1</td><td class="colsep0 rowsep0" align="left">Met</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTK2B</td><td class="colsep0 rowsep0" align="char" char=".">25.4</td><td class="colsep0 rowsep0" align="char" char=".">57.1</td><td class="colsep0 rowsep0" align="left">Met</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Molecular Operating Environment (MOE)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was used for kinase sequence identity and similarity calculations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">In comparison with LRRK2 kinase domain (1873–2141).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Binding site is defined as all residues within 5 Å of bound staurosporine (<b>1</b>).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Met1947 in LRRK2.</p></div></div></div><div class="NLM_p">Of the potential LRRK2 surrogate templates, CHK1 was selected as the starting point, guided by previous in-house experience of the expression, purification, and crystallization of CHK1 constructs to enable ligand-bound X-ray crystal structures, and their utility in the design of novel inhibitors of this kinase for the treatment of cancer.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> Additionally, it has been previously reported that certain CHK1 inhibitors can inhibit LRRK2,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> which further suggested similarities in the ATP binding sites of these kinases. An initial selection of 10 residues in CHK1 to be mutated (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was based on their <4 Å proximity to <b>1</b> in the published ligand bound X-ray structure with CHK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR">1NVR</a> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A).<a onclick="showRef(event, 'ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref64 ref65">(64, 65)</a> These residues form key areas of the ATP binding site of the kinase domain, which encompass the hinge, gatekeeper, and activation loop. Importantly, the list of mutations also includes areas known for kinase selectivity. Two further constructs, an 8- and 12-point mutant of CHK1, were also considered. The latter contains two additional mutations in the flexible glycine-rich loop of the ATP binding site (Ser19 and Phe20, equivalent to Ser1889 and Phe1890 in LRRK2). The 8-pt mutant is identical to the 10-pt mutant but does not bear the F149Y mutation in the activation loop of CHK1 (equivalent to Tyr2018 in LRRK2), nor does it have the G150S mutation (equivalent to the G2019S mutation in LRRK2). Equivalent residues in Roco4<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and the humanized Roco4,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> which have been previously reported as LRRK2 surrogates, are also shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of selected LRRK2 WT and G2019S mutant ATP binding site residues, with equivalents in CHK1 WT, and 8-, 10-, and 12-pt mutants, as well as Roco4 WT<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and humanized Roco4 mutant.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Mutations are highlighted in bold and red. Glycine loop is shaded in gray. Salt bridge residues (SB) are shaded in tan, gatekeeper (GK) residues shaded in blue, hinge residues shaded in green, and activation loop is shaded in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) X-ray structure of <b>1</b> (cyan)/CHK1 (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR">1NVR</a>). (B) X-ray structure of <b>1</b> (cyan)/CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR">5OOR</a>). Ten residues mutated from CHK1 are highlighted in green. Key intermolecular contacts are shown as dashed lines (polar ligand to backbone contacts of <3.3 Å in blue; polar ligand to side chain contacts of <3.3 Å in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The CHK1 10-pt mut was investigated as a potential LRRK2 kinase domain surrogate in the first instance and was successfully expressed in insect cells infected with baculovirus, purified, and then crystallized. Following the soak of a protein crystal with <b>1</b>, X-ray data were collected and a crystal structure of the resulting protein–ligand complex was obtained (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Reassuringly, binding of the amide moiety of <b>1</b> to the hinge via the backbone of Ala87 and Glu85 (equivalent to Ala1950 and Glu1948 in LRRK2, and Cys87 and Glu85 in CHK1) is similar to that seen in CHK1 structure, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR">1NVR</a> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). A crystal structure of adenylyl imidodiphosphate (AMP-PNP) in complex with CHK1 10-pt mut was also obtained, and interactions with the ATP binding site are as expected (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOP">5OOP</a>).</div><div class="NLM_p">With the new LRRK2 kinase domain surrogate in hand, its further usefulness was investigated by soaking selective LRRK2 inhibitors with apo CHK1 10-pt mut crystals and obtaining ligand-bound X-ray crystal structures. A structure of <b>2</b> with CHK1 10-pt mut was obtained (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A) and compared with the published crystal structure of the same compound in complex with humanized Roco4 kinase (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZM">4YZM</a>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Hydrogen bonds between the backbone carbonyl and NH of Ala87 in the hinge and the aminopyrimidine moiety of <b>2</b> are equivalent to those seen between Val1108 and the same ligand in the humanized Roco4 structure. Similarly, the phenyl moiety of the tricyclic core is accommodated by the adenine binding pocket of CHK1 10-pt mut and makes contact with Ala147 (equivalent to Ala2016 in LRRK2), which is 3.6 Å away. The other side of the ring is partly covered by the hinge, with the methoxy substituent 3.9 Å away from Leu86 (equivalent to Leu1949 in LRRK2). This interaction is significant for kinase selectivity, since analysis has shown<a onclick="showRef(event, 'ref45 ref55'); return false;" href="javascript:void(0);" class="ref ref45 ref55">(45, 55)</a> that 40% of kinases have a more sterically encumbered Tyr and 18% have a Phe in the position equivalent to 1949 (as shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A with CHK1), whereas 25% of kinases have Leu. In both structures, the electron density of the (4-methylpiperazin-1-yl)piperidinyl moiety is weak, since it is solvent exposed and likely very flexible. A difference in the glycine loop placement was observed between the two structures, however. CHK1 10-pt mut incorporates Tyr20, whereas humanized Roco4 has Phe1037, identical to Phe1890 in LRRK2. Tyr20 of CHK1 10-pt mut makes a polar interaction with the carbonyl group of <b>2</b>, and Lys38 of the salt bridge (Lys1906 in LRRK2) is more distant. In contrast, the equivalent Lys1055 in the humanized Roco4 structure makes a polar contact with the same carbonyl group of the ligand.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) X-ray structure of <b>2</b> (cyan)/CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOT">5OOT</a>). Ten residues mutated from CHK1 are highlighted in green. (B) X-ray structure of <b>2</b> (cyan)/humanized Roco4 kinase (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZM">4YZM</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Two residues mutated from Roco4 kinase are highlighted in green. Residues different from CHK1 12-pt mut and LRRK2 G2019S are highlighted in salmon pink. (C) X-ray structure of <b>2</b> (cyan)/CHK1 12-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ6">5OQ6</a>). Twelve residues mutated from CHK1 are highlighted in green. (D) X-ray structure of <b>2</b> (cyan)/CHK1 8-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ5">5OQ5</a>). Eight residues mutated from CHK1 are highlighted in green. Key intermolecular contacts are shown as dashed lines (polar ligand to backbone contacts of <3.3 Å in blue; polar ligand to side chain contacts of <3.3 Å in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To address the sequence differences in the glycine rich loop, a crystal structure of <b>2</b> in complex with a CHK1 12-pt mutant was also obtained (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C), in which Ser19 and Phe20 (equivalent to Ser1889 and Phe1890 in LRRK2) are present. The glycine loop also remains in the open position in this structure, and Lys38 (Lys1906 in LRRK2) remains in the same position. It is considered that the flexibility of the glycine loop would enable its adjustment to the bound ligand, regardless of whether residue 20 is Tyr or Phe, and should not be overinterpreted in the structures of complexes with surrogate kinases.</div><div class="NLM_p">A crystal structure of <b>2</b> in complex with a CHK1 8-pt mutant was also obtained (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>D), identical to the 10-pt mutant but without the F149Y and G150S mutations. This was in agreement with the structure obtained with the 10- and 12-point mutants, other than the placement of the flexible (4-methylpiperazin-1-yl)piperidinyl solubilizer. All three structures of the CHK1 mutant complexes with <b>2</b> reveal they are good models for LRRK2, as residue 19, 20, and 147 mutations do not play a significant role in the binding of this ligand.</div><div class="NLM_p">An X-ray crystal structure of <b>3a</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in complex with CHK1 10-pt mut was attempted to further explore the utility of CHK1 mutants as crystallographic surrogates for LRRK2. Due to the low solubility of the ligand and its immediate crystallization in the soaking solution, only partial occupancy of <b>3a</b> in the binding site was observed, with the quality of electron density maps and resulting model below accepted standards. Pleasingly, however, a structure of the analogous arylbenzamide <b>3b</b><a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> in complex with CHK1 10-pt mut (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>) was obtained. The ligand adopts a conformation that accommodates an intramolecular hydrogen bond between the arylbenzamide NH and the ether oxygen atom (2.6 Å) and is sandwiched between Leu15 of the glycine loop and Leu137, already present in CHK1, and equivalent to Leu1949 and Leu2001 in LRRK2. The crystal structure also shows a polar ligand to backbone interaction between the amide carbonyl of the ligand and mutated Ala87 in the hinge (equivalent to Ala1950 in LRRK2), as well as a hydrophobic contact between the 3-pyridyl moiety of <b>3b</b>, Ile68, and gatekeeper Met84 (equivalent to Ile1933 and Met1947 in LRRK2). The <i>N</i>-methylpiperazinyl moiety occupies a space next to Ser88 and Leu86 (Ser1951 and Leu1949 in LRRK2), known to impart selectivity for LRRK2 over other kinases with a Phe or Tyr at this position.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of <b>3b</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP2">5OP2</a>). Residues mutated from CHK1 are highlighted in green. Key polar contact of <3.3 Å are in blue dashed line. Likely intramolecular hydrogen bond is indicated in yellow dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding mode of <b>3b</b> in CHK1 10-pt mut is consistent with both that reported for <b>3a</b> in a LRRK2 homology model based on ROCK1,<a onclick="showRef(event, 'ref29 ref53'); return false;" href="javascript:void(0);" class="ref ref29 ref53">(29, 53)</a> in which the ligand avoids steric clash with Ala2106 in LRRK2 (Ala147 in CHK1 10-pt mut, 4.2 Å from the pyridyl moiety of the ligand), and also MLK1-based homology modeling studies on analogous arylbenzamides.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Two further X-ray crystal structures of <b>3b</b> in complex with the CHK1 8- and 12-pt mutants were also obtained (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ7">5OQ7</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ8">5OQ8</a>), and these structures are highly analogous to that obtained with CHK1 10-pt mut. On the basis of the three structures of the CHK1 mutant complexes with <b>3b</b>, as well as structures of complexes with <b>2</b>, we concluded that the CHK1 10-pt mut is a good representation of a LRRK2 kinase domain surrogate, and that protein was then used for all further structure determinations.</div><div class="NLM_p">A crystal structure of <b>4a</b> in complex with CHK1 10-pt mut was also obtained (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A) and compared with the published structure of analogous <b>4b</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> bound to humanized Roco4 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The hinge binding aminopyrimidine moiety of <b>4a</b> forms characteristic hydrogen bonds with the backbone carbonyl and NH of Ala87 in CHK1 10-pt mut (Ala1950 in LRRK2), which are equivalent to those seen between <b>4b</b> and Val1108 in the humanized Roco4 structure. The trifluoromethyl substituent of <b>4a</b> forms multiple hydrophobic contacts with Val23 of the glycine loop, Ile68, Met84 gatekeeper, Leu137 and Ala147 of the activation loop, which are comparable with interactions between the same moiety of <b>4b</b> and Val1040, Val1091, Met1105, Leu1161, and Ala1176 in the humanized Roco4 structure. The trifluoromethyl group of <b>4a</b> makes a water mediated contact with Glu55 (Glu1920 in LRRK2) of the α-helix, in a similar fashion to that of <b>4b</b> and Glu1078 of Roco4. A water mediated contact between the ligand and Asp148 (Asp2017 in LRRK2) of the activation loop is not observed, as is seen with the equivalent Asp1177 in the Roco4 structure, since Asp148 makes a hydrogen bond contact with Ser150, equivalent to Ser2019 in the LRRK2 G2019S mutant. Additionally, a water mediated contact is observed between the fluoro substituent of <b>4a</b> and Ser91 in the hinge (equivalent to Ser1954 in LRRK2). This residue remains as Asp1112 in the Roco4 structure. The methoxy group of <b>4a</b> occupies space in the roof of the hinge created by the backbone of Ser88 and residue of Leu86, equivalent to Pro1109 (which confers additional rigidity on the protein backbone in comparison with LRRK2) and Leu1107 in the Roco4 structure. The morpholino moiety of <b>4a</b> has some electron density; this part is solvent exposed and not recognized specifically by the kinase domain.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure of (A) <b>4a</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP4">5OP4</a>) and (B) <b>4b</b> (cyan) in complex with humanized Roco4 kinase (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZN">4YZN</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Mutated residues are highlighted in green. Residues different from CHK1 10-pt mut and LRRK2 G2019S in humanized Roco4 are highlighted in salmon pink. Polar intermolecular contacts of <3.3 Å are shown as blue dashed lines. Likely water-mediated hydrogen bonds are indicated in yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar relationships between LRRK2 selectivity and binding mode in the surrogate were observed in other inhibitor chemotypes disclosed more recently. Indazole <b>7</b> bears a 1-methylcyclopropoxy substituent, the methyl group of which is placed 4.0 Å from Ala147 in the CHK1 10-pt mut crystal structure (Ala1950 in LRRK2), while the cyclopropyl moiety is enclosed by the glycine-rich loop, including hydrophobic interaction with Val23 (Val1893) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). The 2,6-dimethylmorpholinyl moiety occupies the space next to Leu86, analogous to Leu1949 in LRRK2. These interactions are in agreement with those observed in an ERK2-dervived homology model.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Aminopyridine <b>8</b><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> adopts a conformation in which one methyl group of its isopropyl substituent is 4.2 Å away from Ala147 and C6 of the pyridine ring sits 3.7 Å from Leu86; it is likely that both hydrophobic contacts increase selectivity for LRRK2.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray structures of (A) indazole <b>7</b> and (B) 2-aminopyridine <b>8</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPB">5OPB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPR">5OPR</a>). Mutated residues are highlighted in green. Polar intermolecular contacts of <3.3 Å are shown as blue dashed lines. Distances between ligands and Ala147 are shown as gray dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The LRRK2 G2019S activity of 41 LRRK2 inhibitors previously described in the literature, including 2-aminopyridines<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and also pyrrolopyridines disclosed herein, was determined and compared with binding affinity for CHK1 10-pt mut in a LanthaScreen europium binding assay (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). The correlation coefficient (<i>r</i><sup>2</sup>) was 0.57 and the Spearman’s ρ rank correlation coefficient was 0.77, showing a reasonable statistical dependence between the two variables. In contrast, there was no correlation between LRRK2 G2019S activity and CHK1 binding affinity (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf" class="ext-link">Supporting Information</a>), thus providing further evidence for the utility of the CHK1 10-pt mutant as a LRRK2 surrogate.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plot of <i>p</i>(LRRK2 G2019S Lanthascreen activity cK<sub>i</sub>) vs <i>p</i>(CHK1 10-pt mut binding affinity cK<sub>i</sub>) for 41 LRRK2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding affinity of a subset of 32 LRRK2 inhibitors was also determined for the CHK1 8- and 12-pt mutants (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf" class="ext-link">Supporting Information</a>). There was a lower correlation between CHK1 12-pt mut affinity and their LRRK2 G2019S activity (<i>r</i><sup>2</sup> = 0.27), CHK1 8-pt mut affinity and their LRRK2 G2019S activity (<i>r</i><sup>2</sup> = 0.25), and CHK1 8-pt mut affinity and their LRRK2 WT activity (<i>r</i><sup>2</sup> = 0.17). These data further supported the choice of the CHK1 10-pt mutant as the preferred LRRK2 surrogate.</div><div class="NLM_p">Pyrrolopyrimidines<a onclick="showRef(event, 'ref31 ref32 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref68 ref69 ref70">(31, 32, 68-70)</a> and pyrrolopyridines<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> have been under investigation as LRRK2 inhibitors by a number of groups. A crystal structure of highly potent and brain penetrant <b>5</b> in complex with CHK1 10-pt mut was obtained (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). Binding of the ligand to the hinge via the backbone of Ala87 and Glu85 (equivalent to Ala1950 and Glu1948 in LRRK2) was observed, and the bicyclic core is positioned 3.6 Å from Leu86 (Leu1949 in LRRK2) in the roof of the hinge. The nitrile group makes a weak hydrogen bond to Lys38 (3.7 Å) and a water mediated contact with Glu55 of the α-helix. These data are in good overall agreement with the published structure of <b>5</b> in complex with MST3 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4U8Z">4U8Z</a>);<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> however MST3 does not bear the Y101L mutation, equivalent to Leu86 in CHK1 10-pt mut, and Leu1949 in LRRK2, which may enable binding of more selective ligands.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray crystal structures of pyrrolopyrimidines (A) <b>5</b> and (B) <b>6</b> and (C) pyrrolopyridine <b>9</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP5">5OP5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP7">5OP7</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPS">5OPS</a>). Residues mutated from CHK1 are highlighted in green. Key polar contacts of <3.3 Å are indicated with blue dashed lines. Likely water-mediated hydrogen bonds are indicated in yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A crystal structure of CHK1 10-pt mut and <b>6</b>, reported as a highly potent, selective, and brain penetrant LRRK2 inhibitor,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> was also obtained (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B). Key ligand–protein interactions are consistent with a reported docking study based on Roco4 kinase, which predicted three hydrogen bonds from the pyrrolopyrimidine to the hinge via Glu1948 and Ala1950. Additionally, docking suggested the possibility of a halogen interaction with the gatekeeper Met1947 and the 5-chloro substituent of the ligand. The equivalent interactions with Glu85, Ala87, and Met84 in CHK1 10-pt mut are observed. In addition, the 5-chloro substituent makes a water mediated interaction with the salt bridge comprising Lys38 and Asp148, as well as Glu55. The methoxy group sits between the Leu86 residue and Ser88 backbone in the hinge extension, and the amide carbonyl sits out-of-plane, making a water-mediated contact with Asp94, so that the morpholine substituent tucks under the glycine loop. Asp94 is equivalent to Arg1957 in LRRK2, His1115 in Roco4, and Asp109 in MST3; there is therefore potential in LRRK2 for a direct contact between Arg1957 and the amide carbonyl, which is not observed in these surrogates.</div><div class="NLM_p">The present authors identified pyrrolopyridine <b>9</b><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> [LRRK2 G2019S IC<sub>50</sub> = 415 nM, cK<sub>i</sub> = 27 nM,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> ligand efficiency (LE)<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> of 0.58] in a biochemical screen of an in-house library focused on low molecular weight compounds with known kinase hinge binding motifs (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This was a representative of fragment hit 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (48% at 200 μM, estimated <i>K</i><sub>i</sub> of 15 μM, LE of 0.74) which arose from a fragment library screen which was also conducted using the same biochemical assay format. An X-ray crystal structure of <b>9</b> in complex with CHK1 10-pt mut was obtained (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C). Binding of <b>9</b> to the hinge via the backbone of Ala87 and Glu85 (equivalent to Ala1950 and Glu1948 in LRRK2) was observed, and the bicyclic core is positioned 3.9 Å from Leu86 (Leu1949 in LRRK2) in the roof of the hinge. The nitrile moiety sits close to the Met84 gatekeeper (Met1947 in LRRK2) and makes water mediated interactions with the salt bridge comprising Asp148 and Lys38, as well as a water mediated contact with Glu55 of the α-helix. Subsequent screening of fragments <b>10</b><a onclick="showRef(event, 'ref72 ref75'); return false;" href="javascript:void(0);" class="ref ref72 ref75">(72, 75)</a> (cK<sub>i</sub> ≈ 3 μM, LE = 0.68) and <b>11</b><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> (cK<sub>i</sub> ≈ 2 μM, LE = 0.65) indicated that a significant binding efficiency arose from the polar interactions in the hinge and water mediated contact with the salt bridge via the nitrile.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. LRRK2 G2019S and WT Lanthascreen Activity of Pyrrolo[2,3-<i>b</i>]pyridines <b>9</b>–<b>22</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">LRRK2 Lanthascreen activity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">G2019S</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">WT</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">cK<sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">LE</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">cK<sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">LE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-hydroxyphenyl</td><td class="colsep0 rowsep0" align="char" char=".">415</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">487</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">46522</td><td class="colsep0 rowsep0" align="char" char=".">2702</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">101080</td><td class="colsep0 rowsep0" align="char" char=".">3026</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">37765</td><td class="colsep0 rowsep0" align="char" char=".">2193</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char=".">1178</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td><td class="colsep0 rowsep0" align="char" char=".">954</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">thiophen-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">870</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">1279</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">9271</td><td class="colsep0 rowsep0" align="char" char=".">538</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char=".">7531</td><td class="colsep0 rowsep0" align="char" char=".">225</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">1275</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">784</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char=".">1983</td><td class="colsep0 rowsep0" align="char" char=".">136</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-methylphenyl</td><td class="colsep0 rowsep0" align="char" char=".">27838</td><td class="colsep0 rowsep0" align="char" char=".">1617</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">26163</td><td class="colsep0 rowsep0" align="char" char=".">783</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-methylphenyl</td><td class="colsep0 rowsep0" align="char" char=".">195</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-methylphenyl</td><td class="colsep0 rowsep0" align="char" char=".">1639</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td><td class="colsep0 rowsep0" align="char" char=".">4135</td><td class="colsep0 rowsep0" align="char" char=".">124</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td><td class="colsep0 rowsep0" align="char" char=".">354</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td><td class="colsep0 rowsep0" align="char" char=".">247</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char=".">176</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">140</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-methylphenyl</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">250 pM protein, 1.3 mM ATP.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">1 nM protein, 1.3 mM ATP; nd, not determined.</p></div></div></div><div class="NLM_p">The phenol substituent of <b>9</b>, positioned between the flexible Gly loop, Ala147, and Asp148, underwent initial optimization. The corresponding phenyl and thiophen-3-yl analogues <b>12</b> and <b>13</b><a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> had activities within 3-fold of the start point <b>9</b>. Chloro or methyl substitution of the phenyl ring of <b>9</b> (<b>14</b>–<b>19</b>) indicated that the meta-substituted examples <b>15</b> and <b>18</b> were better tolerated than ortho or para. This was further confirmed by 3-methoxy derivative <b>20</b> (cK<sub>i</sub> = 24 nM). 6-Amino substitution of the pyrrolopyridine core of <b>12</b> was carried out with a view to enhancing interaction with the hinge region of the ATP binding site of the kinase. This gave rise to <b>21</b> (cK<sub>i</sub> = 12 nM), which was 7-fold more potent on LRRK2. A similar uplift in potency was observed with the 6-amino derivative of <b>18</b>; <b>22</b> had a LRRK2 G2019S cK<sub>i</sub> of 2 nM while maintaining a high LE of 0.62. LRRK2 WT activities of compounds were 1- to 4-fold within those determined on LRRK2 G2019S; <b>22</b> had a LRRK2 WT cK<sub>i</sub> of 0.5 nM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), however, these differences were not considered significant.</div><div class="NLM_p">An X-ray crystal structure of <b>22</b> in complex with CHK1 10-pt mut was obtained (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>A). As also seen with the original hit <b>9</b>, binding of the ligand to the hinge via the backbone of Ala87 and Glu85 (equivalent to Ala1950 and Glu1948 in LRRK2) was observed. The nitrile group is also placed next to the Met84 gatekeeper and links via waters to the salt bridge comprising Lys38, Glu55, and Asp148. The 3-tolyl substituent is bounded by the Gly loop, with which it likely makes van der Waals interactions. The methyl group points toward a small hydrophobic pocket formed of Ala147 and the stem of Asp148. Ala147, equivalent to Ala2016 in LRRK2, is not well conserved across the kinome, and interaction in this region of space may impart selectivity for LRRK2.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. X-ray crystal structures of (A) <b>22</b> and (B) <b>23</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPU">5OPU</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPV">5OPV</a>). Residues mutated from CHK1 are highlighted in green. Key polar contacts of <3.3 Å are indicated with blue dashed lines. Likely intramolecular and water-mediated hydrogen bonds are indicated in yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Phosphorylation sites, including Ser935 and Ser1292, have been used as pharmacodynamic markers for LRRK2 target engagement in vitro and in vivo.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a> Further evidence for the interaction of <b>22</b> with Ala2016 was therefore obtained from in-cell Western (ICW) assay based LRRK2 IC<sub>50</sub> values, which were determined using HEK293 LRRK2-pSer935 assays in either a 96-well (transient transfected cells) or a 384-well setup (BacMam transduced cells). <b>22</b> had LRRK2-pSer935 IC<sub>50</sub> values of 24 nM, 40 nM, and 471 nM for LRRK2 WT, G2019S, and A2016T, respectively (<a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a> and <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, 96-well assay). In a 384-well setup, <b>22</b> showed similar potencies in ICW LRRK2 G2019S cell-based Ser935 and Ser1292 phosphorylation assays, with IC<sub>50</sub> values of 70 nM and 61 nM, respectively (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0011.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) In-cell Western (ICW) assay data showing inhibition of LRRK2-Ser935 phosphorylation in HEK293 cells transiently overexpressing LRRK2 WT, and the G2019S and A2016T mutants, by <b>22</b>. (B) Image of 96-well microplate scan from the LI-COR Odyssey, pertaining to ICW data in (A). Red and green dots denote dye colors for total LRRK2 and pSer935 antibodies, respectively; red and yellow/orange indicate dephosphorylated and phosphorylated LRRK2, respectively. In the assay, compound <b>23</b> (red) and DMSO (yellow/orange) were used as positive and negative controls, respectively (in duplicate determination). The bottom row (black) is mock transfected HEK293 cells, where no immunoreactivity can be observed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cell-Based IC<sub>50</sub> Values of <b>22</b> on LRRK2 WT, G2019S, and A2016T</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">LRRK2-pSer935 (96-well)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">LRRK2-pSer935 (384-well)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">LRRK2-pSer1292 (384-well)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">LRRK2 variant</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">7.61 ± 0.06 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">7.17 ± 0.20 (<i>n</i> = 6)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">G2019S</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">7.40 ± 0.01 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">7.16 ± 0.16 (<i>n</i> = 6)</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">7.21 ± 0.17 (<i>n</i> = 3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A2016T</td><td class="colsep0 rowsep0" align="left">471</td><td class="colsep0 rowsep0" align="left">6.33 ± 0.05 (<i>n</i> = 3)</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Transient transfection LI-COR ICW assay (HEK293).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">BacMAM LI-COR ICW assay (HEK293); nd, not determined.</p></div></div></div><div class="NLM_p">The ∼10-fold drop in potency of <b>22</b> between LRRK2 WT and G2019S when compared to A2016T that is observed in the cell-based assay is consistent with previous studies with inhibitor resistant mutants<a onclick="showRef(event, 'ref29 ref53'); return false;" href="javascript:void(0);" class="ref ref29 ref53">(29, 53)</a> and in agreement with the crystallographic evidence obtained from the CHK1 10-pt mut that <b>22</b>, via the methyl group on the tolyl substituent, engages with Ala2016 in both human LRRK2 WT and G2019S.</div><div class="NLM_p">Compound <b>22</b> had moderate permeability in a monolayer of Madin–Darby canine kidney (MDCK) epithelial cells transfected with human multidrug resistance 1 (MDR1), which expresses human P-gp. The apparent permeability coefficient in the apical to basolateral direction (<i>P</i><sub>app</sub>(A:B)) was 8.6 cm/s × 10<sup>–6</sup> with a low efflux ratio (B:A/A:B of 0.7). Rat and human microsomal clearance was also moderate (9 and 1.5 L kg<sup>–1</sup> h<sup>–1</sup>, respectively). Pharmacokinetic and pharmacodynamic profiling on <b>22</b> in wild-type mice was performed using LRRK2 phosphorylation at serine 935 as the readout for LRRK2 inhibition (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>). Following 25 mg/kg oral dosing of <b>22</b> in wild-type mice, full LRRK2 inhibition in mouse brain was observed for at least 12 h. The mean unbound drug concentration at 12 h was 10 ng/g (∼40 nM), and the <i>K</i><sub>p,uu</sub> (concentration ratio of unbound drug in brain to blood) was 0.12. LRRK2-pSer935 levels were back to 80% 24 h after dosing.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0012.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Pharmacokinetic and pharmacodynamic profile of <b>22</b> in mouse brain following 25 mg/kg po dosing: (A, B) Western blot images of total LRRK2 and LRRK2-pSer935 immunoreactivity from mouse brain lysates at various time points after dosing of compound <b>22</b>; (C) exposure of <b>22</b> over 24 h; (D) relative LRRK2-pSer935 levels in mouse brain over 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further in vivo exploration at <i>C</i><sub>max</sub> in wild-type mice found that LRRK2-pSer935 IC<sub>50</sub> values for <b>22</b> in mouse brain and kidney were 1.3 nM and 5 nM, respectively (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>A and <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>B).</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0013.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Dose–response relationship of <b>22</b> in mouse brain and kidney: (A) mouse brain studies (<i>n</i> = 3); (B) mouse kidney studies (<i>n</i> = 2). LRRK2-pSer935 levels were assessed 1 h after po dosing. The data were used to estimate IC<sub>50</sub> values for <b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Assessment of the in vitro kinase selectivity of <b>22</b> by a DiscoveRx KINOMEscan assay at 1 μM identified 21 off-target hits with % control of <5% (i.e., >95% inhibition), including JAK3, Tyk2, and TTK, indicating that further improvement to selectivity would be required. Since the KINOMEscan assay assesses kinase binding affinities in the absence of ATP, a more physiologically relevant method is to perform cell-based kinase profiling that takes differences in the <i>K</i><sub>m</sub> value for ATP of the individual kinases into account. Thus, <b>22</b> was also assessed in cultured human peripheral blood mononuclear cells (PBMCs) using ActivX KiNativ technology<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> in order to give further indication of LRRK2 potency and a wider assessment of kinase selectivity. In PBMCs, <b>22</b> inhibited no other kinase than LRRK2 (59% inhibition) at 100 nM and gave 91% inhibition on LRRK2 at 1 μM, with no inhibition of other kinases of >60% (including JAK3; Tyk2 and TTK were not present in this panel). In total, seven off-target kinases were significantly inhibited (>35%) at 1 μM, including GSK3α, IKKβ, PKD1–3, TAO1, and TAO3. <b>22</b> also underwent broad in vitro pharmacology profiling at 1 μM. Although <b>22</b> showed radioligand binding affinity for adenosine A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, and 5-HT<sub>2B</sub> receptors, no significant agonist or antagonist effects were observed at concentrations up to 10 μM in follow-up studies. Compound <b>22</b> was negative in an Ames bacterial mutagenicity study but was positive in an assessment of compound-induced genomic instability in TK6 cells. Further optimization, with a focus on improving potency and kinase selectivity, was therefore required.</div><div class="NLM_p">1-Methyl-1<i>H</i>-pyrazol-3-yl substitution on the primary amino group of <b>22</b> gave rise to Lu AF58786 (<b>23</b>)<a onclick="showRef(event, 'ref75 ref79'); return false;" href="javascript:void(0);" class="ref ref75 ref79">(75, 79)</a> which had increased LRRK2 activity on the G2019S mutant (IC<sub>50</sub> = 8 nM, cK<sub>i</sub> = 0.1 nM) and WT (IC<sub>50</sub> = 3 nM, cK<sub>i</sub> = 0.06 nM (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). As seen in compound <b>22</b>, a trend toward increased activity on LRRK2 WT for <b>23</b> was observed; however the magnitude of this difference was not considered significant. An X-ray crystal structure of <b>23</b> in complex with CHK1 10-pt mut was obtained (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>B) in which the ligand forms the same interactions as <b>22</b>. In addition, <b>23</b> adopts a conformation such that the 6-(1-methyl-1<i>H</i>-pyrazol-3-yl)amino substituent forms an intramolecular hydrogen bond between N2 of the pyrazole and the CH of the pyrrolopyridine core. C4 and C5 of the pyrazole ring also make van der Waals contact with Gly90 in the roof of the hinge (Gly1953 in LRRK2), which likely explains the increased potency on LRRK2.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. LRRK2 G2019S and WT Lanthascreen and Cell-Based Activity, Human Liver Microsomal Clearance, MDR1-MDCK Permeability, and Efflux Ratio of Pyrrolo[2,3-<i>b</i>]pyridines <b>23</b>–<b>34</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0018.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">LRRK2 kinase activity</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">LRRK2 pSer935 HEK293 (384-well)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">G2019S IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">WT IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">G2019S IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">WT IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub>(A:B) (MDR1-MDCK) (cm/s ×10<sup><b>-6</b></sup>)</th><th class="colsep0 rowsep0" align="center" char=".">(B:A)/(A:B)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-methylphenyl</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char=".">112</td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-methylpyridin-2-yl</td><td class="colsep0 rowsep0" align="char" char=".">324</td><td class="colsep0 rowsep0" align="char" char=".">205</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">nd</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5-methylpyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-methylpyridin-4-yl</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">700</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6-methylpyridin-2-yl</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">5-methylpyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">17.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2-methylpyridin-4-yl</td><td class="colsep0 rowsep0" align="char" char=".">108</td><td class="colsep0 rowsep0" align="char" char=".">215</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">580</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">6-methylpyridin-2-yl</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">170</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">27.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">5-methylpyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">2-methylpyridin-4-yl</td><td class="colsep0 rowsep0" align="char" char=".">158</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">1300</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">6-methylpyridin-2-yl</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">250 pM protein, 1.3 mM ATP.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">1 nM protein, 1.3 mM ATP.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">nd, not determined.</p></div></div></div><div class="NLM_p"><b>23</b> also had enhanced activity in the LRRK2 G2019S-pSer935 HEK293 ICW 384-well assay, with IC<sub>50</sub> = 18 nM. The aqueous solubility of crystalline material was low (<0.1 μg/mL); however MDR1-MDCK permeability was moderate (<i>P</i><sub>app</sub>(A:B) = 8.8 cm/s × 10<sup>–6</sup>), and efflux ratio was low (B:A/A:B of 0.6). Rat and human microsomal clearance were 6 and 8.5 L kg<sup>–1</sup> h<sup>–1</sup>, respectively, indicating a disconnect between the two species. Following 10 mg/kg oral dosing of <b>23</b> in mouse, there was no plasma exposure. A vehicle screen, followed by subcutaneous injection in mouse of 2 mg/kg of <b>23</b>, resulted in a maximum brain concentration of 25 ng/g at time points of 30 min and 1 h after dosing. The free brain concentration was ∼0.025 ng/g (corresponding to 0.076 nM, close to the LRRK2 G2019S cK<sub>i</sub> of 0.1 nM), and the <i>K</i><sub>p,uu</sub> was 0.02. Compound <b>23</b> was also assessed in human cultured PBMCs using the ActivX KiNativ assay.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Encouragingly, <b>23</b> gave 83% inhibition at 100 nM on LRRK2 and 93% inhibition at 1 μM. At 100 nM, there was no inhibition of other kinases, and at 1 μM, there was no inhibition of other kinases of >50% other than JAK1 (55%), JAK3 (53%), and JNK1 (71%).</div><div class="NLM_p">Modifications to the structure of <b>23</b> were carried out with a view to optimizing its physicochemical properties, and thus PK profile, for exposure in the CNS (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Removal of the methyl substituent (<b>24</b>) reduced human microsomal clearance significantly. This also led to a reduction in LRRK2 G2019S and WT activity of <b>24</b>, however, likely explained by loss of hydrophobic contact between the methyl group and stem of Asp148 and Ala147 in CHK1 10-pt mut. Replacing R<sup>2</sup> with a range of methylpyridyl substituents was also explored (<b>25</b>–<b>28</b>). This led to a reduction in human microsomal clearance in each case; however, the 4-methylpyridin-2yl analogue <b>25</b> was significantly less active in the LRRK2 G2019S and WT kinase assays. It is likely that introduction of a nitrogen atom at this position would encourage co-planarity between the bicyclic core of the molecule and the pyridyl substituent, thus disrupting hydrophobic contacts with the molecule. Additionally, the nitrogen atom would likely be positioned in the vicinity of the conserved Val23 residue of the Gly loop, with which it would form an unfavorable interaction. Furthermore, <b>25</b>–<b>28</b> had an efflux ratio of >2 and therefore unlikely to have the desired CNS exposure in vivo.</div><div class="NLM_p last">4-Methyl substitution on the pyrazole ring was well tolerated in the LRRK2 enzyme and cell assays (<b>29</b>–<b>31</b>), which is consistent with space being available in the hinge extension adjacent to Ser88 and Leu86, as shown in the crystal structure of <b>23</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>B). Unfortunately, this modification led to increased microsomal clearance and efflux. 4-Chloro substitution on the pyrazole ring was also well tolerated in the LRRK2 enzyme and cell assays. In comparison with methyl derivatives <b>29</b>–<b>31</b>, <b>32</b>–<b>34</b> had lower efflux ratio. This was still in excess of 2, however, and high human microsomal clearance rendered compounds from this series unsuitable for further progression.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of <b>12</b>–<b>21</b> is summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Commercially available <b>11</b> underwent Suzuki cross-coupling with boronic acids to give <b>12</b>–<b>20</b> directly. Treatment of <b>11</b> with <i>m</i>-CPBA, followed by methanesulfonic acid, afforded the <i>N</i>-oxide <b>35</b>. Subsequent treatment of <b>35</b> with dimethyl sulfate and then 7 N ammonia in methanol afforded <b>36</b>, which underwent Suzuki cross-coupling with phenylboronic acid to give <b>21</b>.</div><figure id="sch1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0014.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>12</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArB(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, H<sub>2</sub>O, 150 °C; (b) ArB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, THF, H<sub>2</sub>O, 120 °C; (c) <i>m</i>-CPBA, CHCl<sub>3</sub>, 0 °C to rt; (d) MeSO<sub>3</sub>H; (e) Me<sub>2</sub>SO<sub>4</sub>, MeCN, 60 °C; (f) 7 N NH<sub>3</sub>/MeOH, 70 °C; (g) PhB(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, H<sub>2</sub>O, 120 °C; (h) PhB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(dtbpf)Cl<sub>2</sub>, THF, H<sub>2</sub>O, 120 °C.</p></p></figure><div class="NLM_p">The synthesis of <b>22</b> is summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Trimethylsilylethoxymethyl (SEM) protection of <b>11</b> gave <b>37</b>, which underwent Suzuki coupling to give <b>38</b>; subsequent SEM deprotection with TBAF gave <b>18</b>. Treatment of <b>18</b> with <i>m</i>-CPBA, followed by methanesulfonic acid, afforded the <i>N</i>-oxide <b>39</b>. Reaction of <b>39</b> with methanesulfonyl chloride gave intermediate <b>40</b>, which underwent reaction with LHMDS followed by XPhos and tris(dibenzylideneacetone)dipalladium(0) to give <b>22</b>.</div><figure id="sch2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0015.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SEMCl, NaH, DMF, 0 °C to rt; (b) 3-MePhB(OH)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C; (c) TBAF, Et<sub>3</sub>N, THF, 70 °C; (d) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (e) MeSO<sub>3</sub>H, rt; (f) MeSO<sub>2</sub>Cl, DMF, 80 °C; (g) LiHMDS, XPhos, Pd<sub>2</sub>(dba)<sub>3</sub>, THF, 60 °C.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>23</b>−<b>34</b> is described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Reaction of <i>N</i>-oxide intermediate <b>35</b> with methanesulfonyl chloride gave 4,6-dichloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile <b>41</b>. Buchwald–Hartwig amination of <b>41</b> with 1-Me-1<i>H</i>-pyrazol-3-amine gave <b>42</b> (R<sup>1</sup> = H), which underwent Suzuki cross-coupling with boronic acids to give <b>23</b> or <b>24</b> (method A). The remaining analogues <b>25</b>–<b>34</b> were prepared by conversion of <b>41</b> to the 6-chloro-4-iodo derivative <b>43</b>. Where R<sup>2</sup> = 5-methylpyridin2-yl, <b>43</b> underwent Suzuki coupling with a boronic acid and the resulting product <b>44</b> underwent treatment with SEM chloride to give <b>45a</b> (method B). For analogues where R<sup>2</sup> = 4- or 6-methylpyridin-2-yl, SEM protection of intermediate <b>43</b> gave <b>46</b>, which underwent Stille coupling with pyridinyl stannanes to afford <b>45b</b> or <b>45c</b> (method C). Where R<sup>2</sup> = 2-methylpyridin-4-yl, Suzuki coupling of <b>46</b> with a boronic acid gave <b>45d</b> (method D). Intermediates <b>45a</b>–<b>d</b> underwent Buchwald–Hartwig amination with a range of 4-substituted 1-Me-1<i>H</i>-pyrazol-3-amines to give intermediates of type <b>47a</b>–<b>j</b>, which underwent deprotection to give <b>25</b>–<b>34</b>.</div><figure id="sch3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0016.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23</b>–<b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeSO<sub>2</sub>Cl, DMF, 80 °C; (b) 1-Me-1<i>H</i>-pyrazol-3-amine, (<i>tert</i>-Bu)ONa, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, DMF, 140 °C; (c) R<sup>2</sup>B(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, water, 120 °C; (d) NaI, AcCl, MeCN, 80 °C; (e) R<sup>2</sup>B(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, H<sub>2</sub>O, 80 °C; (f) NaH, DMF, 0 °C; SEMCl, rt; (g) (<i>n</i>-Bu)<sub>3</sub>SnR<sup>2</sup>, LiCl, CuI, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C; (h) R<sup>2</sup>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4,</sub> Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C; (i) 1-Me-4-R<sup>1</sup>-1<i>H</i>-pyrazol-3-amine, (<i>tert</i>-Bu)ONa, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, PhMe, 90 °C; (j) TBAF, Et<sub>3</sub>N, THF, 70 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Surrogates of the ATP binding site of the LRRK2 kinase domain derived from mutants of CHK1 were designed, expressed in insect cells infected with baculovirus, purified, and then crystallized. X-ray crystal structures of the surrogates complexed with known LRRK2 inhibitors rationalized compound potency and selectivity. Comparison of the binding affinity of the mutant proteins with LRRK2 inhibitors was undertaken. The CHK1 10-pt mut showed a moderate correlation between its binding affinity with a set of LRRK2 inhibitors and their activity on LRRK2 G2019S. The effectiveness of the CHK1 10-pt mut surrogate was further demonstrated in the structure-guided optimization of a series of fragment-derived arylpyrrolo[2,3-<i>b</i>]pyridines, leading to the discovery of moderately selective LRRK2 inhibitors <b>22</b> and <b>23</b>.</div><div class="NLM_p">In LRRK2-pSer935 HEK293 cell-based assays, the IC<sub>50</sub> for compound <b>22</b> on LRRK2 WT, the overactive variant G2019S, and the A2016T mutant was 24 nM, 40 nM, and 471 nM, respectively. This confirmed that <b>22</b> is an inhibitor of LRRK2 WT and G2019S that engages Ala2016 in LRRK2, equivalent to Ala147 in the surrogate crystal structure.</div><div class="NLM_p last">Compound <b>22</b> was shown to be potent, selective, orally available, and brain-penetrant in wild-type mice, and confirmation of target engagement was demonstrated with LRRK2-pSer935 IC<sub>50</sub> values for <b>22</b> in mouse brain and kidney being 1.3 and 5 nM, respectively. Compound <b>23</b> and analogues had increased potency and selectivity for LRRK2 but had a pharmacokinetic profile unsuited to further progression as CNS drug candidates. Further work demonstrating the utility of the CHK1 10-pt mut crystallographic surrogate of the LRRK2 kinase domain in the optimization of other chemical series of inhibitors as potential treatments for Parkinson’s disease will be published in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Expression and Purification of CHK1 8-, 10-, and 12-Point Mutants</h3><div class="NLM_p">A clone representing the constitutively active CHK1 10-point mutant (N59L, V68I, L84M, Y86L, C87A, E91S, E134H, S147A, F149Y, G150S) was ordered from DNA2.0 Inc. (<a href="http://www.dna20.com" class="extLink">www.dna20.com</a>), codon optimized for expression in baculovirus.</div><div class="NLM_p">Bacmid generation using the pFastBac-1 vector was adopted as a cloning strategy with protein expression in <i>Spodoptera frugiperda</i> (Sf21) cells infected at (1 × 10<sup>6</sup>)/mL using a viral multiplicity of infection of 3 and incubated at 27 °C, 120 rpm for 48 h.</div><div class="NLM_p">The resulting cell pellet was resuspended in lysis buffer (25 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 20 mM imidazole, Roche EDTA free protease inhibitor cocktail, 4 mg/L DNase) and Dounce homogenized using 20 strokes on ice. The homogenate was then centrifuged at 18 000 rpm for 90 min, 4 °C.</div><div class="NLM_p">The clarified supernatant was loaded onto a 5 mL GE Healthcare chelating column charged with Ni<sup>2+</sup> and pre-equilibrated in lysis buffer. The protein load was applied at 1 mL/min and the column then washed back to baseline with lysis buffer. The column was then eluted (lysis buffer pH 8.0 + 500 mM imidazole) at 2 mL/min over 20 CV with a linear gradient to 100% elution buffer. Fractions of interest were analyzed using SDS–PAGE, and those containing the CHK1 10-pt mutant protein were pooled and concentrated using Pierce 9K MWCO spin concentrators at 4 °C to achieve a size exclusion column load volume of <5% of the bed volume.</div><div class="NLM_p">The concentrated pool was then applied at 1 mL/min onto a GE Healthcare Hiload 16/60 Superdex 75 pg size exclusion chromatography (SEC) column pre-equilibrated in SEC buffer (25 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 5% glycerol, 5 mM DTT) and eluted with SEC buffer at 1 mL/min over 1.2 CV, collecting 0.5 mL fractions.</div><div class="NLM_p">Samples of interest were analyzed by SDS–PAGE, and the protein pool was concentrated using Pierce 9K MWCO spin concentrators at 4 °C.</div><div class="NLM_p">The final protein yield was 0.5 mg/L culture volume at 1.9 mg/mL (58 μM), 95% purity. This was then snap-frozen in a dry ice–methanol bath prior to being stored at −80 °C.</div><div class="NLM_p last">The constitutively active 12-point mutant (A19S, Y20F, N59L, V68I, L84M, Y86L, C87A, E91S, E134H, S147A, F149Y, G150S) was also ordered from DNA2.0, codon optimized for expression in baculovirus. The 8-point mutant (N59L, V68I, L84M, Y86L, C87A, E91S, E134H, S147A) was generated retrospectively, with DNA being generated using site directed mutagenesis to back-mutate two of the mutations in the 10-point mutant. Similar methodologies for gene cloning, protein expression, and purification were used for each of the mutants produced.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> CHK1 8-, 10-, and 12-Point Mutant Crystallization</h3><div class="NLM_p">The CHK1 10-point mutant protein was thawed and concentrated to 19 mg/mL. Crystals were grown using the sitting drop vapor diffusion method at 20 °C. The protein was mixed with an equal volume of reservoir solution containing 7% (w/v) PEG 8000; 0.1 M MES, pH 6.5; 20% (v/v) ethylene glycol. Crystals appeared overnight.</div><div class="NLM_p">Individual crystals were then harvested and transferred to a drop containing reservoir solution plus ligand at a final concentration of 2 mM. This was incubated at 20 °C overnight.</div><div class="NLM_p">Soaked crystals were then briefly equilibrated in a cryoprotectant buffer containing reservoir solution plus 20% (v/v) glycerol and then flash-frozen in liquid nitrogen.</div><div class="NLM_p">Other mutants were crystallized and soaked in ligand solutions using an identical method.</div><div class="NLM_p last">Structures of complexes of CHK1 10 and 8-point mutants with <b>3b</b> were obtained by cocrystallization, where protein was mixed with compound (in molar ratio 1:4) prior to crystallization.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> CHK1 8-, 10-, and 12-Point Mutant X-ray Structure Determination and Refinement</h3><div class="NLM_p last">Diffraction data were indexed and integrated using XDS<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> or SAINT<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> and SADABS<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> (CHK1 10-point mutant complex with <b>1</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR">5OOR</a>), scaled, and truncated using XSCALE<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> or SCALA from the CCP4 suite of programs.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The structures were solved by molecular replacement with MolRep,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> with the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR">1NVR</a><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> structure used as a starting model. All structures were refined using REFMAC,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> and model building was done with Coot.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Topology files for the compounds were created by PRODRG<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> or AceDRG.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> LRRK2 WT and G2019S Kinase Activity Assays</h3><div class="NLM_p">LRRK2 kinase activity was measured using a LanthaScreen kinase activity assay available from Invitrogen (ThermoFisher Scientific). GST-tagged truncated LRRK2 kinases were also obtained from Invitrogen (ThermoFisher Scientific), and comprising residues 970–2527 of the full length human LRRK2 WT kinase (catalogue no. PV4874) or a similar sequence with the G2019S mutation (catalogue no. PV4882). The kinase reactions were performed in a 20 μL volume, in 384 well plates. The kinase reaction buffer consisted of 50 mM Tris, pH 8.5, 0.01% polyoxyethylene (23) lauryl ether (BRIJ-35), 10 mM MgCl<sub>2</sub>, 1 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA), and 2 mM <span class="smallcaps smallerCapital">dl</span>-dithiothreitol (DTT).</div><div class="NLM_p">In the assay, test compound (typically at 0–30 μM) was added to 1.3 mM ATP and 0.4 μM fluorescein-LRRKtide, and then the kinase reaction was initiated by addition of either 1 nM LRRK2 WT or 250 pM LRRK2 G2019S kinase. The reaction mixture (20 μL total volume) was incubated for 2 h at 30 °C before the reaction was terminated by addition of 10 mM EDTA and 1 nM terbium-labeled anti-phospho-LRRKtide antibody (final volume 40 μL). The mixture was further incubated for 30 min at rt. TR-FRET was measured by excitation of the terbium donor with 340 nm light and subsequent measurement (delay time 100 μs) of terbium and fluorescein emission at 495 and 520 nm respectively; over a time window of 1000 μs. TR-FRET measurements were performed on a Biomek Synergy Neo plate reader. The TR-FRET signal was calculated as the emission ratio at 520 nm over 495 nm. The TR-FRET ratio readout for test compounds was normalized to 0% inhibition, corresponding to TR-FRET ratio measured in control wells with no inhibition of the kinase activity and 100% inhibition, corresponding to TR-FRET ratio measured in control wells with 1 μM staurosporine. Test compound potency (IC<sub>50</sub>) was estimated by nonlinear regression using the sigmoidal dose–response (variable slope) using Xlfit 4 (IDBS, Guildford, Surrey, U.K., model 205). <i>y</i> = <i>A</i> + (<i>B</i> – <i>A</i>)/(1 + (<i>C</i>/<i>x</i>)<sup><i>D</i></sup>), where <i>y</i> is the normalized TR-FRET ratio measurement for a given concentration of test compound, <i>x</i> is the concentration of test compound, <i>A</i> is the estimated efficacy (% inhibition) at infinite compound dilution, and <i>B</i> is the maximal efficacy (% inhibition). <i>C</i> is the IC<sub>50</sub> value, and <i>D</i> is the Hill slope coefficient. IC<sub>50</sub> estimates were obtained from a minimum of two independent experiments, and the logarithmic average was calculated.</div><div class="NLM_p"><i>K</i><sub>i</sub> values were calculated as follows. <i>K</i><sub>i</sub> = [I]<sub>50</sub>/([L]<sub>50</sub>/<i>K</i><sub>D</sub> + [P]<sub>0</sub>/<i>K</i><sub>D</sub> + 1), where [I]<sub>50</sub> denotes the concentration of the free inhibitor at 50% inhibition, [L]<sub>50</sub> is the concentration of the free ligand (ATP) at 50% inhibition, [P]<sub>0</sub> is the concentration of the free protein at 0% inhibition, and <i>K</i><sub>D</sub> is the dissociation constant of the protein–ligand complex (ATP <i>K</i><sub>m</sub> for LRRK2 G2019S is 96 μM; ATP <i>K</i><sub>m</sub> for LRRK2 WT is 32 μM).</div><div class="NLM_p last">Ligand efficiency (LE) is defined as the free energy change (Δ<i>G</i>) associated with ligand binding per heavy atom, i.e., LE = −Δ<i>G</i>/HAC = (<i>RT</i> ln <i>K</i><sub>i</sub>)/HAC, where <i>R</i> = 0.001 987 (gas constant in kcal mol<sup>–1</sup> K<sup>–1</sup>), <i>T</i> = 300 (temp in K), and HAC = heavy atom count.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> LRRK2 pSer935 and pSer1292 Kinase Inhibition in LRRK2 WT, G2019S, and A2016T Expressing HEK293 Cells</h3><div class="NLM_p last">A cell-based quantitative immunocytochemistry LRRK2 mechanistic kinase inhibition assay based on LRRK2-Ser935 phosphorylation as the primary readout was developed using the LI-COR Odyssey near-infrared technology, also denoted as in-cell Western (ICW). The assay was performed in 96-well microplate format as previously described.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Additionally, the assay was performed in 384-well microplate format for LRRK2 WT and G2019S expressed in HEK293 cells. For the 384-well format assay, cells were transduced using BacMam technology (ThermoFisher Scientific). HEK293 cells were seeded in black, clear bottom 384-well cell-treated and poly-<span class="smallcaps smallerCapital">l</span>-lysine-coated plates (Corning Costar 3683) at a density of 20 000 cells/well in 25 μL of medium with 5% (v/v) BacMam LRRK2 WT or G2019S. The cells were incubated for 48 h before the assay was performed as previously described.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> A LRRK2-Ser1292 phosphorylation assay was established for human LRRK2 G2019S, expressed by BacMam-transduced HEK293 cells grown in 384-well microplates as described for the LRRK2-pSer935 assay above. Phosphorylation of human LRRK2 Ser1292 was detected using rabbit anti-LRRK2-pSer1292 antibody diluted 1:800 (Epitomics).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Dosing of Animals for in Vivo Studies</h3><div class="NLM_p last">All animal experiments were carried out in accordance with Danish law regulating experiments on animals, in compliance with EC directive 2010/63/EU, and the NIH guidelines on animal welfare. The protocol used for dosing of mice was approved by the Institutional Animal Ethics Committee. Compound <b>22</b> was administered by po dosing to 6- to 8-week-old male C57BL/6 mice (Taconic Europe A/S) using 2-hydroxypropyl-β-cyclodextrin (25% w/v) as vehicle. A compound dosing range of 0.3–24 mg/kg was used. Following 1 h of compound administration, brain hemispheres were snap-frozen at −80 °C using dry ice. One brain hemisphere to be analyzed for LRRK2-pSer935 levels using either Western blotting or the LRRK2-pSer935 MSD immunoassay was homogenized (10% w/v) in a standard tissue homogenization buffer (ThermoFisher, catalog no. FNN0071). The other brain hemisphere was used to determine exposure of the compound. The experiment was performed three times (<i>n</i> = 3 male mice per treatment group per experiment; total <i>n</i> = 9 male mice per treatment group).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> SDS–PAGE and Western Blot-Based Determination of in Vivo LRRK2-pSer935 Inhibition</h3><div class="NLM_p last">Brain and kidney samples were homogenized using Precellys lysing kit 0.5 mL (CK14 0.5 mL) in a cell lysis buffer (Sigma, C2978) with added protease (Roche, 11 697 498 011) and phosphatase inhibitors (Roche, 04 906 837 001). Total protein concentration was measured using a bicinchoninic acid (BCA) assay (ThermoFisher Pierce BCA protein assay kit, catalog no. 23225). Protein lysates were subjected to SDS–PAGE on a 3–8% Tris-acetate gel (ThermoFisher NuPAGE Tris-acetate Mini Gels, catalog no. EA0375PK2) and transferred onto Immobilon-FL PVDF membranes (Merck Millipore, Billerica, MA, USA). After 1 h in blocking buffer, membranes were incubated overnight at 4 °C with primary antibodies diluted in blocking buffer: mouse monoclonal [N241A/34] anti-LRRK2 antibody (1:2000; NeuroMab, Davis, CA, USA) and rabbit monoclonal [UDD2 10(12)] anti-pS935-LRRK2 antibody (1:1000; RabMAb, Abcam, Cambridge, U.K.). Incubation with secondary antibodies was carried out for 1 h at rt: anti-rabbit IgG F(c) (GOAT) antibody IRDye 800CW conjugated (1:10,000; Rockland Immunochemicals Inc., Gilbertsville, PA, USA) and anti-mouse Alexa Fluor 680 goat anti-mouse IgM (1:20,000; ThermoFisher, U.K.). Protein visualization was detected using the LI-COR Odyssey CLx (LI-COR, NE, USA), and total LRRK2 and pSer935 band intensities were quantified using the LI-COR Odyssey software (Image Studio, version 3.1.4).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo LRRK2-pSer935 MSD Assay for IC<sub>50</sub> Determination of LRRK2 Inhibitors</h3><div class="NLM_p last">Standard Meso Scale Diagnostics (MSD) multiarray 96-well plates (catalog no. L15XA-3, MSD, Gaithersburg, MD, USA) were first coated with LRRK2 antibody (LRRK2-N241A/34, NeuroMab) at a concentration of 0.5 μg/mL in 30 μL of Tris-base saline (TBS). The plate was incubated overnight at 4 °C without shaking. The plate was hereafter blocked by adding 150 μL of 5% blocker A (from MSD) and incubated at an orbital shaker (700 rpm) for 1.5 h at rt, followed by washing three times with 150 μL of TBS including 0.05% Tween-20. Brain protein homogenates were diluted in TBS to a final concentration of 6.4 μg/ μL, and a volume of 25 μL (160 μg total protein) was added to each well in the MSD plate. Each individual protein lysate was added in duplicate for either pSer935-LRRK2 or total-LRRK2 measurement on either half of the plate. In one-half of the plate, 25 μL (0.5 μg/mL) of the pSer935-LRRK2 antibody (Epitomics 5099-1) diluted in TBS including 0.05% Tween-20 and 1% blocker A was added, while 25 μL (0.5 μg/mL) of the LRRK2 antibody (MJFF3, Abcam) diluted in TBS including 0.05% Tween-20 and 1% blocker A was added to the other half of the plate. The MJFF3 LRRK2 antibody and Epitomics pS935-LRRK2 antibody recognize a different epitope compared to the LRRK2 antibody used in the coating, thus allowing their binding and detection of the LRKK2 protein. The plates were incubated for 1 h at rt with shaking at 700 rpm. The plate was hereafter washed three times with 150 μL per well of TBS including 0.05% Tween-20. The secondary anti-rabbit antibody, MSD SULFO-TAG conjugated, was added to the plate (25 μL/well, 1 μg/mL) and incubated at an orbital shaker (700 rpm) for 1 h at rt, followed by three times washing with TBS including 0.05% Tween-20. After addition of 150 μL of 2 × Read buffer (MSD) the plate was measured in the MSD SECTOR S 600. The raw data were analyzed using the default setting of the Discovery Workbench 4.0 software (MSD). For each sample, the signal derived from the pSer935-LRRK2 antibody was first normalized to the signal derived from the total-LRRK2 antibody and then expressed as a percentage of pSer935-LRRK2 of vehicle treated samples. IC<sub>50</sub> values were determined by nonlinear regression analysis using a sigmoidal variable slope curve fitting using the XLfit Excel add-in.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry. General Methods</h3><div class="NLM_p last">All solvents and reagents were used as obtained from commercial vendors. <sup>1</sup>H NMR spectra were collected on Bruker spectrometers, and chemical shifts are reported in ppm relative to the residual solvent peak. All tested compounds were determined to be >95% pure on HPLC chromatograms obtained on an Agilent 1290 Infinity II series instrument (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf" class="ext-link">Supporting Information</a> for LC–MS method details). Purity was calculated as a percentage of total area at 254 nm. The mass spectra were obtained using the same instrument connected to an Agilent TOF 6230 single quadrupole with a ESI source. All active compounds were analyzed for and found to be free of pan assay interference compounds (PAINS).<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div></div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 6-Amino-4-(3-methylphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile (<b>22</b>)</h3><div class="NLM_p"><i>Step 1</i>. Sodium hydride (15.12 g, 0.63 mol) was added to a solution of 4-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile (<b>11</b>) (38.0 g, 0.21 mol) in DMF (750 mL) at 0 °C. After 10 min, 2-(trimethylsilyl)ethoxymethyl chloride (42.8 g, 0.25 mol) was added dropwise at 0 °C. After completion of addition, the reaction mixture was slowly warmed to rt. After 6 h, the reaction mixture was poured into ice-cold water, and the resulting precipitate was filtered and dried in vacuo. The material was subjected to silica gel (100–200 mesh) column chromatography [EtOAc–petroleum ether 40–60 (5–10%) as eluent]. The eluted material, obtained as a white solid (48.6 g, 74%), was identified as 4-chloro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile <b>37</b>. LC–MS (method C) (<i>m</i>/<i>z</i>) 308 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 2.78 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ: 8.33 (1 H, d, <i>J</i> 5.6 Hz), 7.92 (1 H, s), 7.27 (1 H, d, <i>J</i> 5.2 Hz), 5.69 (2 H, s), 3.57 (2 H, t, <i>J</i> 8.4 Hz), 0.92 (2 H, t, <i>J</i> 8.4 Hz), −0.04 (9 H, s).</div><div class="NLM_p"><i>Step 2</i>. Cesium carbonate (151 g, 0.47 mol) was added to a solution of <b>37</b> (48.0 g, 0.16 mol) and 3-phenylboronic acid (25.4 g, 0.19 mol) in 1,4-dioxane (1000 mL) and water (500 mL) at rt. The reaction mixture was degassed with argon for 30 min, and then tetrakis(triphenylphosphine)palladium(0) (8.6 g, 0.0075 mol) was added. The reaction mixture was heated at 100 °C, with stirring. After 4 h, the reaction mixture was cooled to rt, diluted with ethyl acetate (2000 mL), and washed with water (1000 mL). The organic phase was washed with brine (1000 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated. The material was subjected to silica gel (100–200 mesh) column chromatography [EtOAc–hexanes (5–10%) as eluent]. The eluted material, obtained as a yellow solid (39.2 g, 69%), was identified as 4-(3-methylphenyl)-1-{[2-(trimethylsilyl)ethoxy]methyl}-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile <b>38</b>. LC–MS (method F) (<i>m</i>/<i>z</i>) 364 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 1.47 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ: 8.47 (1 H, d, <i>J</i> 4.8 Hz), 7.94 (1 H, s), 7.45–7.40 (3 H, m), 7.31 (1 H, d, <i>J</i> 6.8 Hz), 7.25 (1 H, s), 5.74 (2 H, s), 3.61 (2 H, t, <i>J</i> 8.4 Hz), 2.47 (3 H, s), 0.94 (2 H, t, <i>J</i> 8.4 Hz), −0.04 (9 H, s).</div><div class="NLM_p"><i>Step 3</i>. Triethylamine (59.8 mL, 0.43 mol) and TBAF (1 M in THF, 429 mL, 0.43 mol) were added to a solution of <b>38</b> (39.0 g, 0.11 mol) in THF (200 mL) at rt. The reaction mixture was heated to 65 °C. After 16 h, the reaction was cooled to rt and evaporated. The residue was diluted with water (1000 mL), and the resulting precipitate was filtered and dried to a white solid (21.0 g, 84%), identified as 4-(3-methylphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile <b>18</b>, containing traces of TBAF. LC–MS (method E) (<i>m</i>/<i>z</i>) 234 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 3.29 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ: 8.52 (1 H, d, <i>J</i> 2.0 Hz), 8.44 (1 H, d, <i>J</i> 4.8 Hz), 7.45–7.41 (3 H, m), 7.32–7.31 (1 H, m), 7.26 (1 H, d, <i>J</i> 4.8 Hz), 2.40 (3 H, s).</div><div class="NLM_p"><i>Step 4</i>. <i>m</i>-CPBA (77%, 31.0 g, 0.18 mol) was added to a solution of <b>18</b> (21.0 g, 0.090 mol) in DCM (300 mL) at 0 °C. The reaction mixture was slowly warmed to rt. After 16 h, methanesulfonic acid (9.25 mL, 0.135 mol) was added, and the reaction mixture was stirred at rt for 15 min. Diethyl ether (1 L) was added, and the resulting precipitate was then filtered and the residue dried to a white solid (23.69 g, 76%), identified as 3-cyano-4-(3-methylphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-7-ium-7-olate methylsulfonate salt <b>39</b>. LC–MS (method C) (<i>m</i>/<i>z</i>) 250 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 1.76 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ: 8.49 (1 H, s), 8.37 (1 H, d, <i>J</i> 6.4 Hz), 7.44–7.40 (3 H, m), 7.31–7.29 (1 H, m), 7.26 (1 H, d, <i>J</i> 6.4 Hz), 2.39 (3 H, s), 2.32 (3 H, s).</div><div class="NLM_p"><i>Step 5</i>. Methanesulfonyl chloride (23.15 g, 0.205 mol) was added to a solution of <b>39</b> (23.6 g, 0.068 mol) in DMF (500 mL) at rt. The reaction mixture was heated to 100 °C. After 2 h, the reaction mixture was cooled to rt and poured onto ice-cold water (1000 mL). The resulting precipitate was filtered, and the residue was dried to a white solid (17.2 g, 94%), identified as 6-chloro-4-(3-methylphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile <b>40</b>. LC–MS (method C) (<i>m</i>/<i>z</i>) 268 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 2.39 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ: 10.74 (1 H, s), 7.94 (1 H, d, <i>J</i> 3.2 Hz), 7.45–7.40 (3 H, m), 7.35–7.33 (1 H, d, <i>J</i> 7.6 Hz), 7.30 (1 H, s), 2.48 (3 H, s).</div><div class="NLM_p last"><i>Step 6</i>. A mixture of <b>40</b> (20.0 g, 74.90 mmol) and LHMDS (1.0 M in THF, 300 mL, 300 mmol) in THF (400 mL) was degassed with argon for 10 min. 2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (X-Phos, 3.56 g, 7.49 mmol) and tris(dibenzylideneacetone)dipalladium(0) (6.85 g, 7.49 mmol) were added and allowed to stir at 65 °C. After 16 h, the reaction mixture was cooled to rt, 5 N hydrochloric acid (300 mL) was added, and the reaction mixture was stirred for 15 min. The mixture was then basified with sodium carbonate solution, extracted with ethyl acetate (2 × 500 mL), and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated. The residue was subjected to silica gel (100–200 mesh) column chromatography [ethyl acetate–petroleum ether 40–60 (20–30%)]. The eluted material was evaporated to a brown solid (14.2 g), which was further washed with diethyl ether (250 mL). The resulting brown solid (13.4 g, 72%) was identified as <b>22</b>. LC–MS (method A) (<i>m</i>/<i>z</i>) 249 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 0.88 min. <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) δ: 12.03 (1 H, s), 7.91 (1 H, d, <i>J</i> 2.8 Hz), 7.39–7.25 (4 H, m), 6.38 (1 H, s), 6.04 (1 H, s), 2.38 (3 H, s).</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-(3-Methylphenyl)-6-[(1-methylpyrazol-3-yl)amino]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile (<b>23</b>)</h3><div class="NLM_p"><i>Step 1</i>. <b>11</b> (3.00 g, 16.89 mmol) was suspended in chloroform (60 mL) and the reaction mixture cooled to 0 °C. <i>m</i>-CPBA (10.3 g, 59.12 mmol) was then added portionwise over 10 min, and the reaction mixture was then stirred at rt for 16 h. Methanesulfonic acid (1.64 mL, 21.18 mmol) was then added dropwise over 1 min. The reaction mixture was then diluted with diethyl ether (60 mL), cooled (ice–water bath), and then stirred for 30 min. The resulting precipitate was filtered, and the residue was washed with diethyl ether (3 × 20 mL). The resulting solid was dried in vacuo (60 °C) for 2 h to give 5.23 g (18.03 mmol, quantitative) of a beige solid, identified as 4-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile-7-oxide methanesulfonic acid salt <b>35</b>. LC–MS (method B) (<i>m</i>/<i>z</i>) 194 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 1.37 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ: 8.55 (1 H, s), 8.33 (1 H, d, <i>J</i> 6.7 Hz), 7.42 (1 H, d, <i>J</i> 6.7 Hz).</div><div class="NLM_p"><i>Step 2</i>. <b>35</b> (5.37 g, 18.53 mmol) was suspended in DMF (50 mL). Methanesulfonyl chloride (10.87 g, 95 mmol) was then added, and the reaction mixture was then heated to 80 °C for 10 min, resulting in a pale-brown solution. The reaction mixture was then cooled and evaporated under reduced pressure. The resulting yellow gum was triturated with DCM. The precipitate was filtered and then dried to afford a light yellow powder (2.72 g, 8.52 mmol, 46%), identified as 4,6-dichloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile <b>41</b>. LC–MS (method B) (<i>m</i>/<i>z</i>) 210 [M – H]<sup>−</sup>; <i>t</i><sub>R</sub> = 2.27 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ: 13.37 (1 H, s), 8.61 (1 H, d, <i>J</i> 3.0 Hz), 7.64 (1 H, s).</div><div class="NLM_p"><i>Step 3</i>. <b>41</b> (0.376 g, 1.77 mmol), 1-methyl-1<i>H</i>-pyrazol-3-amine (0.189 g, 1.95 mmol), sodium <i>tert</i>-butoxide (0.852 g, 8.87 mmol), tris(dibenzylideneacetone)dipalladium(0) (0.081 g, 0.090 mmol), and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos, 0.113 g, 0.20 mmol) were added to a microwave vial, followed by dry DMF (18 mL). The reaction mixture was flushed with N<sub>2</sub> for ∼10 min and then heated to 140 °C with microwaves for 1 h. The reaction mixture was filtered through Celite and washed with ethyl acetate. The resulting precipitate was filtered and the residue dried and obtained as a yellow solid (0.242 g, 0.44 mmol, 50%) identified as 4-chloro-6-[(1-methyl-1<i>H</i>-pyrazol-3-yl)amino]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-3-carbonitrile (<b>42</b>). LC–MS (method B) (<i>m</i>/<i>z</i>) 273 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 2.11 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ: 9.61 (1 H, s), 8.48 (1 H, s, br), 8.12 (1 H, s), 7.57 (1 H, d, <i>J</i> 2.2 Hz), 7.15 (1 H, s), 6.53 (1 H, d, <i>J</i> 2.3 Hz), 3.76 (3 H, s).</div><div class="NLM_p last"><i>Step 4</i>. <b>42</b> (0.234 g, 0.86 mmol), 3-methylphenylboronic acid (0.233 g, 1.72 mmol), potassium fluoride (0.150 g, 2.57 mmol), and bis(tri-<i>tert</i>-butylphosphine)palladium(0) (0.005 g, 0.010 mmol) were suspended in 1,4-dioxane (15 mL) and water (2.5 mL) and stirred under a stream of nitrogen. The reaction mixture was then heated with microwaves at 120 °C for 60 min in a sealed process vial. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate and washed with brine. The organic phase was dried (MgSO<sub>4</sub>) and concentrated in vacuo. The residue was subjected to silica gel flash column chromatography [ethyl acetate–DCM (2:1) as eluent]. The eluted material, obtained as a white solid (0.068 g), underwent further purification by preparative HPLC to afford a white solid (0.047 g, 17%), identified as <b>23</b>. LC–MS (<i>m</i>/<i>z</i>) (method A) 329 [M + H]<sup>+</sup>; <i>t</i><sub>R</sub> = 0.94 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ: 12.28 (1 H, s, br), 9.44 (1 H, s), 8.05–8.04 (1 H, d), 7.55–7.54 (1 H, d), 7.42–7.38 (2 H, m), 7.35–7.32 (1 H, m), 7.30–7.27 (1 H, m), 6.93 (1 H, s), 6.65–6.64 (1 H, d), 3.74 (3 H, s), 2.39 (3 H, s).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01186">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01186" class="ext-link">10.1021/acs.jmedchem.7b01186</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental details for compounds <b>12</b>–<b>21</b> and <b>24</b>–<b>34</b>, sequence alignment of LRRK2, CHK1, and Roco4 surrogates, tables of X-ray data collection and refinement statistics, electron density maps, details of CHK1 WT and 8-, 10-, and 12-point mutant kinase binding assays, tables of LRRK2 G2019S and WT activity and CHK1 WT and 8-, 10-, and 12-point mutant kinase binding assay data, kinase selectivity data for compounds <b>22</b> and <b>23</b>, broad in vitro pharmacology profiling data for compound <b>23</b> and comparative LRRK2 G2019S and WT enzyme activity and pSer935 HEK293 data for compounds <b>22</b> and <b>23</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings, LRRK2 G2019S and WT IC<sub>50</sub>, cK<sub>i</sub>, p(cK<sub>i</sub>) and LE, LRRK2 G2019S and WT pSer935 HEK293 (384-well) IC<sub>50</sub>, HLM CL, <i>P</i><sub>app</sub> (MDR1-MDCK), CHK1 WT and 8-, 10-, and 12-point mutant IC<sub>50</sub> and p(cK<sub>i</sub>), PDB codes for complexes with CHK1 8-, 10- and 12-point mutants (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf">jm7b01186_si_001.pdf (2.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_002.csv">jm7b01186_si_002.csv (7.65 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for ligand bound structures with CHK1 10-point mutant: AMP-PNP (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOP">5OOP</a>), <b>1</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR">5OOR</a>), <b>2</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOT">5OOT</a>), <b>3b</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP2">5OP2</a>), <b>4a</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP4">5OP4</a>), <b>5</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP5">5OP5</a>), <b>6</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP7">5OP7</a>), <b>7</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPB">5OPB</a>), <b>8</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPR">5OPR</a>), <b>9</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPS">5OPS</a>), <b>22</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPU">5OPU</a>), and <b>23</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPV">5OPV</a>). PDB codes for ligand bound structures with CHK1 8-point mutant: <b>2</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ5">5OQ5</a>) and <b>3b</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ7">5OQ7</a>). PDB codes for ligand bound structures with CHK1 12-point mutant: <b>2</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ6">5OQ6</a>) and <b>3b</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ8">5OQ8</a>). Authors will release the atomic coordinates upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01186" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas S. Williamson</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5094-5200" title="Orcid link">http://orcid.org/0000-0002-5094-5200</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#35511b425c59595c5458465a5b754350475b54595c461b565a58"><span class="__cf_email__" data-cfemail="a0c48ed7c9ccccc9c1cdd3cfcee0d6c5d2cec1ccc9d38ec3cfcd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Garrick P. Smith</span> - <span class="hlFld-Affiliation affiliation">H.
Lundbeck A/S, Ottiliavej
9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamela Acheson-Dossang</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon T. Bedford</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0531-8096" title="Orcid link">http://orcid.org/0000-0003-0531-8096</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victoria Chell</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">I-Jen Chen</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justus C. A. Daechsel</span> - <span class="hlFld-Affiliation affiliation">H.
Lundbeck A/S, Ottiliavej
9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zoe Daniels</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent David</span> - <span class="hlFld-Affiliation affiliation">H.
Lundbeck A/S, Ottiliavej
9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawel Dokurno</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7332-8889" title="Orcid link">http://orcid.org/0000-0002-7332-8889</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Morten Hentzer</span> - <span class="hlFld-Affiliation affiliation">H.
Lundbeck A/S, Ottiliavej
9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin C. Herzig</span> - <span class="hlFld-Affiliation affiliation">H.
Lundbeck A/S, Ottiliavej
9, 2500 Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roderick E. Hubbard</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan D. Moore</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James B. Murray</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1007-8218" title="Orcid link">http://orcid.org/0000-0003-1007-8218</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Newland</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart C. Ray</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry Shaw</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan E. Surgenor</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9869-1430" title="Orcid link">http://orcid.org/0000-0002-9869-1430</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lindsey Terry</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0373-2090" title="Orcid link">http://orcid.org/0000-0003-0373-2090</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Thirstrup</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yikang Wang</span> - <span class="hlFld-Affiliation affiliation">Vernalis
(R&D) Ltd., Granta Park, Great Abington, Cambridge, CB21 6GB, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth V. Christensen</span> - <span class="hlFld-Affiliation affiliation">H.
Lundbeck A/S, Ottiliavej
9, 2500 Valby, Denmark</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1759-8988" title="Orcid link">http://orcid.org/0000-0003-1759-8988</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d241e4387-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Lassina Badolo for DMPK support, Jo Lerpiniere and Mandy Fallowfield for informatics support, Hayley Angove, Chris Pedder, and Jalanie D’Alessandro for additional assay determinations, Loic Le Strat and Heather Simmonite for compound analytical support, James Taylor for assistance with compound sample management, Mike Wood for useful discussions, and James Davidson for his assistance in the preparation of this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">AMPKa2</td><td class="NLM_def"><p class="first last">AMP-activated protein kinase a2</p></td></tr><tr><td class="NLM_term">AMP-PNP</td><td class="NLM_def"><p class="first last">adenylyl imidodiphosphate</p></td></tr><tr><td class="NLM_term">CAMK4</td><td class="NLM_def"><p class="first last">calcium/calmodulin-dependent protein kinase type IV</p></td></tr><tr><td class="NLM_term">CHK1 10-pt mut</td><td class="NLM_def"><p class="first last">10-point mutant of checkpoint kinase 1</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">ICW</td><td class="NLM_def"><p class="first last">in-cell Western</p></td></tr><tr><td class="NLM_term">JAK3</td><td class="NLM_def"><p class="first last">Janus kinase 3</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">MARK3</td><td class="NLM_def"><p class="first last">microtubule affinity regulating kinase 3</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance 1</p></td></tr><tr><td class="NLM_term">MLK1</td><td class="NLM_def"><p class="first last">mixed-lineage kinase 1</p></td></tr><tr><td class="NLM_term">MST1</td><td class="NLM_def"><p class="first last">mammalian sterile twenty-like 1</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub>(A:B)</td><td class="NLM_def"><p class="first last">apparent permeability coefficient in apical to basolateral direction</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PLK4</td><td class="NLM_def"><p class="first last">polo-like kinase 4</p></td></tr><tr><td class="NLM_term">PTK2B</td><td class="NLM_def"><p class="first last">protein tyrosine kinase 2β</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-trimethylsilylethoxymethyl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 88 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Jankovic, J.</span><span> </span><span class="NLM_article-title">Parkinson’s Disease: Clinical Features and Diagnosis</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span><span class="refDoi"> DOI: 10.1136/jnnp.2007.131045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1136%2Fjnnp.2007.131045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=18344392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2008&pages=368-376&author=J.+Jankovic&title=Parkinson%E2%80%99s+Disease%3A+Clinical+Features+and+Diagnosis&doi=10.1136%2Fjnnp.2007.131045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease: clinical features and diagnosis</span></div><div class="casAuthors">Jankovic J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Parkinson's disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree.  This review describes the clinical characteristics of PD with emphasis on those features that differentiate the disease from other parkinsonian disorders.  METHODS:  A MedLine search was performed to identify studies that assess the clinical characteristics of PD.  Search terms included "Parkinson's disease", "diagnosis" and "signs and symptoms".  RESULTS:  Because there is no definitive test for the diagnosis of PD, the disease must be diagnosed based on clinical criteria.  Rest tremor, bradykinesia, rigidity and loss of postural reflexes are generally considered the cardinal signs of PD.  The presence and specific presentation of these features are used to differentiate PD from related parkinsonian disorders.  Other clinical features include secondary motor symptoms (eg, hypomimia, dysarthria, dysphagia, sialorrhoea, micrographia, shuffling gait, festination, freezing, dystonia, glabellar reflexes), non-motor symptoms (eg, autonomic dysfunction, cognitive/neurobehavioral abnormalities, sleep disorders and sensory abnormalities such as anosmia, paresthesias and pain).  Absence of rest tremor, early occurrence of gait difficulty, postural instability, dementia, hallucinations, and the presence of dysautonomia, ophthalmoparesis, ataxia and other atypical features, coupled with poor or no response to levodopa, suggest diagnoses other than PD.  CONCLUSIONS:  A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease.  Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx3pH5zglCwUcLvDNbOD4DfW6udTcc2ebEyIR7lu1eL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D&md5=bb6d7781e6fce93cfb785215840149cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2007.131045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2007.131045%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DParkinson%25E2%2580%2599s%2520Disease%253A%2520Clinical%2520Features%2520and%2520Diagnosis%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2008%26volume%3D79%26spage%3D368%26epage%3D376%26doi%3D10.1136%2Fjnnp.2007.131045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Brundin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span> </span><span class="NLM_article-title">Research in Motion: The Enigma of Parkinson’s Disease Pathology Spread</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span><span class="refDoi"> DOI: 10.1038/nrn2477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fnrn2477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=18769444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFeit7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=741-745&author=P.+Brundinauthor=J.-Y.+Liauthor=J.+L.+Holtonauthor=O.+Lindvallauthor=T.+Revesz&title=Research+in+Motion%3A+The+Enigma+of+Parkinson%E2%80%99s+Disease+Pathology+Spread&doi=10.1038%2Fnrn2477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Research in motion: the enigma of Parkinson's disease pathology spread</span></div><div class="casAuthors">Brundin, Patrik; Li, Jia-Yi; Holton, Janice L.; Lindvall, Olle; Revesz, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">741-745</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease is characterized by progressive neurodegeneration, but the underlying mechanisms are unclear.  Brundin and colleagues discuss how recent reports on the outcome of neuronal grafts carried out in patients with Parkinson's disease might shed light on the disease's progression.  Neuropathol. changes in Parkinson's disease progress slowly and spread according to a characteristic pattern.  Recent papers have shed light on this progression of pathol. by examg. the fate of neurons grafted into the brains of patients with Parkinson's disease.  Two of these studies demonstrate that grafted healthy neurons can gradually develop the same pathol. as host neurons in the diseased brains.  According to these studies, implanted neurons developed α-synuclein- and ubiquitin-pos. Lewy bodies more than a decade after transplantation.  We discuss the possible underlying mechanisms and their implications for how pathol. spreads in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpee4HTnLRoTbVg90H21EOLACvtfcHk0lhLCfif7GcvqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFeit7fP&md5=f77c3ac21698c9300076189f012cf3e9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrn2477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2477%26sid%3Dliteratum%253Aachs%26aulast%3DBrundin%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.-Y.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DLindvall%26aufirst%3DO.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DResearch%2520in%2520Motion%253A%2520The%2520Enigma%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%2520Pathology%2520Spread%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D741%26epage%3D745%26doi%3D10.1038%2Fnrn2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Poewe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahlknecht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankovic, J.</span><span> </span><span class="NLM_article-title">Emerging Therapies for Parkinson’s Disease</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span><span class="refDoi"> DOI: 10.1097/WCO.0b013e3283542fde</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1097%2FWCO.0b013e3283542fde" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22772874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=448-459&author=W.+Poeweauthor=P.+Mahlknechtauthor=J.+Jankovic&title=Emerging+Therapies+for+Parkinson%E2%80%99s+Disease&doi=10.1097%2FWCO.0b013e3283542fde"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapies for Parkinson's disease</span></div><div class="casAuthors">Poewe, Werner; Mahlknecht, Philipp; Jankovic, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">448-459</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: The exptl. therapeutics of Parkinson's disease are reviewed, highlighting the current pipeline of emerging therapeutic approaches.  Recent findings: This review includes novel approaches to dopaminergic drug delivery such as intraintestinal infusions or new extended-release formulations of levodopa and also intrapulmonary delivery of apomorphine as well as novel dopaminergic agents like the monoamine oxidase-B inhibitor safinamide or novel catechol-O-Me transferase inhibitors.  An even greater no. of ongoing clin. trials assess the efficacy and safety of nondopaminergic approaches to enhance motor control or reduce motor complications like fluctuations and dyskinesias.  These include adenosine A2A antagonists, α-adrenergic and serotonergic agonists as well as drugs acting on the glutamatergic system.  Gene-based or cell-based intrastriatal delivery of therapeutic principles that enhance striatal dopaminergic transmission directly or via the stimulation of trophic activity has also reached phase II clin. development with encouraging results in some studies.  Finally, a wide spectrum of agents with a potential for slowing disease progression is currently tested.  Summary: A variety of medical and nonmedical interventions in different phases of clin. development provide an interesting and promising portfolio of emerging therapies for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomNZpxzJjBtrVg90H21EOLACvtfcHk0lhLCfif7GcvqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7zM&md5=421b6b0b289da7fcc8e817ae1808c15a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e3283542fde&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e3283542fde%26sid%3Dliteratum%253Aachs%26aulast%3DPoewe%26aufirst%3DW.%26aulast%3DMahlknecht%26aufirst%3DP.%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DEmerging%2520Therapies%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2012%26volume%3D25%26spage%3D448%26epage%3D459%26doi%3D10.1097%2FWCO.0b013e3283542fde" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, L.</span><span> </span><span class="NLM_article-title">Emerging Targets and New Small Molecule Therapies in Parkinson’s Disease Treatment</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1430</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmc.2016.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26935940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjtleqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1419-1430&author=H.+Zhangauthor=R.+Tongauthor=L.+Baiauthor=J.+Shiauthor=L.+Ouyang&title=Emerging+Targets+and+New+Small+Molecule+Therapies+in+Parkinson%E2%80%99s+Disease+Treatment&doi=10.1016%2Fj.bmc.2016.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging targets and new small molecule therapies in Parkinson's disease treatment</span></div><div class="casAuthors">Zhang, Hongjia; Tong, Rongsheng; Bai, Lan; Shi, Jianyou; Ouyang, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1419-1430</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a common chronic degenerative disease of the central nervous system.  Due to a rapidly aging society worldwide, PD morbidity is on the rise; however, the treatment of PD with conventional drugs carries serious adverse reactions and cannot fix the root cause of PD, the degeneration of dopaminergic neurons, which limits conventional drug usage in clin. practice.  In recent years, research on the pathogenesis of PD and its clin. manifestations has led to the discovery of an increasing no. of novel targets in PD, including several small mol. targeted compds.  In this paper, we analyze and summarize the most recently published PD literature and review several recently discovered novel targets in PD and their small mol. targeted pharmacol. active agents based on their mechanisms of action and pharmacodynamic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUosTXhG2kbrVg90H21EOLACvtfcHk0lhLCfif7GcvqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjtleqt78%253D&md5=46e91b18da67c98f7f93cca0f23166e0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTong%26aufirst%3DR.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DOuyang%26aufirst%3DL.%26atitle%3DEmerging%2520Targets%2520and%2520New%2520Small%2520Molecule%2520Therapies%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%2520Treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1419%26epage%3D1430%26doi%3D10.1016%2Fj.bmc.2016.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mills, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhern, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culvenor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-C.</span><span> </span><span class="NLM_article-title">Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of All Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span><span class="refDoi"> DOI: 10.1002/humu.22515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1002%2Fhumu.22515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24470158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=395-412&author=R.+D.+Millsauthor=T.+D.+Mulhernauthor=F.+Liuauthor=J.+G.+Culvenorauthor=H.-C.+Cheng&title=Prediction+of+the+Repeat+Domain+Structures+and+Impact+of+Parkinsonism-Associated+Variations+on+Structure+and+Function+of+All+Functional+Domains+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29&doi=10.1002%2Fhumu.22515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)</span></div><div class="casAuthors">Mills, Ryan D.; Mulhern, Terrence D.; Liu, Fei; Culvenor, Janetta G.; Cheng, Heung-Chin</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-412</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic variations of leucine-rich repeat kinase 2 (LRRK2) are the major cause of dominantly inherited Parkinson disease (PD).  LRRK2 protein contains seven predicted domains: a tandem Ras-like GTPase (ROC) domain and C-terminal of Roc (COR) domain, a protein kinase domain, and four repeat domains.  PD-causative variations arise in all domains, suggesting that aberrant functioning of any domain can contribute to neurotoxic mechanisms of LRRK2.  Detn. of the three-dimensional structure of LRRK2 is one of the best avenues to decipher its neurotoxic mechanism.  However, with the exception of the Roc domain, the three-dimensional structures of the functional domains of LRRK2 have yet to be detd.  Based on the known three-dimensional structures of repeat domains of other proteins, the tandem Roc-COR domains of the Chlorobium tepidum Rab family protein, and the kinase domain of the Dictyostelium discoideum Roco4 protein, we predicted (1) the motifs essential for protein-protein interactions in all domains, (2) the motifs crit. for catalysis and substrate recognition in the tandem Roc-COR and kinase domains, and (3) the effects of some PD-assocd. missense variations on the neurotoxic action of LRRK2.  Results of our anal. provide a conceptual framework for future investigation into the regulation and the neurotoxic mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCQyitGjwuJ7Vg90H21EOLACvtfcHk0lj9s7wJ-Z2XKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D&md5=71fb35dc3def1fa847bad36b1b38f035</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fhumu.22515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.22515%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DR.%2BD.%26aulast%3DMulhern%26aufirst%3DT.%2BD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DCulvenor%26aufirst%3DJ.%2BG.%26aulast%3DCheng%26aufirst%3DH.-C.%26atitle%3DPrediction%2520of%2520the%2520Repeat%2520Domain%2520Structures%2520and%2520Impact%2520of%2520Parkinsonism-Associated%2520Variations%2520on%2520Structure%2520and%2520Function%2520of%2520All%2520Functional%2520Domains%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%26jtitle%3DHum.%2520Mutat.%26date%3D2014%26volume%3D35%26spage%3D395%26epage%3D412%26doi%3D10.1002%2Fhumu.22515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Tsika, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span> </span><span class="NLM_article-title">Contribution of GTPase Activity to LRRK2-Associated Parkinson Disease</span> <span class="citation_source-journal">Small GTPases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.4161/sgtp.25130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.4161%2Fsgtp.25130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24025585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BC3sbnt1Skuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=164-170&author=E.+Tsikaauthor=D.+J.+Moore&title=Contribution+of+GTPase+Activity+to+LRRK2-Associated+Parkinson+Disease&doi=10.4161%2Fsgtp.25130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of GTPase activity to LRRK2-associated Parkinson disease</span></div><div class="casAuthors">Tsika Elpida; Moore Darren J</div><div class="citationInfo"><span class="NLM_cas:title">Small GTPases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2, PARK8, OMIM 607060) gene represent the most common known cause of hereditary Parkinson's disease (PD) with late-onset and dominant inheritance.  LRRK2 protein is composed of multiple domains including two distinct enzymatic domains, a kinase and a Ras-of-complex (Roc) GTPase, connected by a C-terminal-of-Roc (COR) domain, and belongs to the ROCO protein family.  Disease-causing mutations located in the kinase domain enhance kinase activity (i.e., G2019S) whereas mutations clustering within the Roc-COR tandem domain impair GTPase activity (i.e., R1441C/G and Y1699C).  Familial LRRK2 mutations commonly induce neuronal toxicity that, at least for the frequent G2019S variant, is dependent on kinase activity.  The contribution of GTPase activity to LRRK2-dependent neuronal toxicity is not yet clear.  Therefore, both GTPase and kinase activity may be important for mediating neurodegeneration in PD due to familial LRRK2 mutations.  At present, the physiological function of LRRK2 in the mammalian brain and the regulation of its enzymatic activity are incompletely understood.  In this review, we focus on the GTPase domain of LRRK2 and discuss the recent advances in elucidating its function and its interplay with the kinase domain for the regulation of LRRK2 activity and toxicity.  GTPase activity is an important feature of LRRK2 biology and pathophysiology and represents an underexplored yet potentially tractable therapeutic target for treating LRRK2-associated PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAuS9CObmGsJw7prLlxLOzfW6udTcc2eY0XgdOdeytb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbnt1Skuw%253D%253D&md5=c5f01ec0bf08b72a844a653bdea8aa52</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.4161%2Fsgtp.25130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fsgtp.25130%26sid%3Dliteratum%253Aachs%26aulast%3DTsika%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26atitle%3DContribution%2520of%2520GTPase%2520Activity%2520to%2520LRRK2-Associated%2520Parkinson%2520Disease%26jtitle%3DSmall%2520GTPases%26date%3D2013%26volume%3D4%26spage%3D164%26epage%3D170%26doi%3D10.4161%2Fsgtp.25130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Structural Biology of the LRRK2 GTPase and Kinase Domains: Implications for Regulation</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="refDoi"> DOI: 10.3389/fnmol.2014.00032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.3389%2Ffnmol.2014.00032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24847205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=32&author=B.+K.+Gilsbachauthor=A.+Kortholt&title=Structural+Biology+of+the+LRRK2+GTPase+and+Kinase+Domains%3A+Implications+for+Regulation&doi=10.3389%2Ffnmol.2014.00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation</span></div><div class="casAuthors">Gilsbach, Bernd K.; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32/1-32/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain.  Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD).  Several of the pathogenic mutations in LRRK2 result in decreased GTPase activity and enhanced kinase activity, suggesting a possible PD-related gain of abnormal function.  Important progress in the structural understanding of LRRK2 has come from our work with related Roco proteins from lower organisms.  Atomic structures of Roco proteins from prokaryotes revealed that Roco proteins belong to the GAD class of mol. switches (G proteins activated by nucleotide dependent dimerization).  As in LRRK2, PD-analogous mutations in Roco proteins from bacteria decrease the GTPase reaction.  Studies with Roco proteins from the model organism Dictyostelium discoideum revealed that PD mutants have different effects and most importantly they explained the G2019S-related increased LRRK2 kinase activity.  Furthermore, the structure of Dictyostelium Roco4 kinase in complex with the LRRK2 inhibitor H1152 showed that Roco4 and other Roco family proteins can be important for the optimization of the current, and identification of new, LRRK2 kinase inhibitors.  In this review we highlight the recent progress in structural and biochem. characterization of Roco proteins and discuss its implication for the understanding of the complex regulatory mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnWPIGCCasqLVg90H21EOLACvtfcHk0lhWYvpZ94LxmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN&md5=de1cef27dd0b8e5b5b242a4a1607192f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00032%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DStructural%2520Biology%2520of%2520the%2520LRRK2%2520GTPase%2520and%2520Kinase%2520Domains%253A%2520Implications%2520for%2520Regulation%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D32%26doi%3D10.3389%2Ffnmol.2014.00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span> </span><span class="NLM_article-title">Current Understanding of LRRK2 in Parkinson’s Disease: Biochemical and Structural Features and Inhibitor Design</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span><span class="refDoi"> DOI: 10.4155/fmc.12.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.4155%2Ffmc.12.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22924508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kjsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1701-1713&author=S.+Rayauthor=M.+Liu&title=Current+Understanding+of+LRRK2+in+Parkinson%E2%80%99s+Disease%3A+Biochemical+and+Structural+Features+and+Inhibitor+Design&doi=10.4155%2Ffmc.12.110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current understanding of LRRK2 in Parkinson's disease: biochemical and structural features and inhibitor design</span></div><div class="casAuthors">Ray, Soumya; Liu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1701-1713</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Since leucine-rich repeat kinase 2 (LRRK2) was linked to Parkinson's disease in 2004, kinase activity of LRRK2 has been believed to play a crit. role in the pathogenesis of Parkinson's disease.  As a result, identification of LRRK2 inhibitors has been a focus for drug discovery.  However, most LRRK2 mutations do not simply increase kinase activity.  In this review we summarize the potential mechanisms that regulate the kinase activity of LRRK2.  We outline some currently available kinase inhibitors, including the identification of a DFG-out (type-II) inhibitor.  Finally, we discuss the relationship of LRRK2 with tau and α-synuclein.  The fact that all three proteins are autophapgy-related provides a future strategy for the identification of LRRK2 physiol. substrate(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDtD1AZs4s_7Vg90H21EOLACvtfcHk0lg_9TSrNc7a2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kjsb%252FI&md5=8d9171efda1411ed8a9e25f15859fc47</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.110%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DCurrent%2520Understanding%2520of%2520LRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Biochemical%2520and%2520Structural%2520Features%2520and%2520Inhibitor%2520Design%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1701%26epage%3D1713%26doi%3D10.4155%2Ffmc.12.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Steger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wachter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorentzen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, M.</span><span> </span><span class="NLM_article-title">Phosphoproteomics Reveals That Parkinson’s Disease Kinase LRRK2 Regulates a Subset of Rab GTPases</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e12813</span><span class="refDoi"> DOI: 10.7554/eLife.12813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.7554%2FeLife.12813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26824392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFGjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e12813&author=M.+Stegerauthor=F.+Tonelliauthor=G.+Itoauthor=P.+Daviesauthor=M.+Trostauthor=M.+Vetterauthor=S.+Wachterauthor=E.+Lorentzenauthor=G.+Duddyauthor=S.+Wilsonauthor=M.+A.+S.+Baptistaauthor=B.+K.+Fiskeauthor=M.+J.+Fellauthor=J.+A.+Morrowauthor=A.+D.+Reithauthor=D.+R.+Alessiauthor=M.+Mann&title=Phosphoproteomics+Reveals+That+Parkinson%E2%80%99s+Disease+Kinase+LRRK2+Regulates+a+Subset+of+Rab+GTPases&doi=10.7554%2FeLife.12813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases</span></div><div class="casAuthors">Steger, Martin; Tonelli, Francesca; Ito, Genta; Davies, Paul; Trost, Matthias; Vetter, Melanie; Wachter, Stefanie; Lorentzen, Esben; Duddy, Graham; Wilson, Stephen; Baptista, Marco A. S.; Fiske, Brian K.; Fell, Matthew J.; Morrow, John A.; Reith, Alastair D.; Alessi, Dario R.; Man, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e12813/1-e12813/28</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Mutations in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2) protein, comprise the predominant genetic cause of Parkinson's disease (PD).  G2019S, the most common amino acid substitution activates the kinase two- to threefold.  This has motivated the development of LRRK2 kinase inhibitors; however, poor consensus on physiol. LRRK2 substrates has hampered clin. development of such therapeutics.  We employ a combination of phosphoproteomics, genetics, and pharmacol. to unambiguously identify a subset of Rab GTPases as key LRRK2 substrates.  LRRK2 directly phosphorylates these both in vivo and in vitro on an evolutionary conserved residue in the switch II domain.  Pathogenic LRRK2 variants mapping to different functional domains increase phosphorylation of Rabs and this strongly decreases their affinity to regulatory proteins including Rab GDP dissocn. inhibitors (GDIs).  Our findings uncover a key class of bona-fide LRRK2 substrates and a novel regulatory mechanism of Rabs that connects them to PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8JgdLZ38hbVg90H21EOLACvtfcHk0lg_9TSrNc7a2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFGjur0%253D&md5=e9075908450e709a839f64574286c031</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7554%2FeLife.12813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.12813%26sid%3Dliteratum%253Aachs%26aulast%3DSteger%26aufirst%3DM.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DIto%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DTrost%26aufirst%3DM.%26aulast%3DVetter%26aufirst%3DM.%26aulast%3DWachter%26aufirst%3DS.%26aulast%3DLorentzen%26aufirst%3DE.%26aulast%3DDuddy%26aufirst%3DG.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DMann%26aufirst%3DM.%26atitle%3DPhosphoproteomics%2520Reveals%2520That%2520Parkinson%25E2%2580%2599s%2520Disease%2520Kinase%2520LRRK2%2520Regulates%2520a%2520Subset%2520of%2520Rab%2520GTPases%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De12813%26doi%3D10.7554%2FeLife.12813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">The Role of Leucine-Rich Repeat Kinase 2 (LRRK2) in Parkinson’s Disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span><span class="refDoi"> DOI: 10.1038/nrn2935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fnrn2935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21088684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=791-797&author=M.+R.+Cookson&title=The+Role+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+in+Parkinson%E2%80%99s+Disease&doi=10.1038%2Fnrn2935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</span></div><div class="casAuthors">Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">791-797</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component.  Here, I discuss how mutations in a large complex gene - leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau.  These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ6sTeax7vLVg90H21EOLACvtfcHk0lg9yxjXYsZgPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO&md5=1600eaee5fea809aa325e2d7a7963b35</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrn2935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2935%26sid%3Dliteratum%253Aachs%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DThe%2520Role%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D791%26epage%3D797%26doi%3D10.1038%2Fnrn2935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.-K.</span><span> </span><span class="NLM_article-title">Targeting LRRK2 in Parkinson’s Disease: An Update on Recent Developments</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1080/14728222.2017.1323881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1080%2F14728222.2017.1323881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28443359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVCqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=601-610&author=S.+L.+Chanauthor=E.-K.+Tan&title=Targeting+LRRK2+in+Parkinson%E2%80%99s+Disease%3A+An+Update+on+Recent+Developments&doi=10.1080%2F14728222.2017.1323881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting LRRK2 in Parkinson's disease: an update on recent developments</span></div><div class="casAuthors">Chan, Sharon L.; Tan, Eng-King</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  LRRK2 research has progressed significantly in recent years with more reports of LRRK2 interactors and the development of more specific and sophisticated LRRK2 kinase inhibitors.  Identification of bone fide LRRK2 substrates will provide new therapeutic targets in LRRK2-linked Parkinson's disease (PD).: This review aims to put current LRRK2 research into perspective.  Beginning with recent LRRK2 mammalian models employed for in vivo validation of LRRK2 substrates, followed by updates on reported LRRK2 interactors and their inferred mechanisms.  Finally an overview of commonly used LRRK2 kinase inhibitors will be depicted.: Identification of LRRK2 non-kinase functions suggests the possibility of alternative LRRK2 drug target sites and these should be further explored.  Studies on the effects of LRRK2 kinase inhibition on its non-kinase function and its self-regulatory role will provide further insights on its pathophysiol. mechanisms.  Development of robust measurements of LRRK2 inhibitor efficacy will be required.  These would include identification of specific imaging ligands or direct biochem. assays that can accurately capture its intrinsic activity.  Testing of new therapeutic drug targets in both LRRK2 carriers and non LRRK2-linked patients will be important since their phenotype is similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuDMceyQymlLVg90H21EOLACvtfcHk0lg9yxjXYsZgPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVCqs7k%253D&md5=c07ae116d1b509d0cf82627e0a2d9d9b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1080%2F14728222.2017.1323881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2017.1323881%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DTan%26aufirst%3DE.-K.%26atitle%3DTargeting%2520LRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520An%2520Update%2520on%2520Recent%2520Developments%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2017%26volume%3D21%26spage%3D601%26epage%3D610%26doi%3D10.1080%2F14728222.2017.1323881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westenberger, A.</span><span> </span><span class="NLM_article-title">Genetics of Parkinson’s Disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a008888</span><span class="refDoi"> DOI: 10.1101/cshperspect.a008888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1101%2Fcshperspect.a008888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22315721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a008888&author=C.+Kleinauthor=A.+Westenberger&title=Genetics+of+Parkinson%E2%80%99s+Disease&doi=10.1101%2Fcshperspect.a008888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics of Parkinson's disease</span></div><div class="casAuthors">Klein, Christine; Westenberger, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a008888/1-a008888/15</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Fifteen years of genetic research in Parkinson's disease (PD) have led to the identification of several monogenic forms of the disorder and of numerous genetic risk factors increasing the risk to develop PD.  Monogenic forms, caused by a single mutation in a dominantly or recesSively inherited gene, are well-established, albeit relatively rare types of PD.  They collectively account for about 30% of the familial and 3%-5% of the sporadic cases.  In this article, we will summarize the current knowledge and understanding of the mol. genetics of PD.  In brief, we will review familial forms of PD, basic genetic principles of inheritance (and their exceptions in PD), followed by current methods for the identification of PD genes and risk factors, and implications for genetic testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR7sz1nLEJFbVg90H21EOLACvtfcHk0lg9yxjXYsZgPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7k%253D&md5=680259f05baf38bb26854521a7d3e5aa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a008888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a008888%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DWestenberger%26aufirst%3DA.%26atitle%3DGenetics%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da008888%26doi%3D10.1101%2Fcshperspect.a008888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Trinh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilariño-Güell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szu Tu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben Sassi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zouari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhat, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">A Comparative Study of Parkinson’s Disease and Leucine-Rich Repeat Kinase 2 p.G2019S Parkinsonism</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.neurobiolaging.2013.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24355527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWju73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1125-1131&author=J.+Trinhauthor=R.+Amouriauthor=J.+E.+Dudaauthor=J.+F.+Morleyauthor=M.+Readauthor=A.+Donaldauthor=C.+Vilari%C3%B1o-G%C3%BCellauthor=C.+Thompsonauthor=C.+Szu+Tuauthor=E.+K.+Gustavssonauthor=S.+Ben+Sassiauthor=E.+Hentatiauthor=M.+Zouariauthor=E.+Farhatauthor=F.+Nabliauthor=F.+Hentatiauthor=M.+J.+Farrer&title=A+Comparative+Study+of+Parkinson%E2%80%99s+Disease+and+Leucine-Rich+Repeat+Kinase+2+p.G2019S+Parkinsonism&doi=10.1016%2Fj.neurobiolaging.2013.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism</span></div><div class="casAuthors">Trinh, Joanne; Amouri, Rim; Duda, John E.; Morley, James F.; Read, Matthew; Donald, Alan; Vilarino-Guell, Carles; Thompson, Christina; Szu Tu, Chelsea; Gustavsson, Emil K.; Ben Sassi, Samia; Hentati, Emna; Zouari, Mourad; Farhat, Emna; Nabli, Fatma; Hentati, Faycel; Farrer, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1125-1131</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Parkinson disease is a progressive neurodegenerative disease for which leucine-rich repeat kinase 2 (LRRK2 carriers) p.G2019S confers substantial genotypic and population attributable risk.  With informed consent, we have recruited clin. data from 778 patients from Tunisia (of which 266 have LRRK2 parkinsonism) and 580 unaffected subjects.  Motor, autonomic, and cognitive assessments in idiopathic Parkinson disease and LRRK2 patients were compared with regression models.  The age-assocd. cumulative incidence of LRRK2 parkinsonism was also estd. using case-control and family-based designs.  LRRK2 parkinsonism patients had slightly less gastrointestinal dysfunction and rapid eye movement sleep disorder.  Overall, disease penetrance in LRRK2 carriers was 80% by 70 years but women become affected a median 5 years younger than men.  Idiopathic Parkinson disease patients with younger age at diagnosis have slower disease progression.  However, age at diagnoses does not predict progression in LRRK2 parkinsonism.  LRRK2 p.G2019S mutation is a useful aid to diagnosis and modifiers of disease in LRRK2 parkinsonism may aid in developing therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxbtPiKFSvrbVg90H21EOLACvtfcHk0lg9yxjXYsZgPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWju73N&md5=678cd0e694e6dba631147ab00d87cff0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DTrinh%26aufirst%3DJ.%26aulast%3DAmouri%26aufirst%3DR.%26aulast%3DDuda%26aufirst%3DJ.%2BE.%26aulast%3DMorley%26aufirst%3DJ.%2BF.%26aulast%3DRead%26aufirst%3DM.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DVilari%25C3%25B1o-G%25C3%25BCell%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DSzu%2BTu%26aufirst%3DC.%26aulast%3DGustavsson%26aufirst%3DE.%2BK.%26aulast%3DBen%2BSassi%26aufirst%3DS.%26aulast%3DHentati%26aufirst%3DE.%26aulast%3DZouari%26aufirst%3DM.%26aulast%3DFarhat%26aufirst%3DE.%26aulast%3DNabli%26aufirst%3DF.%26aulast%3DHentati%26aufirst%3DF.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DA%2520Comparative%2520Study%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%2520and%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520p.G2019S%2520Parkinsonism%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D1125%26epage%3D1131%26doi%3D10.1016%2Fj.neurobiolaging.2013.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Webber, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s Disease: Function in Cells and Neurodegeneration</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6436</span><span class="NLM_x">–</span> <span class="NLM_lpage">6444</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07342.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1111%2Fj.1742-4658.2009.07342.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6436-6444&author=P.+J.+Webberauthor=A.+B.+West&title=LRRK2+in+Parkinson%E2%80%99s+Disease%3A+Function+in+Cells+and+Neurodegeneration&doi=10.1111%2Fj.1742-4658.2009.07342.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07342.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07342.x%26sid%3Dliteratum%253Aachs%26aulast%3DWebber%26aufirst%3DP.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Function%2520in%2520Cells%2520and%2520Neurodegeneration%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6436%26epage%3D6444%26doi%3D10.1111%2Fj.1742-4658.2009.07342.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span><span class="refDoi"> DOI: 10.1016/j.neuron.2004.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+M%C3%BCller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+Cause+Autosomal-Dominant+Parkinsonism+with+Pleomorphic+Pathology&doi=10.1016%2Fj.neuron.2004.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0ljEg3QP2v2sRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DM%25C3%25BCller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520Cause%2520Autosomal-Dominant%2520Parkinsonism%2520with%2520Pleomorphic%2520Pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.neuron.2004.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Albrecht, M.</span><span> </span><span class="NLM_article-title">LRRK2 Mutations and Parkinsonism</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="refDoi"> DOI: 10.1016/S0140-6736(05)74810-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2FS0140-6736%2805%2974810-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1230&author=M.+Albrecht&title=LRRK2+Mutations+and+Parkinsonism&doi=10.1016%2FS0140-6736%2805%2974810-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2974810-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252974810-8%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DM.%26atitle%3DLRRK2%2520Mutations%2520and%2520Parkinsonism%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1230%26doi%3D10.1016%2FS0140-6736%2805%2974810-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ramírez, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madero-Pérez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero-Ríos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Salvador, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara Ordóñez, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fdez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfiker, S.</span><span> </span><span class="NLM_article-title">LRRK2 and Parkinson’s Disease: From Lack of Structure to Gain of Function</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span><span class="refDoi"> DOI: 10.2174/1389203717666160311121748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.2174%2F1389203717666160311121748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26965688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=677-686&author=M.+B.+Ram%C3%ADrezauthor=J.+Madero-P%C3%A9rezauthor=P.+Rivero-R%C3%ADosauthor=M.+Mart%C3%ADnez-Salvadorauthor=A.+J.+Lara+Ord%C3%B3%C3%B1ezauthor=B.+Fern%C3%A1ndezauthor=E.+Fdezauthor=S.+Hilfiker&title=LRRK2+and+Parkinson%E2%80%99s+Disease%3A+From+Lack+of+Structure+to+Gain+of+Function&doi=10.2174%2F1389203717666160311121748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and Parkinson';s Disease: From Lack of Structure to Gain of Function</span></div><div class="casAuthors">Ramirez, Marian Blanca; Madero-Perez, Jesus; Rivero-Rios, Pilar; Martinez-Salvador, Mar; Lara Ordonez, Antonio J.; Fernandez, Belen; Fdez, Elena; Hilfiker, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Mutations in LRRK2 comprise the most common cause for familial Parkinson's disease (PD), and variations increase risk for sporadic disease, implicating LRRK2 in the entire disease spectrum.  LRRK2 is a large protein harbouring both GTPase and kinase domains which display measurable catalytic activity.  Most pathogenic mutations increase the kinase activity, with increased activity being cytotoxic under certain conditions.  These findings have spurred great interest in drug development approaches, and various specific LRRK2 kinase inhibitors have been developed.  However, LRRK2 is a largely ubiquitously expressed protein, and inhibiting its function in some non-neuronal tissues has raised safety liability issues for kinase inhibitor approaches.  Therefore, understanding the cellular and cell type-specific role(s) of LRRK2 has become of paramount importance.  This review will highlight current knowledge on the precise biochem. activities of normal and pathogenic LRRK2, and highlight the most common proposed cellular roles so as to gain a better understanding of the cell type-specific effects of LRRK2 modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQvdeTDVE4trVg90H21EOLACvtfcHk0ljEg3QP2v2sRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2juro%253D&md5=431066051fa43d242c87f0c5ea7454cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1389203717666160311121748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203717666160311121748%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez%26aufirst%3DM.%2BB.%26aulast%3DMadero-P%25C3%25A9rez%26aufirst%3DJ.%26aulast%3DRivero-R%25C3%25ADos%26aufirst%3DP.%26aulast%3DMart%25C3%25ADnez-Salvador%26aufirst%3DM.%26aulast%3DLara%2BOrd%25C3%25B3%25C3%25B1ez%26aufirst%3DA.%2BJ.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DFdez%26aufirst%3DE.%26aulast%3DHilfiker%26aufirst%3DS.%26atitle%3DLRRK2%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520From%2520Lack%2520of%2520Structure%2520to%2520Gain%2520of%2520Function%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D677%26epage%3D686%26doi%3D10.2174%2F1389203717666160311121748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s Disease-Associated Mutations in Leucine-Rich Repeat Kinase 2 Augment Kinase Activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span><span class="refDoi"> DOI: 10.1073/pnas.0507360102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1073%2Fpnas.0507360102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+Disease-Associated+Mutations+in+Leucine-Rich+Repeat+Kinase+2+Augment+Kinase+Activity&doi=10.1073%2Fpnas.0507360102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0507360102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0507360102%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520Disease-Associated%2520Mutations%2520in%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520Augment%2520Kinase%2520Activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847%26doi%3D10.1073%2Fpnas.0507360102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhu, H.; Chen, H.; Cho, W.; Estrada, A. A.; Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson’s Disease</span>. In  <span class="citation_source-book">Medicinal Chemistry Approaches to Personalized Medicine</span>; <span class="NLM_contrib-group">Lackey, K.; Roth, B. D.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span>, DOI: <span class="refDoi"> DOI: 10.1002/9783527677252.ch10</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1002%2F9783527677252.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=227-254&author=H.+Zhu&author=H.+Chen&author=W.+Cho&author=A.+A.+Estrada&author=Z.+K.+Sweeneyauthor=K.+Lackey&author=B.+D.+Roth&title=Medicinal+Chemistry+Approaches+to+Personalized+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F9783527677252.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677252.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DFrom%2520Human%2520Genetics%2520to%2520Drug%2520Candidates%253A%2520An%2520Industrial%2520Perspective%2520on%2520LRRK2%2520Inhibition%2520as%2520a%2520Treatment%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26btitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Personalized%2520Medicine%26aulast%3DLackey%26aufirst%3DK.%26pub%3DWiley-VCH%2520Verlag%26date%3D2013%26spage%3D227%26epage%3D254%26doi%3D10.1002%2F9783527677252.ch10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gilligan, P. J.</span><span> </span><span class="NLM_article-title">Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span><span class="refDoi"> DOI: 10.2174/156802661510150328223655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.2174%2F156802661510150328223655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=25832719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1altrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=927-938&author=P.+J.+Gilligan&title=Inhibitors+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29%3A+Progress+and+Promise+for+the+Treatment+of+Parkinson%E2%80%99s+Disease&doi=10.2174%2F156802661510150328223655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson's Disease</span></div><div class="casAuthors">Gilligan, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-938</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Mutations in the gene for leucine-rich repeat kinase 2 (LRRK2) have been linked to several familial and sporadic late-onset cases of Parkinson's disease.  The cumulative data for the effects of mutant forms of this enzyme on neuronal degrdn. and the pathophysiol. of Parkinson's disease create a compelling case for drug discovery based on inhibition of the mutant forms of LRRK2.  This review focuses on structure-activity relationships for inhibitors of LRRK2 and the data supporting a potential role of these agents in treating Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRyfmc0sAcnbVg90H21EOLACvtfcHk0liezvy8n5ncVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1altrc%253D&md5=218f11008606a3215fc1f2b4e917044f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F156802661510150328223655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802661510150328223655%26sid%3Dliteratum%253Aachs%26aulast%3DGilligan%26aufirst%3DP.%2BJ.%26atitle%3DInhibitors%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%253A%2520Progress%2520and%2520Promise%2520for%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D927%26epage%3D938%26doi%3D10.2174%2F156802661510150328223655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6733</span><span class="NLM_x">–</span> <span class="NLM_lpage">6746</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00261</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00261" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6733-6746&author=A.+A.+Estradaauthor=Z.+K.+Sweeney&title=Chemical+Biology+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6733-6746</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is an urgent need for the development of Parkinson's disease (PD) treatments that can slow disease progression.  The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to PD, and modulation of LRRK2 enzymic activity has been proposed as a novel therapeutic strategy.  In this review, we describe the bioactivity of selected small mols. that have been used to inhibit LRRK2 kinase activity in vitro or in vivo.  These compds. are important tools for understanding the cellular biol. of LRRK2 and for evaluating the potential of LRRK2 inhibitors as disease-modifying PD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1REdaTMbQkLVg90H21EOLACvtfcHk0ljPwoEGvTl-rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGiu7g%253D&md5=37336d97c3c51dcea44df4f7a51837c5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00261%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DChemical%2520Biology%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6733%26epage%3D6746%26doi%3D10.1021%2Facs.jmedchem.5b00261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Galatsis, P.</span><span> </span><span class="NLM_article-title">Leucine-Rich Repeat Kinase 2 Inhibitors: A Patent Review (2014–2016)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1080/13543776.2017.1280464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1080%2F13543776.2017.1280464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28117607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Wgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=667-676&author=P.+Galatsis&title=Leucine-Rich+Repeat+Kinase+2+Inhibitors%3A+A+Patent+Review+%282014%E2%80%932016%29&doi=10.1080%2F13543776.2017.1280464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-2016)</span></div><div class="casAuthors">Galatsis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-676</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Leucine-rich repeat kinase 2 (LRRK2) is a member of the Tyrosine Kinase-Like (TKL) branch of the kinome tree and is a multi-domain protein that includes GTPase and kinase activity.  While genome-wide assocn. studies (GWAS) has linked LRRK2 with Crohn's disease and leprosy, it has received the greatest attention due to it being implicated as one of the genetic loci assocd. with autosomal dominant inheritance in Parkinson's disease (PD).  In this review, the small mol. patent literature from 2014-2016 with a focus on compn. of matter and use patents was surveyed.  Scifinder was primarily searched using 'LRRK2' as the query to identify all relevant literature and then triaged for small mol. patents.  The patent landscape around LRRK2 continues to develop.  The early patents covered using existing kinase inhibitors for use against LRRK2.  This evolved to compds. specifically designed for selectivity against LRRK2, but key exemplified compds. lacked sufficient brain exposure to affect sufficient efficacy.  More recent compds. have addressed this deficiency and show greater potential for treating PD.  While potency will be necessary to generate medicines with low human daily doses, brain penetration and safety will be the key differentiators for ultimately detg. the most effective LRRK2 disease-modifying treatment for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwhvhIy4GudLVg90H21EOLACvtfcHk0ljPwoEGvTl-rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Wgur4%253D&md5=15ca6328181a2ecf1531b40d5487a01a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1280464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1280464%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DLeucine-Rich%2520Repeat%2520Kinase%25202%2520Inhibitors%253A%2520A%2520Patent%2520Review%2520%25282014%25E2%2580%25932016%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D667%26epage%3D676%26doi%3D10.1080%2F13543776.2017.1280464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schulz, S.; Göring, S.; Schmidt, B.; Hopf, C.</span><span> </span><span class="NLM_article-title">LRRK2 Kinase Inhibitors as New Drugs for Parkinson’s Disease?</span> In  <span class="citation_source-book">Emerging Drugs and Targets for Parkinson’s Disease</span>; <span class="NLM_contrib-group">Martinez, A.; Gil, C.</span>, Eds.; RSC Drug Discovery Series 34; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span>, DOI: <span class="refDoi"> DOI: 10.1039/9781849737357-00266</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1039%2F9781849737357-00266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=266-293&author=S.+Schulz&author=S.+G%C3%B6ring&author=B.+Schmidt&author=C.+Hopfauthor=A.+Martinez&author=C.+Gil&title=Emerging+Drugs+and+Targets+for+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2F9781849737357-00266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849737357-00266%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DLRRK2%2520Kinase%2520Inhibitors%2520as%2520New%2520Drugs%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%253F%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2013%26spage%3D266%26epage%3D293%26doi%3D10.1039%2F9781849737357-00266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Galatsis, P.; Henderson, J.; Kormos, B. L.; Hirst, W. D.</span><span> </span><span class="NLM_article-title">Development of LRRK2 Kinase Inhibitors for Parkinson’s Disease</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Desai, M. C.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">49</span>, pp  <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2FB978-0-12-800167-7.00004-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=43-58&author=P.+Galatsis&author=J.+Henderson&author=B.+L.+Kormos&author=W.+D.+Hirstauthor=M.+C.+Desai&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-800167-7.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-800167-7.00004-3%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520LRRK2%2520Kinase%2520Inhibitors%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26aulast%3DDesai%26aufirst%3DM.%2BC.%26pub%3DAcademic%2520Press%26date%3D2014%26volume%3D49%26spage%3D43%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Christensen, K. V.; Smith, G. P.; Williamson, D. S.</span><span> </span><span class="NLM_article-title">Development of LRRK2 Inhibitors for the Treatment of Parkinson’s Disease</span>. In  <span class="citation_source-book">Progress in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Witty, D. R.; Cox, B.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">56</span>, pp  <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span>, DOI: <span class="refDoi"> DOI: 10.1016/bs.pmch.2016.11.002</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fbs.pmch.2016.11.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=37-80&author=K.+V.+Christensen&author=G.+P.+Smith&author=D.+S.+Williamsonauthor=D.+R.+Witty&author=B.+Cox&title=Progress+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fbs.pmch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.pmch.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26atitle%3DDevelopment%2520of%2520LRRK2%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26btitle%3DProgress%2520in%2520Medicinal%2520Chemistry%26aulast%3DWitty%26aufirst%3DD.%2BR.%26pub%3DElsevier%26date%3D2017%26volume%3D56%26spage%3D37%26epage%3D80%26doi%3D10.1016%2Fbs.pmch.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hatcher, J. M.; Choi, H. G.; Alessi, D. R.; Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of LRRK2</span>. In  <span class="citation_source-book">Leucine-Rich Repeat Kinase 2 (LRRK2)</span>; <span class="NLM_contrib-group">Rideout, H. J.</span>, Ed.; Advances in Neurobiology, Vol. 14; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-3-319-49969-7_13</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1007%2F978-3-319-49969-7_13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=241-264&author=J.+M.+Hatcher&author=H.+G.+Choi&author=D.+R.+Alessi&author=N.+S.+Grayauthor=H.+J.+Rideout&title=Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-49969-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-49969-7_13%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520LRRK2%26btitle%3DLeucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%26aulast%3DRideout%26aufirst%3DH.%2BJ.%26pub%3DSpringer%26date%3D2017%26spage%3D241%26epage%3D264%26doi%3D10.1007%2F978-3-319-49969-7_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Covy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giasson, B. I.</span><span> </span><span class="NLM_article-title">Identification of Compounds That Inhibit the Kinase Activity of Leucine-Rich Repeat Kinase 2</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2008.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bbrc.2008.11.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2009&pages=473-477&author=J.+P.+Covyauthor=B.+I.+Giasson&title=Identification+of+Compounds+That+Inhibit+the+Kinase+Activity+of+Leucine-Rich+Repeat+Kinase+2&doi=10.1016%2Fj.bbrc.2008.11.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DCovy%26aufirst%3DJ.%2BP.%26aulast%3DGiasson%26aufirst%3DB.%2BI.%26atitle%3DIdentification%2520of%2520Compounds%2520That%2520Inhibit%2520the%2520Kinase%2520Activity%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D378%26spage%3D473%26epage%3D477%26doi%3D10.1016%2Fj.bbrc.2008.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a Selective Inhibitor of the Parkinson’s Disease Kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1038/nchembio.538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+Selective+Inhibitor+of+the+Parkinson%E2%80%99s+Disease+Kinase+LRRK2&doi=10.1038%2Fnchembio.538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0lhE9MaeFs5EnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520Disease%2520Kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205%26doi%3D10.1038%2Fnchembio.538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">GSK2578215A; A Potent and Highly Selective 2-Arylmethyloxy-5-substitutent-<i>N</i>-arylbenzamide LRRK2 Kinase Inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5625</span><span class="NLM_x">–</span> <span class="NLM_lpage">5629</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2012.06.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22863203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5625-5629&author=A.+D.+Reithauthor=P.+Bamboroughauthor=K.+Janduauthor=D.+Andreottiauthor=L.+Mensahauthor=P.+Dossangauthor=H.+G.+Choiauthor=X.+Dengauthor=J.+Zhangauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=GSK2578215A%3B+A+Potent+and+Highly+Selective+2-Arylmethyloxy-5-substitutent-N-arylbenzamide+LRRK2+Kinase+Inhibitor&doi=10.1016%2Fj.bmcl.2012.06.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor</span></div><div class="casAuthors">Reith, Alastair D.; Bamborough, Paul; Jandu, Karamjit; Andreotti, Daniele; Mensah, Lucy; Dossang, Pamela; Choi, Hwan Geun; Deng, Xianming; Zhang, Jinwei; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5625-5629</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) is a promising therapeutic target for some forms of Parkinson's disease.  Here we report the discovery and characterization of 2-arylmethyloxy-5-subtitutent-N-arylbenzamides with potent LRRK2 activities exemplified by GSK2578215A which exhibits biochem. IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant.  GSK2578215A exhibits exceptionally high selectivity for LRRK2 across the kinome, substantially inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concn. of 0.3-1.0 μM in cells and in mouse spleen and kidney, but not in brain, following i.p. injection of 100 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplPAPdmxGOJLVg90H21EOLACvtfcHk0lhE9MaeFs5EnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrfO&md5=b2bf7c7cb191cd297b8f586daca58ab1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.104%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DJandu%26aufirst%3DK.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DMensah%26aufirst%3DL.%26aulast%3DDossang%26aufirst%3DP.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DGSK2578215A%253B%2520A%2520Potent%2520and%2520Highly%2520Selective%25202-Arylmethyloxy-5-substitutent-N-arylbenzamide%2520LRRK2%2520Kinase%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5625%26epage%3D5629%26doi%3D10.1016%2Fj.bmcl.2012.06.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span><span class="refDoi"> DOI: 10.1021/jm301020q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+Highly+Potent%2C+Selective%2C+and+Brain-Penetrable+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Small+Molecule+Inhibitors&doi=10.1021%2Fjm301020q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Liu, Xingrong; Baker-Glenn, Charles; Beresford, Alan; Burdick, Daniel J.; Chambers, Mark; Chan, Bryan K.; Chen, Huifen; Ding, Xiao; DiPasquale, Antonio G.; Dominguez, Sara L.; Dotson, Jennafer; Drummond, Jason; Flagella, Michael; Flynn, Sean; Fuji, Reina; Gill, Andrew; Gunzner-Toste, Janet; Harris, Seth F.; Heffron, Timothy P.; Kleinheinz, Tracy; Lee, Donna W.; Le Pichon, Claire E.; Lyssikatos, Joseph P.; Medhurst, Andrew D.; Moffat, John G.; Mukund, Susmith; Nash, Kevin; Scearce-Levie, Kimberly; Sheng, Zejuan; Shore, Daniel G.; Tran, Thuy; Trivedi, Naimisha; Wang, Shumei; Zhang, Shuo; Zhang, Xiaolin; Zhao, Guiling; Zhu, Haitao; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9416-9433</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a high demand for potent, selective, and brain-penetrant small mol. inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson's disease patients.  Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compds.  High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro-in vivo correlations.  Guided by this data, optimal design parameters were established.  Effective incorporation of these guidelines into our mol. design process resulted in the discovery of small mol. inhibitors such as GNE-7915 (18, I) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species.  Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptu1BnxYNJQrVg90H21EOLACvtfcHk0ljcCthIrdLOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO&md5=9fc7ccca9c973a960e7393c79c1255fa</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Brain-Penetrable%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Small%2520Molecule%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433%26doi%3D10.1021%2Fjm301020q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatsis, P.</span><span> </span><span class="NLM_article-title">Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1021/jm5014055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5014055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVens7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=419-432&author=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=M.+M.+Haywardauthor=K.+J.+Coffmanauthor=J.+Jastiauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirstauthor=P.+Galatsis&title=Discovery+and+Preclinical+Profiling+of+3-%5B4-%28Morpholin-4-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-5-yl%5Dbenzonitrile+%28PF-06447475%29%2C+a+Highly+Potent%2C+Selective%2C+Brain+Penetrant%2C+and+in+Vivo+Active+LRRK2+Kinase+Inhibitor&doi=10.1021%2Fjm5014055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor</span></div><div class="casAuthors">Henderson, Jaclyn L.; Kormos, Bethany L.; Hayward, Matthew M.; Coffman, Karen J.; Jasti, Jayasankar; Kurumbail, Ravi G.; Wager, Travis T.; Verhoest, Patrick R.; Noell, G. Stephen; Chen, Yi; Needle, Elie; Berger, Zdenek; Steyn, Stefanus J.; Houle, Christopher; Hirst, Warren D.; Galatsis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">419-432</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Leucine rich repeat kinase 2 (LRRK2) has been genetically linked to Parkinson's disease (PD) by genome-wide assocn. studies (GWAS).  The most common LRRK2 mutation, G2019S, which is relatively rare in the total population, gives rise to increased kinase activity.  As such, LRRK2 kinase inhibitors are potentially useful in the treatment of PD.  We herein disclose the discovery and optimization of a novel series of potent LRRK2 inhibitors, focusing on improving kinome selectivity using a surrogate crystallog. approach.  This resulted in the identification of 14 (PF-06447475), a highly potent, brain penetrant and selective LRRK2 inhibitor which has been further profiled in in vivo safety and pharmacodynamic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndkJkbl5dB7Vg90H21EOLACvtfcHk0ljcCthIrdLOpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVens7%252FO&md5=d970c348ae4ec899b504e28060b21f13</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm5014055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5014055%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DJasti%26aufirst%3DJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520Preclinical%2520Profiling%2520of%25203-%255B4-%2528Morpholin-4-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-5-yl%255Dbenzonitrile%2520%2528PF-06447475%2529%252C%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Brain%2520Penetrant%252C%2520and%2520in%2520Vivo%2520Active%2520LRRK2%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D419%26epage%3D432%26doi%3D10.1021%2Fjm5014055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=584-589&author=J.+M.+Hatcherauthor=J.+Zhangauthor=H.+G.+Choiauthor=G.+Itoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+a+Pyrrolopyrimidine+%28JH-II-127%29%2C+a+Highly+Potent%2C+Selective%2C+and+Brain+Penetrant+LRRK2+Inhibitor&doi=10.1021%2Facsmedchemlett.5b00064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00064%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DIto%26aufirst%3DG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520a%2520Pyrrolopyrimidine%2520%2528JH-II-127%2529%252C%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Brain%2520Penetrant%2520LRRK2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D584%26epage%3D589%26doi%3D10.1021%2Facsmedchemlett.5b00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheewatrakoolpong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMong, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgraf, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span> </span><span class="NLM_article-title">MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1124/jpet.115.227587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1124%2Fjpet.115.227587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26407721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslamsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2015&pages=397-409&author=M.+J.+Fellauthor=C.+Mirescuauthor=K.+Basuauthor=B.+Cheewatrakoolpongauthor=D.+E.+DeMongauthor=J.+M.+Ellisauthor=L.+A.+Hydeauthor=Y.+Linauthor=C.+G.+Markgrafauthor=H.+Meiauthor=M.+Millerauthor=F.+M.+Pouletauthor=J.+D.+Scottauthor=M.+D.+Smithauthor=Z.+Yinauthor=X.+Zhouauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=J.+A.+Morrow&title=MLi-2%2C+a+Potent%2C+Selective%2C+and+Centrally+Active+Compound+for+Exploring+the+Therapeutic+Potential+and+Safety+of+LRRK2+Kinase+Inhibition&doi=10.1124%2Fjpet.115.227587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition</span></div><div class="casAuthors">Fell, Matthew J.; Mirescu, Christian; Basu, Kallol; Cheewatrakoolpong, Boonlert; DeMong, Duane E.; Ellis, J. Michael; Hyde, Lynn A.; Lin, Yinghui; Markgraf, Carrie G.; Mei, Hong; Miller, Michael; Poulet, Frederique M.; Scott, Jack D.; Smith, Michelle D.; Yin, Zhizhang; Zhou, Xiaoping; Parker, Eric M.; Kennedy, Matthew E.; Morrow, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-409</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of familial and sporadic Parkinson's disease (PD).  That the most prevalent mutation, G2019S, leads to increased kinase activity has led to a concerted effort to identify LRRK2 kinase inhibitors as a potential disease-modifying therapy for PD.  An internal medicinal chem. effort identified several potent and highly selective compds. with favorable drug-like properties.  Here, we characterize the pharmacol. properties of cis-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine (MLi-2), a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity.  MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 (IC50 = 1.4 nM), and a radioligand competition binding assay (IC50 = 3.4 nM).  MLi-2 has greater than 295-fold selectivity for over 300 kinases in addn. to a diverse panel of receptors and ion channels.  Acute oral and subchronic dosing in MLi-2 mice resulted in dose-dependent central and peripheral target inhibition over a 24-h period as measured by dephosphorylation of pSer935 LRRK2.  Treatment of MitoPark mice with MLi-2 was well tolerated over a 15-wk period at brain and plasma exposures >100× the in vivo plasma IC50 for LRRK2 kinase inhibition as measured by pSer935 dephosphorylation.  Morphol. changes in the lung, consistent with enlarged type II pneumocytes, were obsd. in MLi-2-treated MitoPark mice.  These data demonstrate the suitability of MLi-2 as a compd. to explore LRRK2 biol. in cellular and animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpot402TvUrkbVg90H21EOLACvtfcHk0lhRvABhTqWJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslamsbk%253D&md5=83c68f7bb731bef2fa9db880196dbabe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.227587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.227587%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DMirescu%26aufirst%3DC.%26aulast%3DBasu%26aufirst%3DK.%26aulast%3DCheewatrakoolpong%26aufirst%3DB.%26aulast%3DDeMong%26aufirst%3DD.%2BE.%26aulast%3DEllis%26aufirst%3DJ.%2BM.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMarkgraf%26aufirst%3DC.%2BG.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DPoulet%26aufirst%3DF.%2BM.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26atitle%3DMLi-2%252C%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Centrally%2520Active%2520Compound%2520for%2520Exploring%2520the%2520Therapeutic%2520Potential%2520and%2520Safety%2520of%2520LRRK2%2520Kinase%2520Inhibition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D355%26spage%3D397%26epage%3D409%26doi%3D10.1124%2Fjpet.115.227587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMong, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macala, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnihotri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Columbus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiscia, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. W.</span><span> </span><span class="NLM_article-title">Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor That Reduces Brain Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2983</span><span class="NLM_x">–</span> <span class="NLM_lpage">2992</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFaltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2983-2992&author=J.+D.+Scottauthor=D.+E.+DeMongauthor=T.+J.+Greshockauthor=K.+Basuauthor=X.+Daiauthor=J.+Harrisauthor=A.+Hruzaauthor=S.+W.+Liauthor=S.-I.+Linauthor=H.+Liuauthor=M.+K.+Macalaauthor=Z.+Huauthor=H.+Meiauthor=H.+Zhangauthor=P.+Walshauthor=M.+Poirierauthor=Z.-C.+Shiauthor=L.+Xiaoauthor=G.+Agnihotriauthor=M.+A.+S.+Baptistaauthor=J.+Columbusauthor=M.+J.+Fellauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=Y.+Linauthor=C.+Mirescuauthor=J.+A.+Morrowauthor=Z.+Yinauthor=X.+Zhangauthor=X.+Zhouauthor=R.+K.+Changauthor=M.+W.+Embreyauthor=J.+M.+Sandersauthor=H.+E.+Tisciaauthor=R.+E.+Droletauthor=J.+T.+Kernauthor=S.+M.+Surauthor=J.+J.+Rengerauthor=M.+T.+Bilodeauauthor=M.+E.+Kennedyauthor=E.+M.+Parkerauthor=A.+W.+Stamfordauthor=R.+P.+Nargundauthor=J.+A.+McCauleyauthor=M.+W.+Miller&title=Discovery+of+a+3-%284-Pyrimidinyl%29+Indazole+%28MLi-2%29%2C+an+Orally+Available+and+Selective+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Inhibitor+That+Reduces+Brain+Kinase+Activity&doi=10.1021%2Facs.jmedchem.7b00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity</span></div><div class="casAuthors">Scott, Jack D.; DeMong, Duane E.; Greshock, Thomas J.; Basu, Kallol; Dai, Xing; Harris, Joel; Hruza, Alan; Li, Sarah W.; Lin, Sue-Ing; Liu, Hong; Macala, Megan K.; Hu, Zhiyong; Mei, Hong; Zhang, Honglu; Walsh, Paul; Poirier, Marc; Shi, Zhi-Cai; Xiao, Li; Agnihotri, Gautam; Baptista, Marco A. S.; Columbus, John; Fell, Matthew J.; Hyde, Lynn A.; Kuvelkar, Reshma; Lin, Yinghui; Mirescu, Christian; Morrow, John A.; Yin, Zhizhang; Zhang, Xiaoping; Zhou, Xiaoping; Chang, Ronald K.; Embrey, Mark W.; Sanders, John M.; Tiscia, Heather E.; Drolet, Robert E.; Kern, Jonathan T.; Sur, Sylvie M.; Renger, John J.; Bilodeau, Mark T.; Kennedy, Matthew E.; Parker, Eric M.; Stamford, Andrew W.; Nargund, Ravi; McCauley, John A.; Miller, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2983-2992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Leucine-Rich Repeat Kinase 2 (LRRK2) is a large, multidomain protein which contains a kinase domain and GTPase domain among other regions.  Individuals possessing gain of function mutations in the kinase domain such as the most prevalent G2019S mutation have been assocd. with an increased risk for the development of Parkinson's Disease (PD).  Given this genetic validation for inhibition of LRRK2 kinase activity as a potential means of effecting disease progression, the team set out to develop LRRK2 inhibitors to test this hypothesis.  A high throughput screen of the compd. collection afforded a no. of promising indazole leads which were truncated in order to identify a min. pharmacophore.  Further optimization of these indazoles led to the development of MLi-2 I: a potent, highly selective, orally available, brain penetrant inhibitor of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbCbKjwmMvE7Vg90H21EOLACvtfcHk0lhRvABhTqWJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFaltL8%253D&md5=4d18d0d3288d0a9330c385776a9f0b7c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00045%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DDeMong%26aufirst%3DD.%2BE.%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DBasu%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DHruza%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DLin%26aufirst%3DS.-I.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMacala%26aufirst%3DM.%2BK.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWalsh%26aufirst%3DP.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DZ.-C.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DAgnihotri%26aufirst%3DG.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DColumbus%26aufirst%3DJ.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMirescu%26aufirst%3DC.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DTiscia%26aufirst%3DH.%2BE.%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BW.%26atitle%3DDiscovery%2520of%2520a%25203-%25284-Pyrimidinyl%2529%2520Indazole%2520%2528MLi-2%2529%252C%2520an%2520Orally%2520Available%2520and%2520Selective%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Inhibitor%2520That%2520Reduces%2520Brain%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2983%26epage%3D2992%26doi%3D10.1021%2Facs.jmedchem.7b00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chell, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daechsel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span> </span><span class="NLM_article-title">The Design and SAR of a Novel Series of 2-Aminopyridine Based LRRK2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4500</span><span class="NLM_x">–</span> <span class="NLM_lpage">4505</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2017.07.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28802631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4500-4505&author=G.+P.+Smithauthor=L.+Badoloauthor=V.+Chellauthor=I.+Chenauthor=K.+V.+Christensenauthor=L.+Davidauthor=J.+A.+Daechselauthor=M.+Hentzerauthor=M.+C.+Herzigauthor=G.+K.+Mikkelsenauthor=S.+P.+Watsonauthor=D.+S.+Williamson&title=The+Design+and+SAR+of+a+Novel+Series+of+2-Aminopyridine+Based+LRRK2+Inhibitors&doi=10.1016%2Fj.bmcl.2017.07.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors</span></div><div class="casAuthors">Smith, Garrick P.; Badolo, Lassina; Chell, Victoria; Chen, I.-Jen; Christensen, Kenneth Vielsted; David, Laurent; Daechsel, Justus Alfred; Hentzer, Morten; Herzig, Martin Christian; Mikkelsen, Gitte Kobberoee; Watson, Stephen P.; Williamson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4500-4505</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) has attracted considerable interest as a therapeutic target for the treatment of Parkinson's disease.  Compds. derived from a 2-aminopyridine screening hit were optimized using a LRRK2 homol. model based on mixed lineage kinase 1 (MLK1), such that a 2-aminopyridine-based lead mol. 45 (I), with in vivo activity, was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjU_w5MtzRrVg90H21EOLACvtfcHk0lhRvABhTqWJYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrrN&md5=6d46e7e3ed4b977e9f083c45a1923f6f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.072%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DBadolo%26aufirst%3DL.%26aulast%3DChell%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26aulast%3DDavid%26aufirst%3DL.%26aulast%3DDaechsel%26aufirst%3DJ.%2BA.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DM.%2BC.%26aulast%3DMikkelsen%26aufirst%3DG.%2BK.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26atitle%3DThe%2520Design%2520and%2520SAR%2520of%2520a%2520Novel%2520Series%2520of%25202-Aminopyridine%2520Based%2520LRRK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4500%26epage%3D4505%26doi%3D10.1016%2Fj.bmcl.2017.07.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Fuji, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubb, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katavolos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin-Koh, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roose-Girma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urkowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warming, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaylaoglu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Effect of Selective LRRK2 Kinase Inhibition on Nonhuman Primate Lung</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">273ra15</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aaa3634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1126%2Fscitranslmed.aaa3634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=25653221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=273ra15&author=R.+N.+Fujiauthor=M.+Flagellaauthor=M.+Bacaauthor=M.+A.+S.+Baptistaauthor=J.+Brodbeckauthor=B.+K.+Chanauthor=B.+K.+Fiskeauthor=L.+Honigbergauthor=A.+M.+Jubbauthor=P.+Katavolosauthor=D.+W.+Leeauthor=S.-C.+Lewin-Kohauthor=T.+Linauthor=X.+Liuauthor=S.+Liuauthor=J.+P.+Lyssikatosauthor=J.+O%E2%80%99Mahonyauthor=M.+Reicheltauthor=M.+Roose-Girmaauthor=Z.+Shengauthor=T.+Shererauthor=A.+Smithauthor=M.+Solonauthor=Z.+K.+Sweeneyauthor=J.+Tarrantauthor=A.+Urkowitzauthor=S.+Warmingauthor=M.+Yaylaogluauthor=S.+Zhangauthor=H.+Zhuauthor=A.+A.+Estradaauthor=R.+J.+Watts&title=Effect+of+Selective+LRRK2+Kinase+Inhibition+on+Nonhuman+Primate+Lung&doi=10.1126%2Fscitranslmed.aaa3634"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DBrodbeck%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DHonigberg%26aufirst%3DL.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLewin-Koh%26aufirst%3DS.-C.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DJ.%26aulast%3DReichelt%26aufirst%3DM.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DUrkowitz%26aufirst%3DA.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DYaylaoglu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DEffect%2520of%2520Selective%2520LRRK2%2520Kinase%2520Inhibition%2520on%2520Nonhuman%2520Primate%2520Lung%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D273ra15%26doi%3D10.1126%2Fscitranslmed.aaa3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Taymans, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span> </span><span class="NLM_article-title">LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1570159X13666151030102847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.2174%2F1570159X13666151030102847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26517051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=214-225&author=J.-M.+Taymansauthor=E.+Greggio&title=LRRK2+Kinase+Inhibition+as+a+Therapeutic+Strategy+for+Parkinson%E2%80%99s+Disease%2C+Where+Do+We+Stand%3F&doi=10.2174%2F1570159X13666151030102847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?</span></div><div class="casAuthors">Taymans, Jean-Marc; Greggio, Elisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">214-225</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">One of the most promising therapeutic targets for potential disease modifying treatment of Parkinson's disease (PD) is leucine-rich repeat kinase 2 (LRRK2).  Specifically, targeting LRRK2's kinase function has generated a lot of interest from both industry and academia.  This work has yielded several published studies showing the feasibility of developing potent, selective and brain permeable LRRK2 kinase inhibitors.  The availability of these exptl. drugs is contributing to filling in the gaps in our knowledge on the safety and efficacy of LRRK2 kinase inhibition.  Recent studies of LRRK2 kinase inhibition in preclin. models point to potential undesired effects in peripheral tissues such as lung and kidney.  Also, while strategies are now emerging to measure target engagement of LRRK2 inhibitors, there remains an important need to expand efficacy studies in preclin. models of progressive PD.  Future work in the LRRK2 inhibition field must therefore be directed towards developing mols. and treatment regimens which demonstrate efficacy in mammalian models of disease in conditions where safety liabilities are reduced to a min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrE-1Rx3Jzh7Vg90H21EOLACvtfcHk0lj-qj14d8f7Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCgu74%253D&md5=f68fc6814e2add4836aefe53321d1199</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1570159X13666151030102847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X13666151030102847%26sid%3Dliteratum%253Aachs%26aulast%3DTaymans%26aufirst%3DJ.-M.%26aulast%3DGreggio%26aufirst%3DE.%26atitle%3DLRRK2%2520Kinase%2520Inhibition%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%252C%2520Where%2520Do%2520We%2520Stand%253F%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2016%26volume%3D14%26spage%3D214%26epage%3D225%26doi%3D10.2174%2F1570159X13666151030102847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moehle, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli-Daley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLucas, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiyaveettil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moukha-Chafiq, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kezar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">Unique Functional and Structural Properties of the LRRK2 Protein ATP-Binding Pocket</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">32937</span><span class="NLM_x">–</span> <span class="NLM_lpage">32951</span><span class="refDoi"> DOI: 10.1074/jbc.M114.602318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1074%2Fjbc.M114.602318" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=32937-32951&author=Z.+Liuauthor=R.+A.+Galemmoauthor=K.+B.+Fraserauthor=M.+S.+Moehleauthor=S.+Senauthor=L.+A.+Volpicelli-Daleyauthor=L.+J.+DeLucasauthor=L.+J.+Rossauthor=J.+Valiyaveettilauthor=O.+Moukha-Chafiqauthor=A.+K.+Pathakauthor=S.+Ananthanauthor=H.+Kezarauthor=E.+L.+Whiteauthor=V.+Guptaauthor=J.+A.+Maddryauthor=M.+J.+Sutoauthor=A.+B.+West&title=Unique+Functional+and+Structural+Properties+of+the+LRRK2+Protein+ATP-Binding+Pocket&doi=10.1074%2Fjbc.M114.602318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.602318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.602318%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DFraser%26aufirst%3DK.%2BB.%26aulast%3DMoehle%26aufirst%3DM.%2BS.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DVolpicelli-Daley%26aufirst%3DL.%2BA.%26aulast%3DDeLucas%26aufirst%3DL.%2BJ.%26aulast%3DRoss%26aufirst%3DL.%2BJ.%26aulast%3DValiyaveettil%26aufirst%3DJ.%26aulast%3DMoukha-Chafiq%26aufirst%3DO.%26aulast%3DPathak%26aufirst%3DA.%2BK.%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DKezar%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DMaddry%26aufirst%3DJ.%2BA.%26aulast%3DSuto%26aufirst%3DM.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DUnique%2520Functional%2520and%2520Structural%2520Properties%2520of%2520the%2520LRRK2%2520Protein%2520ATP-Binding%2520Pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D32937%26epage%3D32951%26doi%3D10.1074%2Fjbc.M114.602318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a Potent LRRK2 Kinase Inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2012.01.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+Potent+LRRK2+Kinase+Inhibitor&doi=10.1016%2Fj.bmcl.2012.01.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.084%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520Potent%2520LRRK2%2520Kinase%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869%26doi%3D10.1016%2Fj.bmcl.2012.01.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Brain Penetrant LRRK2 Inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1021/ml300123a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300123a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=658-662&author=H.+G.+Choiauthor=J.+Zhangauthor=X.+Dengauthor=J.+M.+Hatcherauthor=M.+P.+Patricelliauthor=Z.+Zhaoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Brain+Penetrant+LRRK2+Inhibitor&doi=10.1021%2Fml300123a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300123a%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DBrain%2520Penetrant%2520LRRK2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D658%26epage%3D662%26doi%3D10.1021%2Fml300123a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaitsev, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span> </span><span class="NLM_article-title">Kinetic, Mechanistic, and Structural Modeling Studies of Truncated Wild-Type LRRK2 and the G2019S Mutant</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">9399</span><span class="NLM_x">–</span> <span class="NLM_lpage">9408</span><span class="refDoi"> DOI: 10.1021/bi201173d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201173d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=9399-9408&author=M.+Liuauthor=S.+Kangauthor=S.+Rayauthor=J.+Jacksonauthor=A.+D.+Zaitsevauthor=S.+A.+Gerberauthor=G.+D.+Cunyauthor=M.+A.+Glicksman&title=Kinetic%2C+Mechanistic%2C+and+Structural+Modeling+Studies+of+Truncated+Wild-Type+LRRK2+and+the+G2019S+Mutant&doi=10.1021%2Fbi201173d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi201173d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201173d%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DZaitsev%26aufirst%3DA.%2BD.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26atitle%3DKinetic%252C%2520Mechanistic%252C%2520and%2520Structural%2520Modeling%2520Studies%2520of%2520Truncated%2520Wild-Type%2520LRRK2%2520and%2520the%2520G2019S%2520Mutant%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D9399%26epage%3D9408%26doi%3D10.1021%2Fbi201173d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Göring, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taymans, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Indolinone Based LRRK2 Kinase Inhibitors with a Key Hydrogen Bond</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4630</span><span class="NLM_x">–</span> <span class="NLM_lpage">4637</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2014.08.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4630-4637&author=S.+G%C3%B6ringauthor=J.-M.+Taymansauthor=V.+Baekelandtauthor=B.+Schmidt&title=Indolinone+Based+LRRK2+Kinase+Inhibitors+with+a+Key+Hydrogen+Bond&doi=10.1016%2Fj.bmcl.2014.08.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ring%26aufirst%3DS.%26aulast%3DTaymans%26aufirst%3DJ.-M.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DIndolinone%2520Based%2520LRRK2%2520Kinase%2520Inhibitors%2520with%2520a%2520Key%2520Hydrogen%2520Bond%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4630%26epage%3D4637%26doi%3D10.1016%2Fj.bmcl.2014.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S. S.</span><span> </span><span class="NLM_article-title">Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span><span class="refDoi"> DOI: 10.1021/bi3012077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3012077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=1725-1736&author=M.+Liuauthor=S.+A.+Benderauthor=G.+D.+Cunyauthor=W.+Shermanauthor=M.+Glicksmanauthor=S.+S.+Ray&title=Type+II+Kinase+Inhibitors+Show+an+Unexpected+Inhibition+Mode+against+Parkinson%E2%80%99s+Disease-Linked+LRRK2+Mutant+G2019S&doi=10.1021%2Fbi3012077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi3012077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3012077%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DGlicksman%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DS.%2BS.%26atitle%3DType%2520II%2520Kinase%2520Inhibitors%2520Show%2520an%2520Unexpected%2520Inhibition%2520Mode%2520against%2520Parkinson%25E2%2580%2599s%2520Disease-Linked%2520LRRK2%2520Mutant%2520G2019S%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D1725%26epage%3D1736%26doi%3D10.1021%2Fbi3012077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gancia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Discovery of LRRK2 Inhibitors by Using an Ensemble of Virtual Screening Methods</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2520</span><span class="NLM_x">–</span> <span class="NLM_lpage">2527</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2017.03.098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2520-2527&author=E.+Ganciaauthor=M.+De+Grootauthor=B.+Burtonauthor=D.+E.+Clark&title=Discovery+of+LRRK2+Inhibitors+by+Using+an+Ensemble+of+Virtual+Screening+Methods&doi=10.1016%2Fj.bmcl.2017.03.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.098%26sid%3Dliteratum%253Aachs%26aulast%3DGancia%26aufirst%3DE.%26aulast%3DDe%2BGroot%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520of%2520LRRK2%2520Inhibitors%2520by%2520Using%2520an%2520Ensemble%2520of%2520Virtual%2520Screening%2520Methods%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2520%26epage%3D2527%26doi%3D10.1016%2Fj.bmcl.2017.03.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5545</span><span class="refDoi"> DOI: 10.1021/jm300452p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5536-5545&author=H.+Chenauthor=B.+K.+Chanauthor=J.+Drummondauthor=A.+A.+Estradaauthor=J.+Gunzner-Tosteauthor=X.+Liuauthor=Y.+Liuauthor=J.+Moffatauthor=D.+Shoreauthor=Z.+K.+Sweeneyauthor=T.+Tranauthor=S.+Wangauthor=G.+Zhaoauthor=H.+Zhuauthor=D.+J.+Burdick&title=Discovery+of+Selective+LRRK2+Inhibitors+Guided+by+Computational+Analysis+and+Molecular+Modeling&doi=10.1021%2Fjm300452p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></div><div class="casAuthors">Chen, Huifen; Chan, Bryan K.; Drummond, Jason; Estrada, Anthony A.; Gunzner-Toste, Janet; Liu, Xingrong; Liu, Yichin; Moffat, John; Shore, Daniel; Sweeney, Zachary K.; Tran, Thuy; Wang, Shumei; Zhao, Guiling; Zhu, Haitao; Burdick, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5536-5545</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson's disease (PD).  Potent and selective small mols. capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD.  In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homol. model was developed that provided robust guidance in the hit-to-lead optimization of small mol. LRRK2 inhibitors.  Through a combination of mol. modeling, sequence anal., and matched mol. pair (MMP) activity cliff anal., a potent and selective lead inhibitor was discovered.  The selectivity of this compd. could be understood using the LRRK2 homol. model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YrcBmeoRILVg90H21EOLACvtfcHk0lirXMpYlWeQSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D&md5=fe4d3a709a35f94e3c092b73bdb09936</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DShore%26aufirst%3DD.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520Selective%2520LRRK2%2520Inhibitors%2520Guided%2520by%2520Computational%2520Analysis%2520and%2520Molecular%2520Modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5536%26epage%3D5545%26doi%3D10.1021%2Fjm300452p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lang, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span> </span><span class="NLM_article-title">Discovery of LRRK2 Inhibitors Using Sequential in Silico Joint Pharmacophore Space (JPS) and Ensemble Docking</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2719</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2015.04.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2713-2719&author=C.+A.+Langauthor=S.+S.+Rayauthor=M.+Liuauthor=A.+K.+Singhauthor=G.+D.+Cuny&title=Discovery+of+LRRK2+Inhibitors+Using+Sequential+in+Silico+Joint+Pharmacophore+Space+%28JPS%29+and+Ensemble+Docking&doi=10.1016%2Fj.bmcl.2015.04.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DC.%2BA.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DDiscovery%2520of%2520LRRK2%2520Inhibitors%2520Using%2520Sequential%2520in%2520Silico%2520Joint%2520Pharmacophore%2520Space%2520%2528JPS%2529%2520and%2520Ensemble%2520Docking%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2713%26epage%3D2719%26doi%3D10.1016%2Fj.bmcl.2015.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Poël, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1021/ml3003007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=85-90&author=B.+K.+Chanauthor=A.+A.+Estradaauthor=H.+Chenauthor=J.+Atherallauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=S.+L.+Dominguezauthor=J.+Drummondauthor=A.+Gillauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=A.+D.+Medhurstauthor=X.+Liuauthor=J.+G.+Moffatauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=H.+Van+de+Po%C3%ABlauthor=S.+Zhangauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+a+Highly+Selective%2C+Brain-Penetrant+Aminopyrazole+LRRK2+Inhibitor&doi=10.1021%2Fml3003007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003007%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DAtherall%26aufirst%3DJ.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520Highly%2520Selective%252C%2520Brain-Penetrant%2520Aminopyrazole%2520LRRK2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D85%26epage%3D90%26doi%3D10.1021%2Fml3003007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Troxler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenidge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drückes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span> </span><span class="NLM_article-title">Discovery of Novel Indolinone-Based, Potent, Selective and Brain Penetrant Inhibitors of LRRK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4090</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2013.05.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4085-4090&author=T.+Troxlerauthor=P.+Greenidgeauthor=K.+Zimmermannauthor=S.+Desrayaudauthor=P.+Dr%C3%BCckesauthor=T.+Schweizerauthor=D.+Staufferauthor=G.+Rovelliauthor=D.+R.+Shimshek&title=Discovery+of+Novel+Indolinone-Based%2C+Potent%2C+Selective+and+Brain+Penetrant+Inhibitors+of+LRRK2&doi=10.1016%2Fj.bmcl.2013.05.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.054%26sid%3Dliteratum%253Aachs%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DGreenidge%26aufirst%3DP.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DSchweizer%26aufirst%3DT.%26aulast%3DStauffer%26aufirst%3DD.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DDiscovery%2520of%2520Novel%2520Indolinone-Based%252C%2520Potent%252C%2520Selective%2520and%2520Brain%2520Penetrant%2520Inhibitors%2520of%2520LRRK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4085%26epage%3D4090%26doi%3D10.1016%2Fj.bmcl.2013.05.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phoa, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemin, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">Optimisation of LRRK2 Inhibitors and Assessment of Functional Efficacy in Cell-Based Models of Neuroinflammation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.ejmech.2015.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=25791676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=29-34&author=L.+Munozauthor=M.+E.+Kavanaghauthor=A.+F.+Phoaauthor=B.+Hengauthor=N.+Dzamkoauthor=E.-J.+Chenauthor=M.+R.+Doddareddyauthor=G.+J.+Guilleminauthor=M.+Kassiou&title=Optimisation+of+LRRK2+Inhibitors+and+Assessment+of+Functional+Efficacy+in+Cell-Based+Models+of+Neuroinflammation&doi=10.1016%2Fj.ejmech.2015.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation</span></div><div class="casAuthors">Munoz, Lenka; Kavanagh, Madeline E.; Phoa, Athena F.; Heng, Benjamin; Dzamko, Nicolas; Chen, Ew-Jun; Doddareddy, Munikumar Reddy; Guillemin, Gilles J.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-34</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">LRRK2IN1 is a highly potent inhibitor of leucine-rich repeat kinase 2 (LRRK2, IC50 = 7.9 nM), an established target for treatment of Parkinson's disease.  Two LRRK2IN1 analogs 2-[[4-[(1,4'-bipiperidine)-1'-carbonyl]-2-chlorophenyl]amino]-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one (1) and (1,4'-bipiperidin)-1'-yl[3-chloro-4-[[5,11-dimethyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-2-yl]amino]phenyl]methanone (2) were synthesized which retained LRRK2 inhibitory activity (1: IC50 = 72 nM; 2: IC50 = 51 nM), were predicted to have improved bioavailability and were efficacious in cell-based models of neuroinflammation.  Analog (1) inhibited IL-6 secretion from LPS-stimulated primary human microglia with EC50 = 4.26 μM.  To further optimize the mol. properties of LRRK2IN1, a library of truncated analogs was designed based on docking studies.  Despite lacking LRRK2 inhibitory activity, these compds. show anti-neuroinflammatory efficacy at micromolar concn.  The compds. developed were valuable tools in establishing a cell-based assay for assessing anti-neuroinflammatory efficacy of LRRK2 inhibitors.  Herein, the authors present data that IL-1β stimulated U87 glioma cell line is a reliable model for neuroinflammation, as data obtained in this model were consistent with results obtained using primary human microglia and astrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdjPn76kjM8rVg90H21EOLACvtfcHk0lh4B4__PWTJbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCjt7w%253D&md5=d5a15af430d40594df5b071c5efebdc9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DKavanagh%26aufirst%3DM.%2BE.%26aulast%3DPhoa%26aufirst%3DA.%2BF.%26aulast%3DHeng%26aufirst%3DB.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DE.-J.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DOptimisation%2520of%2520LRRK2%2520Inhibitors%2520and%2520Assessment%2520of%2520Functional%2520Efficacy%2520in%2520Cell-Based%2520Models%2520of%2520Neuroinflammation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D29%26epage%3D34%26doi%3D10.1016%2Fj.ejmech.2015.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Discovery of 4-Alkylamino-7-Aryl-3-Cyanoquinoline LRRK2 Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2013.02.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1974-1977&author=A.+W.+Garofaloauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=E.+F.+Brighamauthor=D.+Chianauthor=M.+Franziniauthor=E.+Goldbachauthor=G.+T.+Kwongauthor=R.+Motterauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=L.+Ruslimauthor=H.+L.+Shamauthor=D.+Tamauthor=P.+Tanakaauthor=A.+P.+Truongauthor=X.+M.+Yeauthor=Z.+Ren&title=Discovery+of+4-Alkylamino-7-Aryl-3-Cyanoquinoline+LRRK2+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2013.02.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.041%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChian%26aufirst%3DD.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DKwong%26aufirst%3DG.%2BT.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DP.%26aulast%3DTruong%26aufirst%3DA.%2BP.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%25204-Alkylamino-7-Aryl-3-Cyanoquinoline%2520LRRK2%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1974%26epage%3D1977%26doi%3D10.1016%2Fj.bmcl.2013.02.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Triazolopyridazine LRRK2 Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2013.02.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1967-1973&author=M.+Franziniauthor=X.+M.+Yeauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=A.+W.+Garofaloauthor=S.+Gaubyauthor=E.+Goldbachauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=P.+Santiagoauthor=H.+L.+Shamauthor=D.+Tamauthor=A.+Truongauthor=Z.+Ren&title=Triazolopyridazine+LRRK2+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2013.02.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.043%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DGauby%26aufirst%3DS.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSantiago%26aufirst%3DP.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTruong%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DTriazolopyridazine%2520LRRK2%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1967%26epage%3D1973%26doi%3D10.1016%2Fj.bmcl.2013.02.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eatherton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandu, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philps, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, F.</span><span> </span><span class="NLM_article-title">Discovery of 5-Substituent-<i>N</i>-Arylbenzamide Derivatives as Potent, Selective and Orally Bioavailable LRRK2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4034</span><span class="NLM_x">–</span> <span class="NLM_lpage">4038</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2017.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4034-4038&author=X.+Dingauthor=X.+Daiauthor=K.+Longauthor=C.+Pengauthor=D.+Andreottiauthor=P.+Bamboroughauthor=A.+J.+Eathertonauthor=C.+Edgeauthor=K.+S.+Janduauthor=P.+L.+Nicholsauthor=O.+J.+Philpsauthor=L.+P.+Stasiauthor=Z.+Wanauthor=J.-N.+Xiangauthor=K.+Dongauthor=P.+Dossangauthor=M.-H.+Hoauthor=Y.+Liauthor=L.+Mensahauthor=X.+Guanauthor=A.+D.+Reithauthor=F.+Ren&title=Discovery+of+5-Substituent-N-Arylbenzamide+Derivatives+as+Potent%2C+Selective+and+Orally+Bioavailable+LRRK2+Inhibitors&doi=10.1016%2Fj.bmcl.2017.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DLong%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DEatherton%26aufirst%3DA.%2BJ.%26aulast%3DEdge%26aufirst%3DC.%26aulast%3DJandu%26aufirst%3DK.%2BS.%26aulast%3DNichols%26aufirst%3DP.%2BL.%26aulast%3DPhilps%26aufirst%3DO.%2BJ.%26aulast%3DStasi%26aufirst%3DL.%2BP.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DDossang%26aufirst%3DP.%26aulast%3DHo%26aufirst%3DM.-H.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMensah%26aufirst%3DL.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DDiscovery%2520of%25205-Substituent-N-Arylbenzamide%2520Derivatives%2520as%2520Potent%252C%2520Selective%2520and%2520Orally%2520Bioavailable%2520LRRK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4034%26epage%3D4038%26doi%3D10.1016%2Fj.bmcl.2017.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Substrate Specificity and Inhibitors of LRRK2, a Protein Kinase Mutated in Parkinson’s Disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1042/BJ20091035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1042%2FBJ20091035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2009&pages=47-60&author=R.+J.+Nicholsauthor=N.+Dzamkoauthor=J.+E.+Huttiauthor=L.+C.+Cantleyauthor=M.+Deakauthor=J.+Moranauthor=P.+Bamboroughauthor=A.+D.+Reithauthor=D.+R.+Alessi&title=Substrate+Specificity+and+Inhibitors+of+LRRK2%2C+a+Protein+Kinase+Mutated+in+Parkinson%E2%80%99s+Disease&doi=10.1042%2FBJ20091035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1042%2FBJ20091035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091035%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHutti%26aufirst%3DJ.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSubstrate%2520Specificity%2520and%2520Inhibitors%2520of%2520LRRK2%252C%2520a%2520Protein%2520Kinase%2520Mutated%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D424%26spage%3D47%26epage%3D60%26doi%3D10.1042%2FBJ20091035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Yun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DooKim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seol, W.</span><span> </span><span class="NLM_article-title">Identification of Chemicals to Inhibit the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2), a Parkinson’s Disease-Associated Protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2953</span><span class="NLM_x">–</span> <span class="NLM_lpage">2957</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2011.03.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2953-2957&author=H.+Yunauthor=H.+Y.+Heoauthor=H.+H.+Kimauthor=N.+DooKimauthor=W.+Seol&title=Identification+of+Chemicals+to+Inhibit+the+Kinase+Activity+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29%2C+a+Parkinson%E2%80%99s+Disease-Associated+Protein&doi=10.1016%2Fj.bmcl.2011.03.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DH.%26aulast%3DHeo%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BH.%26aulast%3DDooKim%26aufirst%3DN.%26aulast%3DSeol%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520Chemicals%2520to%2520Inhibit%2520the%2520Kinase%2520Activity%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%252C%2520a%2520Parkinson%25E2%2580%2599s%2520Disease-Associated%2520Protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2953%26epage%3D2957%26doi%3D10.1016%2Fj.bmcl.2011.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiscia, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Potent, Selective and Orally Bioavailable Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2631</span><span class="NLM_x">–</span> <span class="NLM_lpage">2635</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2016.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=27106707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFynsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2631-2635&author=T.+J.+Greshockauthor=J.+M.+Sandersauthor=R.+E.+Droletauthor=H.+A.+Rajapakseauthor=R.+K.+Changauthor=B.+Kimauthor=V.+L.+Radaauthor=H.+E.+Tisciaauthor=H.+Suauthor=M.-T.+Laiauthor=S.+M.+Surauthor=R.+I.+Sanchezauthor=M.+T.+Bilodeauauthor=J.+J.+Rengerauthor=J.+T.+Kernauthor=J.+A.+McCauley&title=Potent%2C+Selective+and+Orally+Bioavailable+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Inhibitors&doi=10.1016%2Fj.bmcl.2016.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors</span></div><div class="casAuthors">Greshock, Thomas J.; Sanders, John M.; Drolet, Robert E.; Rajapakse, Hemaka A.; Chang, Ronald K.; Kim, Boyoung; Rada, Vanessa L.; Tiscia, Heather E.; Su, Hua; Lai, Ming-Tain; Sur, Sylvie M.; Sanchez, Rosa I.; Bilodeau, Mark T.; Renger, John J.; Kern, Jonathan T.; McCauley, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2631-2635</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Familial Parkinson's disease cases have recently been assocd. with the leucine rich repeat kinase 2 (LRRK2) gene.  It has been hypothesized that inhibition of the LRRK2 protein may have the potential to alter disease pathogenesis.  A dihydrobenzothiophene series of potent, selective, orally bioavailable LRRK2 inhibitors were identified from a high-throughput screen of the internal Merck sample collection.  Initial SAR studies around the core established the series as a tractable small mol. lead series of LRRK2 inhibitors for potential treatment of Parkinson's disease.  It was also found that incorporation of a lactam into the core drastically improved the CNS and DMPK properties of these small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLXQXzXljjB7Vg90H21EOLACvtfcHk0ljxhh8w9aneUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFynsLc%253D&md5=50dcf355189aba4facaba45fd0aac592</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DRada%26aufirst%3DV.%2BL.%26aulast%3DTiscia%26aufirst%3DH.%2BE.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DSanchez%26aufirst%3DR.%2BI.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DPotent%252C%2520Selective%2520and%2520Orally%2520Bioavailable%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2631%26epage%3D2635%26doi%3D10.1016%2Fj.bmcl.2016.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span> </span><span class="NLM_article-title">Kinase Domain Inhibition of Leucine Rich Repeat Kinase 2 (LRRK2) Using a [1,2,4]triazolo[4,3-<i>b</i>]pyridazine Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4132</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2014.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4132-4140&author=P.+Galatsisauthor=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=S.+Hanauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirst&title=Kinase+Domain+Inhibition+of+Leucine+Rich+Repeat+Kinase+2+%28LRRK2%29+Using+a+%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazine+Scaffold&doi=10.1016%2Fj.bmcl.2014.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26atitle%3DKinase%2520Domain%2520Inhibition%2520of%2520Leucine%2520Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Using%2520a%2520%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazine%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4132%26epage%3D4140%26doi%3D10.1016%2Fj.bmcl.2014.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Haastert, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Roco Kinase Structures Give Insights into the Mechanism of Parkinson Disease-Related Leucine-Rich-Repeat Kinase 2 Mutations</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">10322</span><span class="NLM_x">–</span> <span class="NLM_lpage">10327</span><span class="refDoi"> DOI: 10.1073/pnas.1203223109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1073%2Fpnas.1203223109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22689969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWgt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=10322-10327&author=B.+K.+Gilsbachauthor=F.+Y.+Hoauthor=I.+R.+Vetterauthor=P.+J.+M.+van+Haastertauthor=A.+Wittinghoferauthor=A.+Kortholt&title=Roco+Kinase+Structures+Give+Insights+into+the+Mechanism+of+Parkinson+Disease-Related+Leucine-Rich-Repeat+Kinase+2+Mutations&doi=10.1073%2Fpnas.1203223109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations</span></div><div class="casAuthors">Gilsbach, Bernd K.; Ho, Franz Y.; Vetter, Ingrid R.; van Haastert, Peter J. M.; Wittinghofer, Alfred; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10322-10327, S10322/1-S10322/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in human leucine-rich-repeat kinase 2 (LRRK2) have been found to be the most frequent cause of late-onset Parkinson disease.  Here we show that Dictyostelium discoideum Roco4 is a suitable model to study the structural and biochem. characteristics of the LRRK2 kinase and can be used for optimization of current and identification of new LRRK2 inhibitors.  We have solved the structure of Roco4 kinase wild-type, Parkinson disease-related mutants G1179S and L1180T (G2019S and 12020T in LRRK2) and the structure of Roco4 kinase in complex with the LRRK2 inhibitor H1 152.  Taken together, our data give important insight in the LRRK2 activation mechanism and, most importantly, explain the G2019S- related increase in LRRK2 kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9QBSj5K0PrVg90H21EOLACvtfcHk0ljxhh8w9aneUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWgt7rO&md5=9434ba22e421025a17e354f66402f194</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1203223109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1203223109%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DHo%26aufirst%3DF.%2BY.%26aulast%3DVetter%26aufirst%3DI.%2BR.%26aulast%3Dvan%2BHaastert%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DRoco%2520Kinase%2520Structures%2520Give%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Parkinson%2520Disease-Related%2520Leucine-Rich-Repeat%2520Kinase%25202%2520Mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D10322%26epage%3D10327%26doi%3D10.1073%2Fpnas.1203223109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messias, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Structural Characterization of LRRK2 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3751</span><span class="NLM_x">–</span> <span class="NLM_lpage">3756</span><span class="refDoi"> DOI: 10.1021/jm5018779</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5018779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3751-3756&author=B.+K.+Gilsbachauthor=A.+C.+Messiasauthor=G.+Itoauthor=M.+Sattlerauthor=D.+R.+Alessiauthor=A.+Wittinghoferauthor=A.+Kortholt&title=Structural+Characterization+of+LRRK2+Inhibitors&doi=10.1021%2Fjm5018779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Characterization of LRRK2 Inhibitors</span></div><div class="casAuthors">Gilsbach, Bernd K.; Messias, Ana C.; Ito, Genta; Sattler, Michael; Alessi, Dario R.; Wittinghofer, Alfred; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3751-3756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibition is considered to be an important therapeutic target for LRRK2 mediated Parkinson's disease (PD).  Many LRRK2 kinase inhibitors have been reported but have yet to be optimized in order to qualify as drug candidates for the treatment of the disease.  In order to start a structure-function anal. of such inhibitors, we mutated the active site of Dictyostelium Roco4 kinase to resemble LRRK2.  Here, we show satn. transfer difference (STD) NMR and the first cocrystal structures of two potent in vitro inhibitors, LRRK2-IN-1 and compd. 19, with mutated Roco4.  Our data demonstrate that this system can serve as an excellent tool for the structural characterization and optimization of LRRK2 inhibitors using X-ray crystallog. and NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC3zihwkAhp7Vg90H21EOLACvtfcHk0ljxrXhP_-SI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOitbc%253D&md5=48a13492467bdad081fede8662764285</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm5018779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018779%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DMessias%26aufirst%3DA.%2BC.%26aulast%3DIto%26aufirst%3DG.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DStructural%2520Characterization%2520of%2520LRRK2%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3751%26epage%3D3756%26doi%3D10.1021%2Fjm5018779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0ljxrXhP_-SI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>Molecular Operating Environment (MOE), version <span class="NLM_edition">2016.0802</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc</span>: <span class="NLM_publisher-loc">Montreal, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+version+2016.0802%3B+Chemical+Computing+Group+Inc%3A+Montreal%2C+Canada%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Massey, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiumana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrace, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallowfield, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span> </span><span class="NLM_article-title">Identification of Novel, in Vivo Active Chk1 Inhibitors Utilizing Structure Guided Drug Design</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">35797</span><span class="NLM_x">–</span> <span class="NLM_lpage">35812</span><span class="refDoi"> DOI: 10.18632/oncotarget.5929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.18632%2Foncotarget.5929" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=35797-35812&author=A.+J.+Masseyauthor=S.+Stokesauthor=H.+Browneauthor=N.+Foloppeauthor=A.+Fiumanaauthor=S.+Scraceauthor=M.+Fallowfieldauthor=S.+Bedfordauthor=P.+Webbauthor=L.+Bakerauthor=M.+Christieauthor=M.+J.+Drysdaleauthor=M.+Wood&title=Identification+of+Novel%2C+in+Vivo+Active+Chk1+Inhibitors+Utilizing+Structure+Guided+Drug+Design&doi=10.18632%2Foncotarget.5929"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5929%26sid%3Dliteratum%253Aachs%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFiumana%26aufirst%3DA.%26aulast%3DScrace%26aufirst%3DS.%26aulast%3DFallowfield%26aufirst%3DM.%26aulast%3DBedford%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DChristie%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Novel%252C%2520in%2520Vivo%2520Active%2520Chk1%2520Inhibitors%2520Utilizing%2520Structure%2520Guided%2520Drug%2520Design%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D35797%26epage%3D35812%26doi%3D10.18632%2Foncotarget.5929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">–</span> <span class="NLM_lpage">4345</span><span class="refDoi"> DOI: 10.1021/jm049022c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049022c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVWrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4332-4345&author=N.+Foloppeauthor=L.+M.+Fisherauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potterauthor=A.+G.+S.+Robertsonauthor=A.+E.+Surgenor&title=Structure-Based+Design+of+Novel+Chk1+Inhibitors%3A+Insights+into+Hydrogen+Bonding+and+Protein-Ligand+Affinity&doi=10.1021%2Fjm049022c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity</span></div><div class="casAuthors">Foloppe, Nicolas; Fisher, Lisa M.; Howes, Rob; Kierstan, Peter; Potter, Andrew; Robertson, Alan G. S.; Surgenor, Allan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4332-4345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery, synthesis, and crystallog. binding mode of novel furopyrimidine and pyrrolopyrimidine inhibitors I (X = O, NH; R1 = H, R2 = HOCH2CH2, HO2CCH2, MeOCH2CH2, etc.; R1 = Me, R2 = HOCH2CH2) of the Chk1 kinase, an oncol. target, are reported.  These inhibitors are synthetically tractable and inhibit Chk1 by competing for its ATP site.  A chronol. account allows an objective comparison of modeled compd. docking modes to the subsequently obtained crystal structures.  The comparison provides insights regarding the interpretation of modeling results, in relationship to the multiple reasonable docking modes which may be obtained in a kinase-ATP site.  The crystal structures were used to guide medicinal chem. efforts.  This led to a thorough characterization of a pair of ligand-protein complexes which differ by a single hydrogen bond.  An anal. indicates that this hydrogen bond is expected to contribute a fraction of the 10-fold change in binding affinity, adding a valuable observation to the debate about the energetic role of hydrogen bonding in mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFPaHpTfrMgLVg90H21EOLACvtfcHk0ljxrXhP_-SI1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVWrsbo%253D&md5=a7a8b8b210d73096f09e82990c6191a7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm049022c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049022c%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%2BS.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Chk1%2520Inhibitors%253A%2520Insights%2520into%2520Hydrogen%2520Bonding%2520and%2520Protein-Ligand%2520Affinity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4332%26epage%3D4345%26doi%3D10.1021%2Fjm049022c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Hermanson, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, K.</span><span> </span><span class="NLM_article-title">Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e43580</span><span class="refDoi"> DOI: 10.1371/journal.pone.0043580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1371%2Fjournal.pone.0043580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22952710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yktb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43580&author=S.+B.+Hermansonauthor=C.+B.+Carlsonauthor=S.+M.+Riddleauthor=J.+Zhaoauthor=K.+W.+Vogelauthor=R.+J.+Nicholsauthor=K.+Bi&title=Screening+for+Novel+LRRK2+Inhibitors+Using+a+High-Throughput+TR-FRET+Cellular+Assay+for+LRRK2+Ser935+Phosphorylation&doi=10.1371%2Fjournal.pone.0043580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation</span></div><div class="casAuthors">Hermanson, Spencer B.; Carlson, Coby B.; Riddle, Steven M.; Zhao, Jing; Vogel, Kurt W.; Nichols, R. Jeremy; Bi, Kun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43580</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Mutations in the leucine-rich repeat kinase-2 (LRRK2) have been linked to Parkinson's disease.  Recent studies show that inhibition of LRRK2 kinase activity decreased the level of phosphorylation at its own Ser910 and Ser935, indicating that these sites are prime targets for cellular readouts of LRRK2 inhibition.  Methodol./Principal Findings: Using Time-Resolved Forster Resonance Energy Transfer (TR-FRET) technol., we developed a high-throughput cellular assay for monitoring LRRK2 phosphorylation at Ser935.  LRRK2-Green Fluorescence Protein (GFP) fusions were expressed in cells via BacMam.  Phosphorylation at Ser935 in these cells is detected using a terbium labeled anti-phospho-Ser935 antibody that generates a TR-FRET signal between terbium and GFP.  LRRK2 wild-type and G2019S are constitutively phosphorylated at Ser935 in cells as measured by TR-FRET.  The phosphorylation level is reduced for the R1441C mutant and little could be detected for the kinase-dead mutant D1994A.  The TR-FRET cellular assay was further validated using reported LRRK2 inhibitors including LRRK2-IN-1 and our results confirmed that inhibition of LRRK2 can reduce the phosphorylation level at Ser935.  To demonstrate the utility of this assay for screening, we profiled a small library of 1120 compds.  Three known LRRK2 inhibitors were identified and 16 hits were followed up in the TR-FRET and a cytotoxicity assay.  Interestingly, out of the top 16 hits, five are known inhibitors of IκB phosphorylation, two CHK1 and two CDC25 inhibitors.  Thirteen hits were further tested in a biochem. LRRK2 kinase activity assay and Western blot anal. for their effects on the phosphorylation of Ser910, Ser935, Ser955 and Ser973.  Conclusions/Significance: We developed a TR-FRET cellular assay for LRRK2 Ser935 phosphorylation that can be applied to the screening for LRRK2 inhibitors.  We report for the first time that several compds. such as IKK16, CHK1 inhibitors and GW441756 can inhibit LRRK2 Ser935 phosphorylation in cells and LRRK2 kinase activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_56Cqq9eWnbVg90H21EOLACvtfcHk0lg6rHWagRbK3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yktb7I&md5=adbdb9b8d5812e3d908646240541921b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043580%26sid%3Dliteratum%253Aachs%26aulast%3DHermanson%26aufirst%3DS.%2BB.%26aulast%3DCarlson%26aufirst%3DC.%2BB.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DK.%2BW.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DBi%26aufirst%3DK.%26atitle%3DScreening%2520for%2520Novel%2520LRRK2%2520Inhibitors%2520Using%2520a%2520High-Throughput%2520TR-FRET%2520Cellular%2520Assay%2520for%2520LRRK2%2520Ser935%2520Phosphorylation%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43580%26doi%3D10.1371%2Fjournal.pone.0043580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. S.</span><span> </span><span class="NLM_article-title">Structural Basis for Chk1 Inhibition by UCN-01</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">46609</span><span class="NLM_x">–</span> <span class="NLM_lpage">46615</span><span class="refDoi"> DOI: 10.1074/jbc.M201233200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1074%2Fjbc.M201233200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=12244092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46609-46615&author=B.+Zhaoauthor=M.+J.+Bowerauthor=P.+J.+McDevittauthor=H.+Zhaoauthor=S.+T.+Davisauthor=K.+O.+Johansonauthor=S.+M.+Greenauthor=N.+O.+Conchaauthor=B.+S.+Zhou&title=Structural+Basis+for+Chk1+Inhibition+by+UCN-01&doi=10.1074%2Fjbc.M201233200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Chk1 Inhibition by UCN-01</span></div><div class="casAuthors">Zhao, Baoguang; Bower, Michael J.; McDevitt, Patrick J.; Zhao, Huizhen; Davis, Stephen T.; Johanson, Kyung O.; Green, Susan M.; Concha, Nestor O.; Zhou, Bin-Bing S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46609-46615</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chk1 is a serine-threonine kinase that plays an important role in the DNA damage response, including G2/M cell cycle control.  UCN-01 (7-hydroxystaurosporine), currently in clin. trials, has recently been shown to be a potent Chk1 inhibitor that abrogates the G2/M checkpoint induced by DNA-damaging agents.  To understand the structural basis of Chk1 inhibition by UCN-01, we detd. the crystal structure of the Chk1 kinase domain in complex with UCN-01.  Chk1 structures with staurosporine and its analog SB-218078 were also detd.  All three compds. bind in the ATP-binding pocket of Chk1, producing only slight changes in the protein conformation.  Selectivity of UCN-01 toward Chk1 over cyclin-dependent kinases can be explained by the presence of a hydroxyl group in the lactam moiety interacting with the ATP-binding pocket.  Hydrophobic interactions and hydrogen-bonding interactions were obsd. in the structures between UCN-01 and the Chk1 kinase domain.  The high structural complementarity of these interactions is consistent with the potency and selectivity of UCN-01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6biZWQjRI0rVg90H21EOLACvtfcHk0lg6rHWagRbK3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D&md5=bc5ab22df94aa4f458f752a808d49a92</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M201233200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M201233200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%2BJ.%26aulast%3DMcDevitt%26aufirst%3DP.%2BJ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DS.%2BT.%26aulast%3DJohanson%26aufirst%3DK.%2BO.%26aulast%3DGreen%26aufirst%3DS.%2BM.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DZhou%26aufirst%3DB.%2BS.%26atitle%3DStructural%2520Basis%2520for%2520Chk1%2520Inhibition%2520by%2520UCN-01%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46609%26epage%3D46615%26doi%3D10.1074%2Fjbc.M201233200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">DeLano, W. L.</span>The PyMOL Molecular Graphics System, version <span class="NLM_edition">1.8.6.0</span>; <span class="NLM_publisher-name">Schrödinger LLC</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+L.+DeLano&title=The+PyMOL+Molecular+Graphics+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Nichols, P. L.; Eatherton, A. J.; Bamborough, P.; Jandu, K. S.; Philps, O. J.; Andreotti, D.</span><span> </span><span class="NLM_article-title">Novel Compounds</span>. WO 2011/038572,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+L.+Nichols&author=A.+J.+Eatherton&author=P.+Bamborough&author=K.+S.+Jandu&author=O.+J.+Philps&author=D.+Andreotti&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Afsari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nippe, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, C. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, A. R.</span><span> </span><span class="NLM_article-title">Abnormal Visual Gain Control in a Parkinson’s Disease Model</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4465</span><span class="NLM_x">–</span> <span class="NLM_lpage">4478</span><span class="refDoi"> DOI: 10.1093/hmg/ddu159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1093%2Fhmg%2Fddu159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24718285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=4465-4478&author=F.+Afsariauthor=K.+V.+Christensenauthor=G.+P.+Smithauthor=M.+Hentzerauthor=O.+M.+Nippeauthor=C.+J.+H.+Elliottauthor=A.+R.+Wade&title=Abnormal+Visual+Gain+Control+in+a+Parkinson%E2%80%99s+Disease+Model&doi=10.1093%2Fhmg%2Fddu159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal visual gain control in a Parkinson's disease model</span></div><div class="casAuthors">Afsari, Farinaz; Christensen, Kenneth V.; Smith, Garrick Paul; Hentzer, Morten; Nippe, Olivia M.; Elliott, Christopher J. H.; Wade, Alex R.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4465-4478</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Our understanding of Parkinson's disease (PD) has been revolutionized by the discovery of disease-causing genetic mutations.  The most common of these is the G2019S mutation in the LRRK2 kinase gene, which leads to increased kinase activity.  However, the link between increased kinase activity and PD is unclear.  Previously, we showed that dopaminergic expression of the human LRRK2-G2019S transgene in flies led to an activity-dependent loss of vision in older animals and we hypothesized that this may have been preceded by a failure to regulate neuronal activity correctly in younger animals.  To test this hypothesis, we used a sensitive measure of visual function based on frequency-tagged steady-state visually evoked potentials.  Spectral anal. allowed us to identify signals from multiple levels of the fly visual system and wild-type visual response curves were qual. similar to those from human cortex.  Dopaminergic expression of hLRRK2-G2019S increased contrast sensitivity throughout the retinal network.  To test whether this was due to increased kinase activity, we fed Drosophila with kinase inhibitors targeted at LRRK2.  Contrast sensitivity in both day 1 and day 14 flies was normalized by a novel LRRK2 kinase inhibitor 'BMPPB-32'.  Biochem. and cellular assays suggested that BMPPB-32 would be a more specific kinase inhibitor than LRRK2-IN-1.  We confirmed this in vivo, finding that dLRRK- null flies show large off-target effects with LRRK2-IN-1 but not BMPPB-32.  Our data link the increased Kinase activity of the G2019S-LRRK2 mutation to neuronal dysfunction and demonstrate the power of the Drosophila visual system in assaying the neurol. effects of genetic diseases and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_glJRmFOqrVg90H21EOLACvtfcHk0lg6rHWagRbK3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF&md5=8804121c354a2d548151649497b52bdb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu159%26sid%3Dliteratum%253Aachs%26aulast%3DAfsari%26aufirst%3DF.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DNippe%26aufirst%3DO.%2BM.%26aulast%3DElliott%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DWade%26aufirst%3DA.%2BR.%26atitle%3DAbnormal%2520Visual%2520Gain%2520Control%2520in%2520a%2520Parkinson%25E2%2580%2599s%2520Disease%2520Model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D4465%26epage%3D4478%26doi%3D10.1093%2Fhmg%2Fddu159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Ding, X.; Liu, Q.; Sang, Y.; Stasi, L. P.; Wan, Z.; Zhao, B.; Edge, C. M.</span><span> </span><span class="NLM_article-title">Compounds</span>. WO 2015/113452,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=X.+Ding&author=Q.+Liu&author=Y.+Sang&author=L.+P.+Stasi&author=Z.+Wan&author=B.+Zhao&author=C.+M.+Edge&title=Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DX.%26atitle%3DCompounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Augelli-Szafran, C. E.; Suto, M.; Galemmo, R.; Moukha-Chafiq, O.; Gupta, V.; Ananthan, S.</span><span> </span><span class="NLM_article-title">Pyrrolopyrimdine Compounds, Use as Inhibitors of the Kinase LRRK2, and Methods for Preparation Thereof</span>. US 2017/0174694,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+E.+Augelli-Szafran&author=M.+Suto&author=R.+Galemmo&author=O.+Moukha-Chafiq&author=V.+Gupta&author=S.+Ananthan&title=Pyrrolopyrimdine+Compounds%2C+Use+as+Inhibitors+of+the+Kinase+LRRK2%2C+and+Methods+for+Preparation+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAugelli-Szafran%26aufirst%3DC.%2BE.%26atitle%3DPyrrolopyrimdine%2520Compounds%252C%2520Use%2520as%2520Inhibitors%2520of%2520the%2520Kinase%2520LRRK2%252C%2520and%2520Methods%2520for%2520Preparation%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Estrada, A. A.; Feng, J. A.; Lyssikatos, J. P.; Sweeney, Z. K.; De Vicente Fidalgo, J.</span><span> </span><span class="NLM_article-title">Compound, Compositions and Methods</span>. WO 2017/087905,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+A.+Estrada&author=J.+A.+Feng&author=J.+P.+Lyssikatos&author=Z.+K.+Sweeney&author=J.+De+Vicente+Fidalgo&title=Compound%2C+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26atitle%3DCompound%252C%2520Compositions%2520and%2520Methods%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Galatsis, P.; Hayward, M. M.; Kormos, B. L.; Wager, T. T.; Zhang, L.; Henderson, J. L.; Kurumbail, R. G.; Verhoest, P. R.; Stepan, A. F.</span><span> </span><span class="NLM_article-title">Novel 3,4-Disubstituted 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridines and 4,5-Disubstituted-7<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridazines as LRRK2 Inhibitors</span>. WO 2015/092592,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+Galatsis&author=M.+M.+Hayward&author=B.+L.+Kormos&author=T.+T.+Wager&author=L.+Zhang&author=J.+L.+Henderson&author=R.+G.+Kurumbail&author=P.+R.+Verhoest&author=A.+F.+Stepan&title=Novel+3%2C4-Disubstituted+1H-Pyrrolo%5B2%2C3-b%5Dpyridines+and+4%2C5-Disubstituted-7H-pyrrolo%5B2%2C3-c%5Dpyridazines+as+LRRK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DNovel%25203%252C4-Disubstituted%25201H-Pyrrolo%255B2%252C3-b%255Dpyridines%2520and%25204%252C5-Disubstituted-7H-pyrrolo%255B2%252C3-c%255Dpyridazines%2520as%2520LRRK2%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Brough, P.; Drysdale, M.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine Derivatives Useful as Hsp90 Inhibitors</span>. WO 2008/025947,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Brough&author=M.+Drysdale&title=1H-Pyrrolo%5B2%2C3-b%5Dpyridine+Derivatives+Useful+as+Hsp90+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%26atitle%3D1H-Pyrrolo%255B2%252C3-b%255Dpyridine%2520Derivatives%2520Useful%2520as%2520Hsp90%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Development and Optimization of a Binding Assay for the XIAP BIR3 Domain Using Fluorescence Polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1016/j.ab.2004.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.ab.2004.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15325294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=261-273&author=Z.+Nikolovska-Coleskaauthor=R.+Wangauthor=X.+Fangauthor=H.+Panauthor=Y.+Tomitaauthor=P.+Liauthor=P.+P.+Rollerauthor=K.+Krajewskiauthor=N.+G.+Saitoauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Development+and+Optimization+of+a+Binding+Assay+for+the+XIAP+BIR3+Domain+Using+Fluorescence+Polarization&doi=10.1016%2Fj.ab.2004.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang; Pan, Hongguang; Tomita, York; Li, Peng; Roller, Peter P.; Krajewski, Krzysztof; Saito, Naoyuki G.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The X-linked inhibitor of apoptosis protein (XIAP) is a potent cellular inhibitor of apoptosis.  Designing small-mol. inhibitors that target the BIR3 domain of XIAP, where Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI) and caspase-9 bind, is a promising strategy for inhibiting the antiapoptotic activity of XIAP and for overcoming apoptosis resistance of cancer cells mediated by XIAP.  Herein, we report the development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-mol. inhibitors to the BIR3 domain of XIAP.  Among four fluorescent probes tested, a mutated N-terminal Smac peptide (AbuRPFK-(5-Fam)-NH2) showed the highest affinity (Kd = 17.92 nM) and a large dynamic range (ΔmP=231±0.9), and was selected as the most suitable probe for the binding assay.  The binding conditions (DMSO tolerance and stability) have been investigated.  Under optimized conditions, a Z' factor of 0.88 was achieved in a 96-well format for high-throughput screening.  It was found that the popular Cheng-Prusoff equation is invalid for the calcn. of the competitive inhibition consts. (Ki values) for inhibitors in the FP-based competitive binding assay conditions, and accordingly, a new math. equation was developed, validated, and used to compute the Ki values.  An assocd. Web-based computer program was also developed for this task.  Several known Smac peptides with high and low affinities have been evaluated under the assay conditions and the results obtained indicated that the FP-based competitive binding assay performs correctly as designed: it can quant. and accurately det. the binding affinities of Smac-based peptide inhibitors with a wide range of affinities, and is suitable for high-throughput screening of inhibitors binding to the XIAP BIR3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjEsqtWsZRbVg90H21EOLACvtfcHk0ljRYGo_EuLrSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D&md5=23cade47a4996c7ca4c01278d3e0d3a6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520Optimization%2520of%2520a%2520Binding%2520Assay%2520for%2520the%2520XIAP%2520BIR3%2520Domain%2520Using%2520Fluorescence%2520Polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ab.2004.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: A Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+A+Useful+Metric+for+Lead+Selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaXbMA1efcG7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520A%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Bedford, S. T.; Chen, I.; Wang, Y.; Williamson, D. S.</span><span> </span><span class="NLM_article-title">Arylpyrrolopyridine Derived Compounds as LRRK2 Inhibitors</span>. US 2017/0020850,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+T.+Bedford&author=I.+Chen&author=Y.+Wang&author=D.+S.+Williamson&title=Arylpyrrolopyridine+Derived+Compounds+as+LRRK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBedford%26aufirst%3DS.%2BT.%26atitle%3DArylpyrrolopyridine%2520Derived%2520Compounds%2520as%2520LRRK2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">164ra161</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3004485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1126%2Fscitranslmed.3004485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=23241745" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=164ra161&author=Z.+Shengauthor=S.+Zhangauthor=D.+Bustosauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=S.+L.+Dominguezauthor=H.+O.+Solanoyauthor=J.+Drummondauthor=X.+Zhangauthor=X.+Dingauthor=F.+Caiauthor=Q.+Songauthor=X.+Liauthor=Z.+Yueauthor=M.+P.+van+der+Brugauthor=D.+J.+Burdickauthor=J.+Gunzner-Tosteauthor=H.+Chenauthor=X.+Liuauthor=A.+A.+Estradaauthor=Z.+K.+Sweeneyauthor=K.+Scearce-Levieauthor=J.+G.+Moffatauthor=D.+S.+Kirkpatrickauthor=H.+Zhu&title=Ser1292+Autophosphorylation+Is+an+Indicator+of+LRRK2+Kinase+Activity+and+Contributes+to+the+Cellular+Effects+of+PD+Mutations&doi=10.1126%2Fscitranslmed.3004485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004485%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DSolanoy%26aufirst%3DH.%2BO.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DSer1292%2520Autophosphorylation%2520Is%2520an%2520Indicator%2520of%2520LRRK2%2520Kinase%2520Activity%2520and%2520Contributes%2520to%2520the%2520Cellular%2520Effects%2520of%2520PD%2520Mutations%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D164ra161%26doi%3D10.1126%2Fscitranslmed.3004485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span> </span><span class="NLM_article-title">LRRK2 Phosphorylation</span>. In  <span class="citation_source-book">Leucine-Rich Repeat Kinase 2 (LRRK2)</span>; <span class="NLM_contrib-group">Rideout, H. J.</span>, Ed.; , Advances in Neurobiology; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-3-319-49969-7_3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1007%2F978-3-319-49969-7_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=51-70&author=R.+J.+Nicholsauthor=H.+J.+Rideout&title=Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-49969-7_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-49969-7_3%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26atitle%3DLRRK2%2520Phosphorylation%26btitle%3DLeucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%26aulast%3DRideout%26aufirst%3DH.%2BJ.%26pub%3DSpringer%26date%3D2017%26spage%3D51%26epage%3D70%26doi%3D10.1007%2F978-3-319-49969-7_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Graves, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span> </span><span class="NLM_article-title">“Going KiNativ”: Probing the Native Kinome</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.chembiol.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21700204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=683-684&author=L.+M.+Gravesauthor=D.+W.+Litchfield&title=%E2%80%9CGoing+KiNativ%E2%80%9D%3A+Probing+the+Native+Kinome&doi=10.1016%2Fj.chembiol.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">"Going KiNativ": Probing the Native Kinome</span></div><div class="casAuthors">Graves, Lee M.; Litchfield, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">683-684</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  In this issue, Patricelli et al. describe an in situ chemoproteomics approach (KiNativ) for profiling the kinome and kinome response to specific kinase inhibitors that enables characterization of inhibitor interactions with endogenously expressed kinases in native conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUFZGjHhjv7Vg90H21EOLACvtfcHk0liHGdFweYlxbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbw%253D&md5=268621add2030f7201c8b7933c2b7780</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DGraves%26aufirst%3DL.%2BM.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3D%25E2%2580%259CGoing%2520KiNativ%25E2%2580%259D%253A%2520Probing%2520the%2520Native%2520Kinome%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D683%26epage%3D684%26doi%3D10.1016%2Fj.chembiol.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Thirstrup, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dächsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fog, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span> </span><span class="NLM_article-title">Selective LRRK2 Kinase Inhibition Reduces Phosphorylation of Endogenous Rab10 and Rab12 in Human Peripheral Mononuclear Blood Cells</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">10300</span><span class="refDoi"> DOI: 10.1038/s41598-017-10501-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fs41598-017-10501-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28860483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BC1cbjsFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=10300&author=K.+Thirstrupauthor=J.+C.+D%C3%A4chselauthor=F.+S.+Oppermannauthor=D.+S.+Williamsonauthor=G.+P.+Smithauthor=K.+Fogauthor=K.+V.+Christensen&title=Selective+LRRK2+Kinase+Inhibition+Reduces+Phosphorylation+of+Endogenous+Rab10+and+Rab12+in+Human+Peripheral+Mononuclear+Blood+Cells&doi=10.1038%2Fs41598-017-10501-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells</span></div><div class="casAuthors">Thirstrup Kenneth; Dachsel Justus C; Fog Karina; Christensen Kenneth V; Oppermann Felix S; Williamson Douglas S; Smith Garrick P</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10300</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Genetic variation in the leucine-rich repeat kinase 2 (LRRK2) gene is associated with risk of familial and sporadic Parkinson's disease (PD).  To support clinical development of LRRK2 inhibitors as disease-modifying treatment in PD biomarkers for kinase activity, target engagement and kinase inhibition are prerequisite tools.  In a combined proteomics and phosphoproteomics study on human peripheral mononuclear blood cells (PBMCs) treated with the LRRK2 inhibitor Lu AF58786 a number of putative biomarkers were identified.  Among the phospho-site hits were known LRRK2 sites as well as two phospho-sites on human Rab10 and Rab12.  LRRK2 dependent phosphorylation of human Rab10 and human Rab12 at positions Thr73 and Ser106, respectively, was confirmed in HEK293 and, more importantly, Rab10-pThr73 inhibition was validated in immune stimulated human PBMCs using two distinct LRRK2 inhibitors.  In addition, in non-stimulated human PBMCs acute inhibition of LRRK2 with two distinct LRRK2 inhibitor compounds reduced Rab10-Thr73 phosphorylation in a concentration-dependent manner with apparent IC50's equivalent to IC50's on LRRK2-pSer935.  The identification of Rab10 phosphorylated at Thr73 as a LRRK2 inhibition marker in human PBMCs strongly support inclusion of assays quantifying Rab10-pThr73 levels in upcoming clinical trials evaluating LRRK2 kinase inhibition as a disease-modifying treatment principle in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAuKrO7n1L5z0O18WR3iAofW6udTcc2eY-AMnWU-aBdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbjsFyjug%253D%253D&md5=31bb02a9c7dd8dc8d765c08351e4714f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-10501-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-10501-z%26sid%3Dliteratum%253Aachs%26aulast%3DThirstrup%26aufirst%3DK.%26aulast%3DD%25C3%25A4chsel%26aufirst%3DJ.%2BC.%26aulast%3DOppermann%26aufirst%3DF.%2BS.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DFog%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26atitle%3DSelective%2520LRRK2%2520Kinase%2520Inhibition%2520Reduces%2520Phosphorylation%2520of%2520Endogenous%2520Rab10%2520and%2520Rab12%2520in%2520Human%2520Peripheral%2520Mononuclear%2520Blood%2520Cells%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D10300%26doi%3D10.1038%2Fs41598-017-10501-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Software XDS for Image Rotation, Recognition and Crystal Symmetry Assignment</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Software+XDS+for+Image+Rotation%2C+Recognition+and+Crystal+Symmetry+Assignment&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lid4zCq2f6IIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DSoftware%2520XDS%2520for%2520Image%2520Rotation%252C%2520Recognition%2520and%2520Crystal%2520Symmetry%2520Assignment%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span>SAINT; <span class="NLM_publisher-name">Bruker AXS</span>: <span class="NLM_publisher-loc">Madison, WI</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SAINT%3B+Bruker+AXS%3A+Madison%2C+WI%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSAINT%26pub%3DBruker%2520AXS%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lid4zCq2f6IIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A.</span><span> </span><span class="NLM_article-title">MOLREP: An Automated Program for Molecular Replacement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span><span class="refDoi"> DOI: 10.1107/S0021889897006766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0021889897006766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=1022-1025&author=A.+Vaginauthor=A.+Teplyakov&title=MOLREP%3A+An+Automated+Program+for+Molecular+Replacement&doi=10.1107%2FS0021889897006766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">MOLREP: an automated program for molecular replacement</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement which uses effective new approaches in data processing and rotational and translational searching.  These include an automatic choice of all parameters, scaling by Patterson origin peaks and soft resoln. cutoff.  One of the cornerstones of the program is an original full-symmetry translation function combined with a packing function.  Information from the model already placed in the cell is incorporated in both translation and packing functions.  A no. of tests using exptl. data proved the ability of the program to find the correct soln. in difficult cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGXdZ-nTKxLVg90H21EOLACvtfcHk0lid4zCq2f6IIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D&md5=96af64aedd8a8f018c3c18b57a6b4b21</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1107%2FS0021889897006766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897006766%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMOLREP%253A%2520An%2520Automated%2520Program%2520for%2520Molecular%2520Replacement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D1022%26epage%3D1025%26doi%3D10.1107%2FS0021889897006766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubák, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the Refinement of Macromolecular Crystal Structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+Refinement+of+Macromolecular+Crystal+Structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljjQWqUAWGmrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520Refinement%2520of%2520Macromolecular%2520Crystal%2520Structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljjQWqUAWGmrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Schüttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M. F.</span><span> </span><span class="NLM_article-title">PRODRG: A Tool for High-Throughput Crystallography of Protein-Ligand Complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Sch%C3%BCttelkopfauthor=D.+M.+F.+van+Aalten&title=PRODRG%3A+A+Tool+for+High-Throughput+Crystallography+of+Protein-Ligand+Complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuettelkopf, Alexander W.; van Aalten, Daan M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1355-1363</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The small-mol. topol. generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and mol. topologies suitable for x-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compds. from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the std. libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallog. R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbflrch0bs97Vg90H21EOLACvtfcHk0lirEblU6m-aCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D&md5=f9bfdb14be7b04ea5c0db67feb39f72a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26atitle%3DPRODRG%253A%2520A%2520Tool%2520for%2520High-Throughput%2520Crystallography%2520of%2520Protein-Ligand%2520Complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gražulis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaitkus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span> </span><span class="NLM_article-title">AceDRG: A Stereochemical Description Generator for Ligands</span> <span class="citation_source-journal">Acta Crystallogr. Sect. D Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1107/S2059798317000067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS2059798317000067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2017&pages=112-122&author=F.+Longauthor=R.+A.+Nichollsauthor=P.+Emsleyauthor=S.+Gra%C5%BEulisauthor=A.+Merkysauthor=A.+Vaitkusauthor=G.+N.+Murshudov&title=AceDRG%3A+A+Stereochemical+Description+Generator+for+Ligands&doi=10.1107%2FS2059798317000067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">AceDRG: a stereochemical description generator for ligands</span></div><div class="casAuthors">Long, Fei; Nicholls, Robert A.; Emsley, Paul; Grazulis, Saulius; Merkys, Andrius; Vaitkus, Antanas; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The program AceDRG is designed for the derivation of stereochem. information about small mols.  It uses local chem. and topol. environment-based atom typing to derive and organize bond lengths and angles from a small-mol. database: the Crystallog. Open Database (COD).  Information about the hybridization states of atoms, whether they belong to small rings (up to seven-membered rings), ring aromaticity and nearest-neighbor information is encoded in the atom types.  All atoms from the COD have been classified according to the generated atom types.  All bonds and angles have also been classified according to the atom types and, in a certain sense, bond types.  Derived data are tabulated in a machine-readable form that is freely available from CCP4.  AceDRG can also generate stereochem. information, provided that the basic bonding pattern of a ligand is known.  The basic bonding pattern is perceived from one of the computational chem. file formats, including SMILES, mmCIF, SDF MOL and SYBYL MOL2 files.  Using the bonding chem., atom types, and bond and angle tables generated from the COD, AceDRG derives the 'ideal' bond lengths, angles, plane groups, arom. rings and chirality information, and writes them to an mmCIF file that can be used by the refinement program REFMAC5 and the model-building program Coot.  Other refinement and model-building programs such as PHENIX and BUSTER can also use these files.  AceDRG also generates one or more coordinate sets corresponding to the most favorable conformation(s) of a given ligand.  AceDRG employs RDKit for chem. perception and for initial conformation generation, as well as for the interpretation of SMILES strings, SDF MOL and SYBYL MOL2 files.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0LaF0rLfdLVg90H21EOLACvtfcHk0lirEblU6m-aCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGgu78%253D&md5=0a581d62dd3b00004e37be490ee71fe8</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1107%2FS2059798317000067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798317000067%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DF.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DGra%25C5%25BEulis%26aufirst%3DS.%26aulast%3DMerkys%26aufirst%3DA.%26aulast%3DVaitkus%26aufirst%3DA.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DAceDRG%253A%2520A%2520Stereochemical%2520Description%2520Generator%2520for%2520Ligands%26jtitle%3DActa%2520Crystallogr.%2520Sect.%2520D%2520Struct.%2520Biol.%26date%3D2017%26volume%3D73%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS2059798317000067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lirEblU6m-aCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Douglas S. Williamson, Garrick P. Smith, Gitte K. Mikkelsen, Thomas Jensen, Pamela Acheson-Dossang, Lassina Badolo, Simon T. Bedford, Victoria Chell, I-Jen Chen, Pawel Dokurno, Morten Hentzer, Samantha Newland, Stuart C. Ray, Terry Shaw, Allan E. Surgenor, Lindsey Terry, Yikang Wang, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth V. Christensen</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10312-10332. <a href="https://doi.org/10.1021/acs.jmedchem.1c00720" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine-Derived%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%252BUsing%252Ba%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529-Derived%252BCrystallographic%252BSurrogate%26aulast%3DWilliamson%26aufirst%3DDouglas%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20042021%26date%3D29062021%26volume%3D64%26issue%3D14%26spage%3D10312%26epage%3D10332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominika Natalia  Wojewska</span>, <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (8)
                                     , 1101. <a href="https://doi.org/10.3390/biom11081101" title="DOI URL">https://doi.org/10.3390/biom11081101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11081101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11081101%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DLRRK2%252BTargeting%252BStrategies%252Bas%252BPotential%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DWojewska%26aufirst%3DDominika%2BNatalia%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D8%26spage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anmol  Gulati</span>, <span class="hlFld-ContribAuthor ">Charles S.  Yeung</span>, <span class="hlFld-ContribAuthor ">Blair  Lapointe</span>, <span class="hlFld-ContribAuthor ">Solomon D.  Kattar</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Kaleen K.  Childers</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Vladimir  Simov</span>, <span class="hlFld-ContribAuthor ">Ravi  Kurukulasuriya</span>, <span class="hlFld-ContribAuthor ">Barbara  Pio</span>, <span class="hlFld-ContribAuthor ">Greg J.  Morriello</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Haiqun  Tang</span>, <span class="hlFld-ContribAuthor ">Santhosh  Neelamkavil</span>, <span class="hlFld-ContribAuthor ">Harold B.  Wood</span>, <span class="hlFld-ContribAuthor ">Vanessa L.  Rada</span>, <span class="hlFld-ContribAuthor ">Michael J.  Ardolino</span>, <span class="hlFld-ContribAuthor ">Xin Cindy  Yan</span>, <span class="hlFld-ContribAuthor ">Rachel  Palte</span>, <span class="hlFld-ContribAuthor ">Karin  Otte</span>, <span class="hlFld-ContribAuthor ">Robert  Faltus</span>, <span class="hlFld-ContribAuthor ">Janice  Woodhouse</span>, <span class="hlFld-ContribAuthor ">Laxminarayan G.  Hegde</span>, <span class="hlFld-ContribAuthor ">Paul  Ciaccio</span>, <span class="hlFld-ContribAuthor ">Ellen C.  Minnihan</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fell</span>, <span class="hlFld-ContribAuthor ">Peter H.  Fuller</span>, <span class="hlFld-ContribAuthor ">J. Michael  Ellis</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1164-1173. <a href="https://doi.org/10.1039/D1MD00097G" title="DOI URL">https://doi.org/10.1039/D1MD00097G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00097G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00097G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bbrain-penetrant%252Bpicolinamide%252Bderived%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%26aulast%3DGulati%26aufirst%3DAnmol%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1164%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roman S.  Malykhin</span>, <span class="hlFld-ContribAuthor ">Alexey Yu.  Sukhorukov</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic Halogenation of Heterocyclic
              N
              ‐Oxides: Recent Progress and a Practical Guide. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2021,</strong> <em>363 </em>
                                    (13)
                                     , 3170-3188. <a href="https://doi.org/10.1002/adsc.202100284" title="DOI URL">https://doi.org/10.1002/adsc.202100284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202100284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202100284%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DNucleophilic%252BHalogenation%252Bof%252BHeterocyclic%252BN%252B%2525E2%252580%252590Oxides%25253A%252BRecent%252BProgress%252Band%252Ba%252BPractical%252BGuide%26aulast%3DMalykhin%26aufirst%3DRoman%2BS.%26date%3D2021%26date%3D2021%26volume%3D363%26issue%3D13%26spage%3D3170%26epage%3D3188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sven H.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jui-Hung  Weng</span>, <span class="hlFld-ContribAuthor ">Phillip C.  Aoto</span>, <span class="hlFld-ContribAuthor ">Daniela  Boassa</span>, <span class="hlFld-ContribAuthor ">Sebastian  Mathea</span>, <span class="hlFld-ContribAuthor ">Steve  Silletti</span>, <span class="hlFld-ContribAuthor ">Junru  Hu</span>, <span class="hlFld-ContribAuthor ">Maximilian  Wallbott</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Komives</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Friedrich W.  Herberg</span>, <span class="hlFld-ContribAuthor ">Susan S.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (23)
                                     , e2100844118. <a href="https://doi.org/10.1073/pnas.2100844118" title="DOI URL">https://doi.org/10.1073/pnas.2100844118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2100844118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2100844118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DConformation%252Band%252Bdynamics%252Bof%252Bthe%252Bkinase%252Bdomain%252Bdrive%252Bsubcellular%252Blocation%252Band%252Bactivation%252Bof%252BLRRK2%26aulast%3DSchmidt%26aufirst%3DSven%2BH.%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D23%26spage%3De2100844118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐Based Lead Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-35. <a href="https://doi.org/10.1002/0471266949.bmc265" title="DOI URL">https://doi.org/10.1002/0471266949.bmc265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc265%26sid%3Dliteratum%253Aachs%26atitle%3DFragment%2525E2%252580%252590Based%252BLead%252BDiscovery%26aulast%3DHubbard%26aufirst%3DRoderick%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D35%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongzhao  Wang</span>, <span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>69 </em><a href="https://doi.org/10.1007/s11030-020-10165-4" title="DOI URL">https://doi.org/10.1007/s11030-020-10165-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10165-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10165-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DClassification%252Bmodels%252Band%252BSAR%252Banalysis%252Bon%252BCysLT1%252Breceptor%252Bantagonists%252Busing%252Bmachine%252Blearning%252Balgorithms%26aulast%3DWang%26aufirst%3DHongzhao%26date%3D2021%26date%3D2021%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Fleur M.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Lianbo  Li</span>, <span class="hlFld-ContribAuthor ">Miljan  Kuljanin</span>, <span class="hlFld-ContribAuthor ">Caitlin E.  Mills</span>, <span class="hlFld-ContribAuthor ">Kartik  Subramanian</span>, <span class="hlFld-ContribAuthor ">Wayne  Harshbarger</span>, <span class="hlFld-ContribAuthor ">Sudershan  Gondi</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Mancias</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Westover</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (10)
                                     , 1229-1240.e4. <a href="https://doi.org/10.1016/j.chembiol.2020.07.011" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DChemical%252BBiology%252BToolkit%252Bfor%252BDCLK1%252BReveals%252BConnection%252Bto%252BRNA%252BProcessing%26aulast%3DLiu%26aufirst%3DYan%26date%3D2020%26volume%3D27%26issue%3D10%26spage%3D1229%26epage%3D1240.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reika  Watanabe</span>, <span class="hlFld-ContribAuthor ">Robert  Buschauer</span>, <span class="hlFld-ContribAuthor ">Jan  Böhning</span>, <span class="hlFld-ContribAuthor ">Martina  Audagnotto</span>, <span class="hlFld-ContribAuthor ">Keren  Lasker</span>, <span class="hlFld-ContribAuthor ">Tsan-Wen  Lu</span>, <span class="hlFld-ContribAuthor ">Daniela  Boassa</span>, <span class="hlFld-ContribAuthor ">Susan  Taylor</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Villa</span>. </span><span class="cited-content_cbyCitation_article-title">The In Situ Structure of Parkinson’s Disease-Linked LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2020,</strong> <em>182 </em>
                                    (6)
                                     , 1508-1518.e16. <a href="https://doi.org/10.1016/j.cell.2020.08.004" title="DOI URL">https://doi.org/10.1016/j.cell.2020.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2020.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2020.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DThe%252BIn%252BSitu%252BStructure%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease-Linked%252BLRRK2%26aulast%3DWatanabe%26aufirst%3DReika%26date%3D2020%26volume%3D182%26issue%3D6%26spage%3D1508%26epage%3D1518.e16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Ramonet</span>, <span class="hlFld-ContribAuthor ">Gunnar P. H.  Dietz</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Cell-Based Assay for Identification of LRRK2 Inhibitors Using Its Aberrant Regulation of a Pluripotency Gene. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 104-112. <a href="https://doi.org/10.1177/2472555219864086" title="DOI URL">https://doi.org/10.1177/2472555219864086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219864086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219864086%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DNovel%252BCell-Based%252BAssay%252Bfor%252BIdentification%252Bof%252BLRRK2%252BInhibitors%252BUsing%252BIts%252BAberrant%252BRegulation%252Bof%252Ba%252BPluripotency%252BGene%26aulast%3DRamonet%26aufirst%3DDavid%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D1%26spage%3D104%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James H.  Thorpe</span>, <span class="hlFld-ContribAuthor ">Emma V.  Edgar</span>, <span class="hlFld-ContribAuthor ">Kathrine J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xiao Q.  Lewell</span>, <span class="hlFld-ContribAuthor ">Monika  Rella</span>, <span class="hlFld-ContribAuthor ">Gemma V.  White</span>, <span class="hlFld-ContribAuthor ">Oxana  Polyakova</span>, <span class="hlFld-ContribAuthor ">Pamela  Nassau</span>, <span class="hlFld-ContribAuthor ">Ann L.  Walker</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Pearce</span>, <span class="hlFld-ContribAuthor ">Yichen  Wang</span>, <span class="hlFld-ContribAuthor ">John  Liddle</span>, <span class="hlFld-ContribAuthor ">Alain  Hovnanian</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology Communications</span><span> <strong>2019,</strong> <em>75 </em>
                                    (5)
                                     , 385-391. <a href="https://doi.org/10.1107/S2053230X19003169" title="DOI URL">https://doi.org/10.1107/S2053230X19003169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053230X19003169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053230X19003169%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520Communications%26atitle%3DEvaluation%252Bof%252Ba%252Bcrystallographic%252Bsurrogate%252Bfor%252Bkallikrein%252B5%252Bin%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Binhibitors%252Bfor%252BNetherton%252Bsyndrome%26aulast%3DThorpe%26aufirst%3DJames%2BH.%26date%3D2019%26date%3D2019%26volume%3D75%26issue%3D5%26spage%3D385%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Shi</span>, <span class="hlFld-ContribAuthor ">Mary  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 1981-1991. <a href="https://doi.org/10.1016/j.bmcl.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252Bpenetrant%252Bkinase%252Binhibitors%25253A%252BLearning%252Bfrom%252Bkinase%252Bneuroscience%252Bdiscovery%26aulast%3DShi%26aufirst%3DYuan%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative set of reported LRRK2 inhibitors <b>1</b>–<b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of selected LRRK2 WT and G2019S mutant ATP binding site residues, with equivalents in CHK1 WT, and 8-, 10-, and 12-pt mutants, as well as Roco4 WT<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and humanized Roco4 mutant.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Mutations are highlighted in bold and red. Glycine loop is shaded in gray. Salt bridge residues (SB) are shaded in tan, gatekeeper (GK) residues shaded in blue, hinge residues shaded in green, and activation loop is shaded in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) X-ray structure of <b>1</b> (cyan)/CHK1 (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR">1NVR</a>). (B) X-ray structure of <b>1</b> (cyan)/CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR">5OOR</a>). Ten residues mutated from CHK1 are highlighted in green. Key intermolecular contacts are shown as dashed lines (polar ligand to backbone contacts of <3.3 Å in blue; polar ligand to side chain contacts of <3.3 Å in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) X-ray structure of <b>2</b> (cyan)/CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOT">5OOT</a>). Ten residues mutated from CHK1 are highlighted in green. (B) X-ray structure of <b>2</b> (cyan)/humanized Roco4 kinase (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZM">4YZM</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Two residues mutated from Roco4 kinase are highlighted in green. Residues different from CHK1 12-pt mut and LRRK2 G2019S are highlighted in salmon pink. (C) X-ray structure of <b>2</b> (cyan)/CHK1 12-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ6">5OQ6</a>). Twelve residues mutated from CHK1 are highlighted in green. (D) X-ray structure of <b>2</b> (cyan)/CHK1 8-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ5">5OQ5</a>). Eight residues mutated from CHK1 are highlighted in green. Key intermolecular contacts are shown as dashed lines (polar ligand to backbone contacts of <3.3 Å in blue; polar ligand to side chain contacts of <3.3 Å in green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure of <b>3b</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP2">5OP2</a>). Residues mutated from CHK1 are highlighted in green. Key polar contact of <3.3 Å are in blue dashed line. Likely intramolecular hydrogen bond is indicated in yellow dashed line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure of (A) <b>4a</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP4">5OP4</a>) and (B) <b>4b</b> (cyan) in complex with humanized Roco4 kinase (gray) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZN">4YZN</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Mutated residues are highlighted in green. Residues different from CHK1 10-pt mut and LRRK2 G2019S in humanized Roco4 are highlighted in salmon pink. Polar intermolecular contacts of <3.3 Å are shown as blue dashed lines. Likely water-mediated hydrogen bonds are indicated in yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray structures of (A) indazole <b>7</b> and (B) 2-aminopyridine <b>8</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPB">5OPB</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPR">5OPR</a>). Mutated residues are highlighted in green. Polar intermolecular contacts of <3.3 Å are shown as blue dashed lines. Distances between ligands and Ala147 are shown as gray dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plot of <i>p</i>(LRRK2 G2019S Lanthascreen activity cK<sub>i</sub>) vs <i>p</i>(CHK1 10-pt mut binding affinity cK<sub>i</sub>) for 41 LRRK2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. X-ray crystal structures of pyrrolopyrimidines (A) <b>5</b> and (B) <b>6</b> and (C) pyrrolopyridine <b>9</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP5">5OP5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP7">5OP7</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPS">5OPS</a>). Residues mutated from CHK1 are highlighted in green. Key polar contacts of <3.3 Å are indicated with blue dashed lines. Likely water-mediated hydrogen bonds are indicated in yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. X-ray crystal structures of (A) <b>22</b> and (B) <b>23</b> (cyan) in complex with CHK1 10-pt mut (gray) (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPU">5OPU</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPV">5OPV</a>). Residues mutated from CHK1 are highlighted in green. Key polar contacts of <3.3 Å are indicated with blue dashed lines. Likely intramolecular and water-mediated hydrogen bonds are indicated in yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0011.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) In-cell Western (ICW) assay data showing inhibition of LRRK2-Ser935 phosphorylation in HEK293 cells transiently overexpressing LRRK2 WT, and the G2019S and A2016T mutants, by <b>22</b>. (B) Image of 96-well microplate scan from the LI-COR Odyssey, pertaining to ICW data in (A). Red and green dots denote dye colors for total LRRK2 and pSer935 antibodies, respectively; red and yellow/orange indicate dephosphorylated and phosphorylated LRRK2, respectively. In the assay, compound <b>23</b> (red) and DMSO (yellow/orange) were used as positive and negative controls, respectively (in duplicate determination). The bottom row (black) is mock transfected HEK293 cells, where no immunoreactivity can be observed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0012.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Pharmacokinetic and pharmacodynamic profile of <b>22</b> in mouse brain following 25 mg/kg po dosing: (A, B) Western blot images of total LRRK2 and LRRK2-pSer935 immunoreactivity from mouse brain lysates at various time points after dosing of compound <b>22</b>; (C) exposure of <b>22</b> over 24 h; (D) relative LRRK2-pSer935 levels in mouse brain over 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0013.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Dose–response relationship of <b>22</b> in mouse brain and kidney: (A) mouse brain studies (<i>n</i> = 3); (B) mouse kidney studies (<i>n</i> = 2). LRRK2-pSer935 levels were assessed 1 h after po dosing. The data were used to estimate IC<sub>50</sub> values for <b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0014.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>12</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ArB(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, H<sub>2</sub>O, 150 °C; (b) ArB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, THF, H<sub>2</sub>O, 120 °C; (c) <i>m</i>-CPBA, CHCl<sub>3</sub>, 0 °C to rt; (d) MeSO<sub>3</sub>H; (e) Me<sub>2</sub>SO<sub>4</sub>, MeCN, 60 °C; (f) 7 N NH<sub>3</sub>/MeOH, 70 °C; (g) PhB(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, H<sub>2</sub>O, 120 °C; (h) PhB(OH)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, Pd(dtbpf)Cl<sub>2</sub>, THF, H<sub>2</sub>O, 120 °C.</p></p></figure><figure data-id="sch2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0015.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) SEMCl, NaH, DMF, 0 °C to rt; (b) 3-MePhB(OH)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C; (c) TBAF, Et<sub>3</sub>N, THF, 70 °C; (d) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (e) MeSO<sub>3</sub>H, rt; (f) MeSO<sub>2</sub>Cl, DMF, 80 °C; (g) LiHMDS, XPhos, Pd<sub>2</sub>(dba)<sub>3</sub>, THF, 60 °C.</p></p></figure><figure data-id="sch3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/medium/jm-2017-011863_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0016.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>23</b>–<b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b01186/20171103/images/large/jm-2017-011863_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01186&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeSO<sub>2</sub>Cl, DMF, 80 °C; (b) 1-Me-1<i>H</i>-pyrazol-3-amine, (<i>tert</i>-Bu)ONa, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, DMF, 140 °C; (c) R<sup>2</sup>B(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, water, 120 °C; (d) NaI, AcCl, MeCN, 80 °C; (e) R<sup>2</sup>B(OH)<sub>2</sub>, KF, [(<i>tert</i>-Bu)<sub>3</sub>P]<sub>2</sub>Pd(0), 1,4-dioxane, H<sub>2</sub>O, 80 °C; (f) NaH, DMF, 0 °C; SEMCl, rt; (g) (<i>n</i>-Bu)<sub>3</sub>SnR<sup>2</sup>, LiCl, CuI, Pd(PPh<sub>3</sub>)<sub>4</sub>, 1,4-dioxane, 90 °C; (h) R<sup>2</sup>B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4,</sub> Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 100 °C; (i) 1-Me-4-R<sup>1</sup>-1<i>H</i>-pyrazol-3-amine, (<i>tert</i>-Bu)ONa, Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, PhMe, 90 °C; (j) TBAF, Et<sub>3</sub>N, THF, 70 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 88 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Jankovic, J.</span><span> </span><span class="NLM_article-title">Parkinson’s Disease: Clinical Features and Diagnosis</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span><span class="refDoi"> DOI: 10.1136/jnnp.2007.131045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1136%2Fjnnp.2007.131045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=18344392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2008&pages=368-376&author=J.+Jankovic&title=Parkinson%E2%80%99s+Disease%3A+Clinical+Features+and+Diagnosis&doi=10.1136%2Fjnnp.2007.131045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease: clinical features and diagnosis</span></div><div class="casAuthors">Jankovic J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Parkinson's disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree.  This review describes the clinical characteristics of PD with emphasis on those features that differentiate the disease from other parkinsonian disorders.  METHODS:  A MedLine search was performed to identify studies that assess the clinical characteristics of PD.  Search terms included "Parkinson's disease", "diagnosis" and "signs and symptoms".  RESULTS:  Because there is no definitive test for the diagnosis of PD, the disease must be diagnosed based on clinical criteria.  Rest tremor, bradykinesia, rigidity and loss of postural reflexes are generally considered the cardinal signs of PD.  The presence and specific presentation of these features are used to differentiate PD from related parkinsonian disorders.  Other clinical features include secondary motor symptoms (eg, hypomimia, dysarthria, dysphagia, sialorrhoea, micrographia, shuffling gait, festination, freezing, dystonia, glabellar reflexes), non-motor symptoms (eg, autonomic dysfunction, cognitive/neurobehavioral abnormalities, sleep disorders and sensory abnormalities such as anosmia, paresthesias and pain).  Absence of rest tremor, early occurrence of gait difficulty, postural instability, dementia, hallucinations, and the presence of dysautonomia, ophthalmoparesis, ataxia and other atypical features, coupled with poor or no response to levodopa, suggest diagnoses other than PD.  CONCLUSIONS:  A thorough understanding of the broad spectrum of clinical manifestations of PD is essential to the proper diagnosis of the disease.  Genetic mutations or variants, neuroimaging abnormalities and other tests are potential biomarkers that may improve diagnosis and allow the identification of persons at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTx3pH5zglCwUcLvDNbOD4DfW6udTcc2ebK1QDCTHfyWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7oslamtA%253D%253D&md5=bb6d7781e6fce93cfb785215840149cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.2007.131045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.2007.131045%26sid%3Dliteratum%253Aachs%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DParkinson%25E2%2580%2599s%2520Disease%253A%2520Clinical%2520Features%2520and%2520Diagnosis%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2008%26volume%3D79%26spage%3D368%26epage%3D376%26doi%3D10.1136%2Fjnnp.2007.131045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Brundin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span> </span><span class="NLM_article-title">Research in Motion: The Enigma of Parkinson’s Disease Pathology Spread</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">745</span><span class="refDoi"> DOI: 10.1038/nrn2477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fnrn2477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=18769444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFeit7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=741-745&author=P.+Brundinauthor=J.-Y.+Liauthor=J.+L.+Holtonauthor=O.+Lindvallauthor=T.+Revesz&title=Research+in+Motion%3A+The+Enigma+of+Parkinson%E2%80%99s+Disease+Pathology+Spread&doi=10.1038%2Fnrn2477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Research in motion: the enigma of Parkinson's disease pathology spread</span></div><div class="casAuthors">Brundin, Patrik; Li, Jia-Yi; Holton, Janice L.; Lindvall, Olle; Revesz, Tamas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">741-745</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease is characterized by progressive neurodegeneration, but the underlying mechanisms are unclear.  Brundin and colleagues discuss how recent reports on the outcome of neuronal grafts carried out in patients with Parkinson's disease might shed light on the disease's progression.  Neuropathol. changes in Parkinson's disease progress slowly and spread according to a characteristic pattern.  Recent papers have shed light on this progression of pathol. by examg. the fate of neurons grafted into the brains of patients with Parkinson's disease.  Two of these studies demonstrate that grafted healthy neurons can gradually develop the same pathol. as host neurons in the diseased brains.  According to these studies, implanted neurons developed α-synuclein- and ubiquitin-pos. Lewy bodies more than a decade after transplantation.  We discuss the possible underlying mechanisms and their implications for how pathol. spreads in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpee4HTnLRoTbVg90H21EOLACvtfcHk0lgoV078sUIblA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFeit7fP&md5=f77c3ac21698c9300076189f012cf3e9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrn2477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2477%26sid%3Dliteratum%253Aachs%26aulast%3DBrundin%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.-Y.%26aulast%3DHolton%26aufirst%3DJ.%2BL.%26aulast%3DLindvall%26aufirst%3DO.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DResearch%2520in%2520Motion%253A%2520The%2520Enigma%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%2520Pathology%2520Spread%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2008%26volume%3D9%26spage%3D741%26epage%3D745%26doi%3D10.1038%2Fnrn2477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Poewe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahlknecht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankovic, J.</span><span> </span><span class="NLM_article-title">Emerging Therapies for Parkinson’s Disease</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span><span class="refDoi"> DOI: 10.1097/WCO.0b013e3283542fde</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1097%2FWCO.0b013e3283542fde" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22772874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=448-459&author=W.+Poeweauthor=P.+Mahlknechtauthor=J.+Jankovic&title=Emerging+Therapies+for+Parkinson%E2%80%99s+Disease&doi=10.1097%2FWCO.0b013e3283542fde"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapies for Parkinson's disease</span></div><div class="casAuthors">Poewe, Werner; Mahlknecht, Philipp; Jankovic, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">448-459</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: The exptl. therapeutics of Parkinson's disease are reviewed, highlighting the current pipeline of emerging therapeutic approaches.  Recent findings: This review includes novel approaches to dopaminergic drug delivery such as intraintestinal infusions or new extended-release formulations of levodopa and also intrapulmonary delivery of apomorphine as well as novel dopaminergic agents like the monoamine oxidase-B inhibitor safinamide or novel catechol-O-Me transferase inhibitors.  An even greater no. of ongoing clin. trials assess the efficacy and safety of nondopaminergic approaches to enhance motor control or reduce motor complications like fluctuations and dyskinesias.  These include adenosine A2A antagonists, α-adrenergic and serotonergic agonists as well as drugs acting on the glutamatergic system.  Gene-based or cell-based intrastriatal delivery of therapeutic principles that enhance striatal dopaminergic transmission directly or via the stimulation of trophic activity has also reached phase II clin. development with encouraging results in some studies.  Finally, a wide spectrum of agents with a potential for slowing disease progression is currently tested.  Summary: A variety of medical and nonmedical interventions in different phases of clin. development provide an interesting and promising portfolio of emerging therapies for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomNZpxzJjBtrVg90H21EOLACvtfcHk0lg5rgXw1MGz7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWjs7zM&md5=421b6b0b289da7fcc8e817ae1808c15a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e3283542fde&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e3283542fde%26sid%3Dliteratum%253Aachs%26aulast%3DPoewe%26aufirst%3DW.%26aulast%3DMahlknecht%26aufirst%3DP.%26aulast%3DJankovic%26aufirst%3DJ.%26atitle%3DEmerging%2520Therapies%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2012%26volume%3D25%26spage%3D448%26epage%3D459%26doi%3D10.1097%2FWCO.0b013e3283542fde" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouyang, L.</span><span> </span><span class="NLM_article-title">Emerging Targets and New Small Molecule Therapies in Parkinson’s Disease Treatment</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1430</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.02.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmc.2016.02.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26935940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjtleqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1419-1430&author=H.+Zhangauthor=R.+Tongauthor=L.+Baiauthor=J.+Shiauthor=L.+Ouyang&title=Emerging+Targets+and+New+Small+Molecule+Therapies+in+Parkinson%E2%80%99s+Disease+Treatment&doi=10.1016%2Fj.bmc.2016.02.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging targets and new small molecule therapies in Parkinson's disease treatment</span></div><div class="casAuthors">Zhang, Hongjia; Tong, Rongsheng; Bai, Lan; Shi, Jianyou; Ouyang, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1419-1430</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Parkinson's disease (PD) is a common chronic degenerative disease of the central nervous system.  Due to a rapidly aging society worldwide, PD morbidity is on the rise; however, the treatment of PD with conventional drugs carries serious adverse reactions and cannot fix the root cause of PD, the degeneration of dopaminergic neurons, which limits conventional drug usage in clin. practice.  In recent years, research on the pathogenesis of PD and its clin. manifestations has led to the discovery of an increasing no. of novel targets in PD, including several small mol. targeted compds.  In this paper, we analyze and summarize the most recently published PD literature and review several recently discovered novel targets in PD and their small mol. targeted pharmacol. active agents based on their mechanisms of action and pharmacodynamic profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUosTXhG2kbrVg90H21EOLACvtfcHk0lg5rgXw1MGz7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjtleqt78%253D&md5=46e91b18da67c98f7f93cca0f23166e0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.02.030%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DTong%26aufirst%3DR.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DOuyang%26aufirst%3DL.%26atitle%3DEmerging%2520Targets%2520and%2520New%2520Small%2520Molecule%2520Therapies%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%2520Treatment%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1419%26epage%3D1430%26doi%3D10.1016%2Fj.bmc.2016.02.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mills, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulhern, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culvenor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-C.</span><span> </span><span class="NLM_article-title">Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of All Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span><span class="refDoi"> DOI: 10.1002/humu.22515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1002%2Fhumu.22515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24470158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=395-412&author=R.+D.+Millsauthor=T.+D.+Mulhernauthor=F.+Liuauthor=J.+G.+Culvenorauthor=H.-C.+Cheng&title=Prediction+of+the+Repeat+Domain+Structures+and+Impact+of+Parkinsonism-Associated+Variations+on+Structure+and+Function+of+All+Functional+Domains+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29&doi=10.1002%2Fhumu.22515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2)</span></div><div class="casAuthors">Mills, Ryan D.; Mulhern, Terrence D.; Liu, Fei; Culvenor, Janetta G.; Cheng, Heung-Chin</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">395-412</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Genetic variations of leucine-rich repeat kinase 2 (LRRK2) are the major cause of dominantly inherited Parkinson disease (PD).  LRRK2 protein contains seven predicted domains: a tandem Ras-like GTPase (ROC) domain and C-terminal of Roc (COR) domain, a protein kinase domain, and four repeat domains.  PD-causative variations arise in all domains, suggesting that aberrant functioning of any domain can contribute to neurotoxic mechanisms of LRRK2.  Detn. of the three-dimensional structure of LRRK2 is one of the best avenues to decipher its neurotoxic mechanism.  However, with the exception of the Roc domain, the three-dimensional structures of the functional domains of LRRK2 have yet to be detd.  Based on the known three-dimensional structures of repeat domains of other proteins, the tandem Roc-COR domains of the Chlorobium tepidum Rab family protein, and the kinase domain of the Dictyostelium discoideum Roco4 protein, we predicted (1) the motifs essential for protein-protein interactions in all domains, (2) the motifs crit. for catalysis and substrate recognition in the tandem Roc-COR and kinase domains, and (3) the effects of some PD-assocd. missense variations on the neurotoxic action of LRRK2.  Results of our anal. provide a conceptual framework for future investigation into the regulation and the neurotoxic mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCQyitGjwuJ7Vg90H21EOLACvtfcHk0lg5rgXw1MGz7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlKmurg%253D&md5=71fb35dc3def1fa847bad36b1b38f035</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fhumu.22515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.22515%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DR.%2BD.%26aulast%3DMulhern%26aufirst%3DT.%2BD.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DCulvenor%26aufirst%3DJ.%2BG.%26aulast%3DCheng%26aufirst%3DH.-C.%26atitle%3DPrediction%2520of%2520the%2520Repeat%2520Domain%2520Structures%2520and%2520Impact%2520of%2520Parkinsonism-Associated%2520Variations%2520on%2520Structure%2520and%2520Function%2520of%2520All%2520Functional%2520Domains%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%26jtitle%3DHum.%2520Mutat.%26date%3D2014%26volume%3D35%26spage%3D395%26epage%3D412%26doi%3D10.1002%2Fhumu.22515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Tsika, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span> </span><span class="NLM_article-title">Contribution of GTPase Activity to LRRK2-Associated Parkinson Disease</span> <span class="citation_source-journal">Small GTPases</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span><span class="refDoi"> DOI: 10.4161/sgtp.25130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.4161%2Fsgtp.25130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24025585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BC3sbnt1Skuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=164-170&author=E.+Tsikaauthor=D.+J.+Moore&title=Contribution+of+GTPase+Activity+to+LRRK2-Associated+Parkinson+Disease&doi=10.4161%2Fsgtp.25130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of GTPase activity to LRRK2-associated Parkinson disease</span></div><div class="casAuthors">Tsika Elpida; Moore Darren J</div><div class="citationInfo"><span class="NLM_cas:title">Small GTPases</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2, PARK8, OMIM 607060) gene represent the most common known cause of hereditary Parkinson's disease (PD) with late-onset and dominant inheritance.  LRRK2 protein is composed of multiple domains including two distinct enzymatic domains, a kinase and a Ras-of-complex (Roc) GTPase, connected by a C-terminal-of-Roc (COR) domain, and belongs to the ROCO protein family.  Disease-causing mutations located in the kinase domain enhance kinase activity (i.e., G2019S) whereas mutations clustering within the Roc-COR tandem domain impair GTPase activity (i.e., R1441C/G and Y1699C).  Familial LRRK2 mutations commonly induce neuronal toxicity that, at least for the frequent G2019S variant, is dependent on kinase activity.  The contribution of GTPase activity to LRRK2-dependent neuronal toxicity is not yet clear.  Therefore, both GTPase and kinase activity may be important for mediating neurodegeneration in PD due to familial LRRK2 mutations.  At present, the physiological function of LRRK2 in the mammalian brain and the regulation of its enzymatic activity are incompletely understood.  In this review, we focus on the GTPase domain of LRRK2 and discuss the recent advances in elucidating its function and its interplay with the kinase domain for the regulation of LRRK2 activity and toxicity.  GTPase activity is an important feature of LRRK2 biology and pathophysiology and represents an underexplored yet potentially tractable therapeutic target for treating LRRK2-associated PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAuS9CObmGsJw7prLlxLOzfW6udTcc2eYSqy-h9Tu9T7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbnt1Skuw%253D%253D&md5=c5f01ec0bf08b72a844a653bdea8aa52</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.4161%2Fsgtp.25130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fsgtp.25130%26sid%3Dliteratum%253Aachs%26aulast%3DTsika%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26atitle%3DContribution%2520of%2520GTPase%2520Activity%2520to%2520LRRK2-Associated%2520Parkinson%2520Disease%26jtitle%3DSmall%2520GTPases%26date%3D2013%26volume%3D4%26spage%3D164%26epage%3D170%26doi%3D10.4161%2Fsgtp.25130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Structural Biology of the LRRK2 GTPase and Kinase Domains: Implications for Regulation</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="refDoi"> DOI: 10.3389/fnmol.2014.00032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.3389%2Ffnmol.2014.00032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24847205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=32&author=B.+K.+Gilsbachauthor=A.+Kortholt&title=Structural+Biology+of+the+LRRK2+GTPase+and+Kinase+Domains%3A+Implications+for+Regulation&doi=10.3389%2Ffnmol.2014.00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation</span></div><div class="casAuthors">Gilsbach, Bernd K.; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32/1-32/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain.  Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD).  Several of the pathogenic mutations in LRRK2 result in decreased GTPase activity and enhanced kinase activity, suggesting a possible PD-related gain of abnormal function.  Important progress in the structural understanding of LRRK2 has come from our work with related Roco proteins from lower organisms.  Atomic structures of Roco proteins from prokaryotes revealed that Roco proteins belong to the GAD class of mol. switches (G proteins activated by nucleotide dependent dimerization).  As in LRRK2, PD-analogous mutations in Roco proteins from bacteria decrease the GTPase reaction.  Studies with Roco proteins from the model organism Dictyostelium discoideum revealed that PD mutants have different effects and most importantly they explained the G2019S-related increased LRRK2 kinase activity.  Furthermore, the structure of Dictyostelium Roco4 kinase in complex with the LRRK2 inhibitor H1152 showed that Roco4 and other Roco family proteins can be important for the optimization of the current, and identification of new, LRRK2 kinase inhibitors.  In this review we highlight the recent progress in structural and biochem. characterization of Roco proteins and discuss its implication for the understanding of the complex regulatory mechanism of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnWPIGCCasqLVg90H21EOLACvtfcHk0lifyCBeCNHGXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVChsLbN&md5=de1cef27dd0b8e5b5b242a4a1607192f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2014.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2014.00032%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DStructural%2520Biology%2520of%2520the%2520LRRK2%2520GTPase%2520and%2520Kinase%2520Domains%253A%2520Implications%2520for%2520Regulation%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2014%26volume%3D7%26spage%3D32%26doi%3D10.3389%2Ffnmol.2014.00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span> </span><span class="NLM_article-title">Current Understanding of LRRK2 in Parkinson’s Disease: Biochemical and Structural Features and Inhibitor Design</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1701</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span><span class="refDoi"> DOI: 10.4155/fmc.12.110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.4155%2Ffmc.12.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22924508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Kjsb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1701-1713&author=S.+Rayauthor=M.+Liu&title=Current+Understanding+of+LRRK2+in+Parkinson%E2%80%99s+Disease%3A+Biochemical+and+Structural+Features+and+Inhibitor+Design&doi=10.4155%2Ffmc.12.110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current understanding of LRRK2 in Parkinson's disease: biochemical and structural features and inhibitor design</span></div><div class="casAuthors">Ray, Soumya; Liu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1701-1713</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Since leucine-rich repeat kinase 2 (LRRK2) was linked to Parkinson's disease in 2004, kinase activity of LRRK2 has been believed to play a crit. role in the pathogenesis of Parkinson's disease.  As a result, identification of LRRK2 inhibitors has been a focus for drug discovery.  However, most LRRK2 mutations do not simply increase kinase activity.  In this review we summarize the potential mechanisms that regulate the kinase activity of LRRK2.  We outline some currently available kinase inhibitors, including the identification of a DFG-out (type-II) inhibitor.  Finally, we discuss the relationship of LRRK2 with tau and α-synuclein.  The fact that all three proteins are autophapgy-related provides a future strategy for the identification of LRRK2 physiol. substrate(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDtD1AZs4s_7Vg90H21EOLACvtfcHk0ligvaT-4MgBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Kjsb%252FI&md5=8d9171efda1411ed8a9e25f15859fc47</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.110%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DCurrent%2520Understanding%2520of%2520LRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Biochemical%2520and%2520Structural%2520Features%2520and%2520Inhibitor%2520Design%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1701%26epage%3D1713%26doi%3D10.4155%2Ffmc.12.110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Steger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wachter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorentzen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, M.</span><span> </span><span class="NLM_article-title">Phosphoproteomics Reveals That Parkinson’s Disease Kinase LRRK2 Regulates a Subset of Rab GTPases</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e12813</span><span class="refDoi"> DOI: 10.7554/eLife.12813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.7554%2FeLife.12813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26824392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFGjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e12813&author=M.+Stegerauthor=F.+Tonelliauthor=G.+Itoauthor=P.+Daviesauthor=M.+Trostauthor=M.+Vetterauthor=S.+Wachterauthor=E.+Lorentzenauthor=G.+Duddyauthor=S.+Wilsonauthor=M.+A.+S.+Baptistaauthor=B.+K.+Fiskeauthor=M.+J.+Fellauthor=J.+A.+Morrowauthor=A.+D.+Reithauthor=D.+R.+Alessiauthor=M.+Mann&title=Phosphoproteomics+Reveals+That+Parkinson%E2%80%99s+Disease+Kinase+LRRK2+Regulates+a+Subset+of+Rab+GTPases&doi=10.7554%2FeLife.12813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases</span></div><div class="casAuthors">Steger, Martin; Tonelli, Francesca; Ito, Genta; Davies, Paul; Trost, Matthias; Vetter, Melanie; Wachter, Stefanie; Lorentzen, Esben; Duddy, Graham; Wilson, Stephen; Baptista, Marco A. S.; Fiske, Brian K.; Fell, Matthew J.; Morrow, John A.; Reith, Alastair D.; Alessi, Dario R.; Man, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e12813/1-e12813/28</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Mutations in Park8, encoding for the multidomain Leucine-rich repeat kinase 2 (LRRK2) protein, comprise the predominant genetic cause of Parkinson's disease (PD).  G2019S, the most common amino acid substitution activates the kinase two- to threefold.  This has motivated the development of LRRK2 kinase inhibitors; however, poor consensus on physiol. LRRK2 substrates has hampered clin. development of such therapeutics.  We employ a combination of phosphoproteomics, genetics, and pharmacol. to unambiguously identify a subset of Rab GTPases as key LRRK2 substrates.  LRRK2 directly phosphorylates these both in vivo and in vitro on an evolutionary conserved residue in the switch II domain.  Pathogenic LRRK2 variants mapping to different functional domains increase phosphorylation of Rabs and this strongly decreases their affinity to regulatory proteins including Rab GDP dissocn. inhibitors (GDIs).  Our findings uncover a key class of bona-fide LRRK2 substrates and a novel regulatory mechanism of Rabs that connects them to PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8JgdLZ38hbVg90H21EOLACvtfcHk0ligvaT-4MgBHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFGjur0%253D&md5=e9075908450e709a839f64574286c031</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7554%2FeLife.12813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.12813%26sid%3Dliteratum%253Aachs%26aulast%3DSteger%26aufirst%3DM.%26aulast%3DTonelli%26aufirst%3DF.%26aulast%3DIto%26aufirst%3DG.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DTrost%26aufirst%3DM.%26aulast%3DVetter%26aufirst%3DM.%26aulast%3DWachter%26aufirst%3DS.%26aulast%3DLorentzen%26aufirst%3DE.%26aulast%3DDuddy%26aufirst%3DG.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DMann%26aufirst%3DM.%26atitle%3DPhosphoproteomics%2520Reveals%2520That%2520Parkinson%25E2%2580%2599s%2520Disease%2520Kinase%2520LRRK2%2520Regulates%2520a%2520Subset%2520of%2520Rab%2520GTPases%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De12813%26doi%3D10.7554%2FeLife.12813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">The Role of Leucine-Rich Repeat Kinase 2 (LRRK2) in Parkinson’s Disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span><span class="refDoi"> DOI: 10.1038/nrn2935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fnrn2935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21088684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=791-797&author=M.+R.+Cookson&title=The+Role+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+in+Parkinson%E2%80%99s+Disease&doi=10.1038%2Fnrn2935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</span></div><div class="casAuthors">Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">791-797</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component.  Here, I discuss how mutations in a large complex gene - leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau.  These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ6sTeax7vLVg90H21EOLACvtfcHk0lipyO00vDMW9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO&md5=1600eaee5fea809aa325e2d7a7963b35</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrn2935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2935%26sid%3Dliteratum%253Aachs%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DThe%2520Role%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D791%26epage%3D797%26doi%3D10.1038%2Fnrn2935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chan, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.-K.</span><span> </span><span class="NLM_article-title">Targeting LRRK2 in Parkinson’s Disease: An Update on Recent Developments</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1080/14728222.2017.1323881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1080%2F14728222.2017.1323881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28443359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVCqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=601-610&author=S.+L.+Chanauthor=E.-K.+Tan&title=Targeting+LRRK2+in+Parkinson%E2%80%99s+Disease%3A+An+Update+on+Recent+Developments&doi=10.1080%2F14728222.2017.1323881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting LRRK2 in Parkinson's disease: an update on recent developments</span></div><div class="casAuthors">Chan, Sharon L.; Tan, Eng-King</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">601-610</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  LRRK2 research has progressed significantly in recent years with more reports of LRRK2 interactors and the development of more specific and sophisticated LRRK2 kinase inhibitors.  Identification of bone fide LRRK2 substrates will provide new therapeutic targets in LRRK2-linked Parkinson's disease (PD).: This review aims to put current LRRK2 research into perspective.  Beginning with recent LRRK2 mammalian models employed for in vivo validation of LRRK2 substrates, followed by updates on reported LRRK2 interactors and their inferred mechanisms.  Finally an overview of commonly used LRRK2 kinase inhibitors will be depicted.: Identification of LRRK2 non-kinase functions suggests the possibility of alternative LRRK2 drug target sites and these should be further explored.  Studies on the effects of LRRK2 kinase inhibition on its non-kinase function and its self-regulatory role will provide further insights on its pathophysiol. mechanisms.  Development of robust measurements of LRRK2 inhibitor efficacy will be required.  These would include identification of specific imaging ligands or direct biochem. assays that can accurately capture its intrinsic activity.  Testing of new therapeutic drug targets in both LRRK2 carriers and non LRRK2-linked patients will be important since their phenotype is similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuDMceyQymlLVg90H21EOLACvtfcHk0lipyO00vDMW9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVCqs7k%253D&md5=c07ae116d1b509d0cf82627e0a2d9d9b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1080%2F14728222.2017.1323881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2017.1323881%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BL.%26aulast%3DTan%26aufirst%3DE.-K.%26atitle%3DTargeting%2520LRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520An%2520Update%2520on%2520Recent%2520Developments%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2017%26volume%3D21%26spage%3D601%26epage%3D610%26doi%3D10.1080%2F14728222.2017.1323881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westenberger, A.</span><span> </span><span class="NLM_article-title">Genetics of Parkinson’s Disease</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a008888</span><span class="refDoi"> DOI: 10.1101/cshperspect.a008888</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1101%2Fcshperspect.a008888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22315721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a008888&author=C.+Kleinauthor=A.+Westenberger&title=Genetics+of+Parkinson%E2%80%99s+Disease&doi=10.1101%2Fcshperspect.a008888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics of Parkinson's disease</span></div><div class="casAuthors">Klein, Christine; Westenberger, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">a008888/1-a008888/15</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Fifteen years of genetic research in Parkinson's disease (PD) have led to the identification of several monogenic forms of the disorder and of numerous genetic risk factors increasing the risk to develop PD.  Monogenic forms, caused by a single mutation in a dominantly or recesSively inherited gene, are well-established, albeit relatively rare types of PD.  They collectively account for about 30% of the familial and 3%-5% of the sporadic cases.  In this article, we will summarize the current knowledge and understanding of the mol. genetics of PD.  In brief, we will review familial forms of PD, basic genetic principles of inheritance (and their exceptions in PD), followed by current methods for the identification of PD genes and risk factors, and implications for genetic testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR7sz1nLEJFbVg90H21EOLACvtfcHk0lipyO00vDMW9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvFKls7k%253D&md5=680259f05baf38bb26854521a7d3e5aa</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a008888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a008888%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DWestenberger%26aufirst%3DA.%26atitle%3DGenetics%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da008888%26doi%3D10.1101%2Fcshperspect.a008888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Trinh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilariño-Güell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szu Tu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben Sassi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zouari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhat, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">A Comparative Study of Parkinson’s Disease and Leucine-Rich Repeat Kinase 2 p.G2019S Parkinsonism</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1131</span><span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2013.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.neurobiolaging.2013.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24355527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWju73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=1125-1131&author=J.+Trinhauthor=R.+Amouriauthor=J.+E.+Dudaauthor=J.+F.+Morleyauthor=M.+Readauthor=A.+Donaldauthor=C.+Vilari%C3%B1o-G%C3%BCellauthor=C.+Thompsonauthor=C.+Szu+Tuauthor=E.+K.+Gustavssonauthor=S.+Ben+Sassiauthor=E.+Hentatiauthor=M.+Zouariauthor=E.+Farhatauthor=F.+Nabliauthor=F.+Hentatiauthor=M.+J.+Farrer&title=A+Comparative+Study+of+Parkinson%E2%80%99s+Disease+and+Leucine-Rich+Repeat+Kinase+2+p.G2019S+Parkinsonism&doi=10.1016%2Fj.neurobiolaging.2013.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism</span></div><div class="casAuthors">Trinh, Joanne; Amouri, Rim; Duda, John E.; Morley, James F.; Read, Matthew; Donald, Alan; Vilarino-Guell, Carles; Thompson, Christina; Szu Tu, Chelsea; Gustavsson, Emil K.; Ben Sassi, Samia; Hentati, Emna; Zouari, Mourad; Farhat, Emna; Nabli, Fatma; Hentati, Faycel; Farrer, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1125-1131</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Parkinson disease is a progressive neurodegenerative disease for which leucine-rich repeat kinase 2 (LRRK2 carriers) p.G2019S confers substantial genotypic and population attributable risk.  With informed consent, we have recruited clin. data from 778 patients from Tunisia (of which 266 have LRRK2 parkinsonism) and 580 unaffected subjects.  Motor, autonomic, and cognitive assessments in idiopathic Parkinson disease and LRRK2 patients were compared with regression models.  The age-assocd. cumulative incidence of LRRK2 parkinsonism was also estd. using case-control and family-based designs.  LRRK2 parkinsonism patients had slightly less gastrointestinal dysfunction and rapid eye movement sleep disorder.  Overall, disease penetrance in LRRK2 carriers was 80% by 70 years but women become affected a median 5 years younger than men.  Idiopathic Parkinson disease patients with younger age at diagnosis have slower disease progression.  However, age at diagnoses does not predict progression in LRRK2 parkinsonism.  LRRK2 p.G2019S mutation is a useful aid to diagnosis and modifiers of disease in LRRK2 parkinsonism may aid in developing therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxbtPiKFSvrbVg90H21EOLACvtfcHk0lgWlxNkvHSWZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWju73N&md5=678cd0e694e6dba631147ab00d87cff0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2013.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2013.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DTrinh%26aufirst%3DJ.%26aulast%3DAmouri%26aufirst%3DR.%26aulast%3DDuda%26aufirst%3DJ.%2BE.%26aulast%3DMorley%26aufirst%3DJ.%2BF.%26aulast%3DRead%26aufirst%3DM.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DVilari%25C3%25B1o-G%25C3%25BCell%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DSzu%2BTu%26aufirst%3DC.%26aulast%3DGustavsson%26aufirst%3DE.%2BK.%26aulast%3DBen%2BSassi%26aufirst%3DS.%26aulast%3DHentati%26aufirst%3DE.%26aulast%3DZouari%26aufirst%3DM.%26aulast%3DFarhat%26aufirst%3DE.%26aulast%3DNabli%26aufirst%3DF.%26aulast%3DHentati%26aufirst%3DF.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DA%2520Comparative%2520Study%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%2520and%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520p.G2019S%2520Parkinsonism%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D1125%26epage%3D1131%26doi%3D10.1016%2Fj.neurobiolaging.2013.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Webber, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s Disease: Function in Cells and Neurodegeneration</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6436</span><span class="NLM_x">–</span> <span class="NLM_lpage">6444</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07342.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1111%2Fj.1742-4658.2009.07342.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6436-6444&author=P.+J.+Webberauthor=A.+B.+West&title=LRRK2+in+Parkinson%E2%80%99s+Disease%3A+Function+in+Cells+and+Neurodegeneration&doi=10.1111%2Fj.1742-4658.2009.07342.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07342.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07342.x%26sid%3Dliteratum%253Aachs%26aulast%3DWebber%26aufirst%3DP.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Function%2520in%2520Cells%2520and%2520Neurodegeneration%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6436%26epage%3D6444%26doi%3D10.1111%2Fj.1742-4658.2009.07342.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span><span class="refDoi"> DOI: 10.1016/j.neuron.2004.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+M%C3%BCller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+Cause+Autosomal-Dominant+Parkinsonism+with+Pleomorphic+Pathology&doi=10.1016%2Fj.neuron.2004.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0liaKS3PB9auqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DM%25C3%25BCller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520Cause%2520Autosomal-Dominant%2520Parkinsonism%2520with%2520Pleomorphic%2520Pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607%26doi%3D10.1016%2Fj.neuron.2004.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Albrecht, M.</span><span> </span><span class="NLM_article-title">LRRK2 Mutations and Parkinsonism</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="refDoi"> DOI: 10.1016/S0140-6736(05)74810-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2FS0140-6736%2805%2974810-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=1230&author=M.+Albrecht&title=LRRK2+Mutations+and+Parkinsonism&doi=10.1016%2FS0140-6736%2805%2974810-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2805%2974810-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252805%252974810-8%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DM.%26atitle%3DLRRK2%2520Mutations%2520and%2520Parkinsonism%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26spage%3D1230%26doi%3D10.1016%2FS0140-6736%2805%2974810-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ramírez, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madero-Pérez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivero-Ríos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Salvador, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara Ordóñez, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fdez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfiker, S.</span><span> </span><span class="NLM_article-title">LRRK2 and Parkinson’s Disease: From Lack of Structure to Gain of Function</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span><span class="refDoi"> DOI: 10.2174/1389203717666160311121748</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.2174%2F1389203717666160311121748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26965688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=677-686&author=M.+B.+Ram%C3%ADrezauthor=J.+Madero-P%C3%A9rezauthor=P.+Rivero-R%C3%ADosauthor=M.+Mart%C3%ADnez-Salvadorauthor=A.+J.+Lara+Ord%C3%B3%C3%B1ezauthor=B.+Fern%C3%A1ndezauthor=E.+Fdezauthor=S.+Hilfiker&title=LRRK2+and+Parkinson%E2%80%99s+Disease%3A+From+Lack+of+Structure+to+Gain+of+Function&doi=10.2174%2F1389203717666160311121748"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and Parkinson';s Disease: From Lack of Structure to Gain of Function</span></div><div class="casAuthors">Ramirez, Marian Blanca; Madero-Perez, Jesus; Rivero-Rios, Pilar; Martinez-Salvador, Mar; Lara Ordonez, Antonio J.; Fernandez, Belen; Fdez, Elena; Hilfiker, Sabine</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Mutations in LRRK2 comprise the most common cause for familial Parkinson's disease (PD), and variations increase risk for sporadic disease, implicating LRRK2 in the entire disease spectrum.  LRRK2 is a large protein harbouring both GTPase and kinase domains which display measurable catalytic activity.  Most pathogenic mutations increase the kinase activity, with increased activity being cytotoxic under certain conditions.  These findings have spurred great interest in drug development approaches, and various specific LRRK2 kinase inhibitors have been developed.  However, LRRK2 is a largely ubiquitously expressed protein, and inhibiting its function in some non-neuronal tissues has raised safety liability issues for kinase inhibitor approaches.  Therefore, understanding the cellular and cell type-specific role(s) of LRRK2 has become of paramount importance.  This review will highlight current knowledge on the precise biochem. activities of normal and pathogenic LRRK2, and highlight the most common proposed cellular roles so as to gain a better understanding of the cell type-specific effects of LRRK2 modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQvdeTDVE4trVg90H21EOLACvtfcHk0liaKS3PB9auqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2juro%253D&md5=431066051fa43d242c87f0c5ea7454cc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F1389203717666160311121748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203717666160311121748%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez%26aufirst%3DM.%2BB.%26aulast%3DMadero-P%25C3%25A9rez%26aufirst%3DJ.%26aulast%3DRivero-R%25C3%25ADos%26aufirst%3DP.%26aulast%3DMart%25C3%25ADnez-Salvador%26aufirst%3DM.%26aulast%3DLara%2BOrd%25C3%25B3%25C3%25B1ez%26aufirst%3DA.%2BJ.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DFdez%26aufirst%3DE.%26aulast%3DHilfiker%26aufirst%3DS.%26atitle%3DLRRK2%2520and%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520From%2520Lack%2520of%2520Structure%2520to%2520Gain%2520of%2520Function%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D677%26epage%3D686%26doi%3D10.2174%2F1389203717666160311121748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s Disease-Associated Mutations in Leucine-Rich Repeat Kinase 2 Augment Kinase Activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span><span class="refDoi"> DOI: 10.1073/pnas.0507360102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1073%2Fpnas.0507360102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+Disease-Associated+Mutations+in+Leucine-Rich+Repeat+Kinase+2+Augment+Kinase+Activity&doi=10.1073%2Fpnas.0507360102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0507360102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0507360102%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520Disease-Associated%2520Mutations%2520in%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520Augment%2520Kinase%2520Activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847%26doi%3D10.1073%2Fpnas.0507360102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhu, H.; Chen, H.; Cho, W.; Estrada, A. A.; Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson’s Disease</span>. In  <span class="citation_source-book">Medicinal Chemistry Approaches to Personalized Medicine</span>; <span class="NLM_contrib-group">Lackey, K.; Roth, B. D.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span>, DOI: <span class="refDoi"> DOI: 10.1002/9783527677252.ch10</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1002%2F9783527677252.ch10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=227-254&author=H.+Zhu&author=H.+Chen&author=W.+Cho&author=A.+A.+Estrada&author=Z.+K.+Sweeneyauthor=K.+Lackey&author=B.+D.+Roth&title=Medicinal+Chemistry+Approaches+to+Personalized+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2F9783527677252.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677252.ch10%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DFrom%2520Human%2520Genetics%2520to%2520Drug%2520Candidates%253A%2520An%2520Industrial%2520Perspective%2520on%2520LRRK2%2520Inhibition%2520as%2520a%2520Treatment%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26btitle%3DMedicinal%2520Chemistry%2520Approaches%2520to%2520Personalized%2520Medicine%26aulast%3DLackey%26aufirst%3DK.%26pub%3DWiley-VCH%2520Verlag%26date%3D2013%26spage%3D227%26epage%3D254%26doi%3D10.1002%2F9783527677252.ch10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gilligan, P. J.</span><span> </span><span class="NLM_article-title">Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson’s Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span><span class="refDoi"> DOI: 10.2174/156802661510150328223655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.2174%2F156802661510150328223655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=25832719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1altrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=927-938&author=P.+J.+Gilligan&title=Inhibitors+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29%3A+Progress+and+Promise+for+the+Treatment+of+Parkinson%E2%80%99s+Disease&doi=10.2174%2F156802661510150328223655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson's Disease</span></div><div class="casAuthors">Gilligan, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">927-938</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Mutations in the gene for leucine-rich repeat kinase 2 (LRRK2) have been linked to several familial and sporadic late-onset cases of Parkinson's disease.  The cumulative data for the effects of mutant forms of this enzyme on neuronal degrdn. and the pathophysiol. of Parkinson's disease create a compelling case for drug discovery based on inhibition of the mutant forms of LRRK2.  This review focuses on structure-activity relationships for inhibitors of LRRK2 and the data supporting a potential role of these agents in treating Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRyfmc0sAcnbVg90H21EOLACvtfcHk0liyaGQa35J_6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1altrc%253D&md5=218f11008606a3215fc1f2b4e917044f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F156802661510150328223655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802661510150328223655%26sid%3Dliteratum%253Aachs%26aulast%3DGilligan%26aufirst%3DP.%2BJ.%26atitle%3DInhibitors%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%253A%2520Progress%2520and%2520Promise%2520for%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D927%26epage%3D938%26doi%3D10.2174%2F156802661510150328223655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6733</span><span class="NLM_x">–</span> <span class="NLM_lpage">6746</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00261</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00261" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6733-6746&author=A.+A.+Estradaauthor=Z.+K.+Sweeney&title=Chemical+Biology+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6733-6746</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is an urgent need for the development of Parkinson's disease (PD) treatments that can slow disease progression.  The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to PD, and modulation of LRRK2 enzymic activity has been proposed as a novel therapeutic strategy.  In this review, we describe the bioactivity of selected small mols. that have been used to inhibit LRRK2 kinase activity in vitro or in vivo.  These compds. are important tools for understanding the cellular biol. of LRRK2 and for evaluating the potential of LRRK2 inhibitors as disease-modifying PD therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1REdaTMbQkLVg90H21EOLACvtfcHk0lhIvq03iJUvCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGiu7g%253D&md5=37336d97c3c51dcea44df4f7a51837c5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00261%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DChemical%2520Biology%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6733%26epage%3D6746%26doi%3D10.1021%2Facs.jmedchem.5b00261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Galatsis, P.</span><span> </span><span class="NLM_article-title">Leucine-Rich Repeat Kinase 2 Inhibitors: A Patent Review (2014–2016)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1080/13543776.2017.1280464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1080%2F13543776.2017.1280464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28117607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1Wgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=667-676&author=P.+Galatsis&title=Leucine-Rich+Repeat+Kinase+2+Inhibitors%3A+A+Patent+Review+%282014%E2%80%932016%29&doi=10.1080%2F13543776.2017.1280464"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-2016)</span></div><div class="casAuthors">Galatsis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">667-676</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Leucine-rich repeat kinase 2 (LRRK2) is a member of the Tyrosine Kinase-Like (TKL) branch of the kinome tree and is a multi-domain protein that includes GTPase and kinase activity.  While genome-wide assocn. studies (GWAS) has linked LRRK2 with Crohn's disease and leprosy, it has received the greatest attention due to it being implicated as one of the genetic loci assocd. with autosomal dominant inheritance in Parkinson's disease (PD).  In this review, the small mol. patent literature from 2014-2016 with a focus on compn. of matter and use patents was surveyed.  Scifinder was primarily searched using 'LRRK2' as the query to identify all relevant literature and then triaged for small mol. patents.  The patent landscape around LRRK2 continues to develop.  The early patents covered using existing kinase inhibitors for use against LRRK2.  This evolved to compds. specifically designed for selectivity against LRRK2, but key exemplified compds. lacked sufficient brain exposure to affect sufficient efficacy.  More recent compds. have addressed this deficiency and show greater potential for treating PD.  While potency will be necessary to generate medicines with low human daily doses, brain penetration and safety will be the key differentiators for ultimately detg. the most effective LRRK2 disease-modifying treatment for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwhvhIy4GudLVg90H21EOLACvtfcHk0lhIvq03iJUvCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1Wgur4%253D&md5=15ca6328181a2ecf1531b40d5487a01a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1280464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1280464%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DLeucine-Rich%2520Repeat%2520Kinase%25202%2520Inhibitors%253A%2520A%2520Patent%2520Review%2520%25282014%25E2%2580%25932016%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D667%26epage%3D676%26doi%3D10.1080%2F13543776.2017.1280464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schulz, S.; Göring, S.; Schmidt, B.; Hopf, C.</span><span> </span><span class="NLM_article-title">LRRK2 Kinase Inhibitors as New Drugs for Parkinson’s Disease?</span> In  <span class="citation_source-book">Emerging Drugs and Targets for Parkinson’s Disease</span>; <span class="NLM_contrib-group">Martinez, A.; Gil, C.</span>, Eds.; RSC Drug Discovery Series 34; <span class="NLM_publisher-name">Royal Society of Chemistry</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span>, DOI: <span class="refDoi"> DOI: 10.1039/9781849737357-00266</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1039%2F9781849737357-00266" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=266-293&author=S.+Schulz&author=S.+G%C3%B6ring&author=B.+Schmidt&author=C.+Hopfauthor=A.+Martinez&author=C.+Gil&title=Emerging+Drugs+and+Targets+for+Parkinson%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2F9781849737357-00266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849737357-00266%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DLRRK2%2520Kinase%2520Inhibitors%2520as%2520New%2520Drugs%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%253F%26btitle%3DEmerging%2520Drugs%2520and%2520Targets%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26aulast%3DMartinez%26aufirst%3DA.%26pub%3DRoyal%2520Society%2520of%2520Chemistry%26date%3D2013%26spage%3D266%26epage%3D293%26doi%3D10.1039%2F9781849737357-00266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Galatsis, P.; Henderson, J.; Kormos, B. L.; Hirst, W. D.</span><span> </span><span class="NLM_article-title">Development of LRRK2 Kinase Inhibitors for Parkinson’s Disease</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Desai, M. C.</span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">49</span>, pp  <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2FB978-0-12-800167-7.00004-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=43-58&author=P.+Galatsis&author=J.+Henderson&author=B.+L.+Kormos&author=W.+D.+Hirstauthor=M.+C.+Desai&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-800167-7.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-800167-7.00004-3%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520LRRK2%2520Kinase%2520Inhibitors%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26aulast%3DDesai%26aufirst%3DM.%2BC.%26pub%3DAcademic%2520Press%26date%3D2014%26volume%3D49%26spage%3D43%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Christensen, K. V.; Smith, G. P.; Williamson, D. S.</span><span> </span><span class="NLM_article-title">Development of LRRK2 Inhibitors for the Treatment of Parkinson’s Disease</span>. In  <span class="citation_source-book">Progress in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Witty, D. R.; Cox, B.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">56</span>, pp  <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span>, DOI: <span class="refDoi"> DOI: 10.1016/bs.pmch.2016.11.002</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fbs.pmch.2016.11.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=37-80&author=K.+V.+Christensen&author=G.+P.+Smith&author=D.+S.+Williamsonauthor=D.+R.+Witty&author=B.+Cox&title=Progress+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fbs.pmch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252Fbs.pmch.2016.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26atitle%3DDevelopment%2520of%2520LRRK2%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26btitle%3DProgress%2520in%2520Medicinal%2520Chemistry%26aulast%3DWitty%26aufirst%3DD.%2BR.%26pub%3DElsevier%26date%3D2017%26volume%3D56%26spage%3D37%26epage%3D80%26doi%3D10.1016%2Fbs.pmch.2016.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hatcher, J. M.; Choi, H. G.; Alessi, D. R.; Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of LRRK2</span>. In  <span class="citation_source-book">Leucine-Rich Repeat Kinase 2 (LRRK2)</span>; <span class="NLM_contrib-group">Rideout, H. J.</span>, Ed.; Advances in Neurobiology, Vol. 14; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-3-319-49969-7_13</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1007%2F978-3-319-49969-7_13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=241-264&author=J.+M.+Hatcher&author=H.+G.+Choi&author=D.+R.+Alessi&author=N.+S.+Grayauthor=H.+J.+Rideout&title=Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-49969-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-49969-7_13%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520LRRK2%26btitle%3DLeucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%26aulast%3DRideout%26aufirst%3DH.%2BJ.%26pub%3DSpringer%26date%3D2017%26spage%3D241%26epage%3D264%26doi%3D10.1007%2F978-3-319-49969-7_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Covy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giasson, B. I.</span><span> </span><span class="NLM_article-title">Identification of Compounds That Inhibit the Kinase Activity of Leucine-Rich Repeat Kinase 2</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2008.11.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bbrc.2008.11.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2009&pages=473-477&author=J.+P.+Covyauthor=B.+I.+Giasson&title=Identification+of+Compounds+That+Inhibit+the+Kinase+Activity+of+Leucine-Rich+Repeat+Kinase+2&doi=10.1016%2Fj.bbrc.2008.11.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2008.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2008.11.048%26sid%3Dliteratum%253Aachs%26aulast%3DCovy%26aufirst%3DJ.%2BP.%26aulast%3DGiasson%26aufirst%3DB.%2BI.%26atitle%3DIdentification%2520of%2520Compounds%2520That%2520Inhibit%2520the%2520Kinase%2520Activity%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D378%26spage%3D473%26epage%3D477%26doi%3D10.1016%2Fj.bbrc.2008.11.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a Selective Inhibitor of the Parkinson’s Disease Kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1038/nchembio.538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+Selective+Inhibitor+of+the+Parkinson%E2%80%99s+Disease+Kinase+LRRK2&doi=10.1038%2Fnchembio.538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0liFynSyRcI5UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520Selective%2520Inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520Disease%2520Kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205%26doi%3D10.1038%2Fnchembio.538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">GSK2578215A; A Potent and Highly Selective 2-Arylmethyloxy-5-substitutent-<i>N</i>-arylbenzamide LRRK2 Kinase Inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5625</span><span class="NLM_x">–</span> <span class="NLM_lpage">5629</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2012.06.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22863203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5625-5629&author=A.+D.+Reithauthor=P.+Bamboroughauthor=K.+Janduauthor=D.+Andreottiauthor=L.+Mensahauthor=P.+Dossangauthor=H.+G.+Choiauthor=X.+Dengauthor=J.+Zhangauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=GSK2578215A%3B+A+Potent+and+Highly+Selective+2-Arylmethyloxy-5-substitutent-N-arylbenzamide+LRRK2+Kinase+Inhibitor&doi=10.1016%2Fj.bmcl.2012.06.104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor</span></div><div class="casAuthors">Reith, Alastair D.; Bamborough, Paul; Jandu, Karamjit; Andreotti, Daniele; Mensah, Lucy; Dossang, Pamela; Choi, Hwan Geun; Deng, Xianming; Zhang, Jinwei; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5625-5629</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) is a promising therapeutic target for some forms of Parkinson's disease.  Here we report the discovery and characterization of 2-arylmethyloxy-5-subtitutent-N-arylbenzamides with potent LRRK2 activities exemplified by GSK2578215A which exhibits biochem. IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant.  GSK2578215A exhibits exceptionally high selectivity for LRRK2 across the kinome, substantially inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concn. of 0.3-1.0 μM in cells and in mouse spleen and kidney, but not in brain, following i.p. injection of 100 mg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplPAPdmxGOJLVg90H21EOLACvtfcHk0liHmSDFgLKAeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCgsrfO&md5=b2bf7c7cb191cd297b8f586daca58ab1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.104%26sid%3Dliteratum%253Aachs%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DJandu%26aufirst%3DK.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DMensah%26aufirst%3DL.%26aulast%3DDossang%26aufirst%3DP.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DGSK2578215A%253B%2520A%2520Potent%2520and%2520Highly%2520Selective%25202-Arylmethyloxy-5-substitutent-N-arylbenzamide%2520LRRK2%2520Kinase%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5625%26epage%3D5629%26doi%3D10.1016%2Fj.bmcl.2012.06.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span><span class="refDoi"> DOI: 10.1021/jm301020q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+Highly+Potent%2C+Selective%2C+and+Brain-Penetrable+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Small+Molecule+Inhibitors&doi=10.1021%2Fjm301020q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors</span></div><div class="casAuthors">Estrada, Anthony A.; Liu, Xingrong; Baker-Glenn, Charles; Beresford, Alan; Burdick, Daniel J.; Chambers, Mark; Chan, Bryan K.; Chen, Huifen; Ding, Xiao; DiPasquale, Antonio G.; Dominguez, Sara L.; Dotson, Jennafer; Drummond, Jason; Flagella, Michael; Flynn, Sean; Fuji, Reina; Gill, Andrew; Gunzner-Toste, Janet; Harris, Seth F.; Heffron, Timothy P.; Kleinheinz, Tracy; Lee, Donna W.; Le Pichon, Claire E.; Lyssikatos, Joseph P.; Medhurst, Andrew D.; Moffat, John G.; Mukund, Susmith; Nash, Kevin; Scearce-Levie, Kimberly; Sheng, Zejuan; Shore, Daniel G.; Tran, Thuy; Trivedi, Naimisha; Wang, Shumei; Zhang, Shuo; Zhang, Xiaolin; Zhao, Guiling; Zhu, Haitao; Sweeney, Zachary K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9416-9433</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a high demand for potent, selective, and brain-penetrant small mol. inhibitors of leucine-rich repeat kinase 2 (LRRK2) to test whether inhibition of LRRK2 kinase activity is a potentially viable treatment option for Parkinson's disease patients.  Herein we disclose the use of property and structure-based drug design for the optimization of highly ligand efficient aminopyrimidine lead compds.  High throughput in vivo rodent cassette pharmacokinetic studies enabled rapid validation of in vitro-in vivo correlations.  Guided by this data, optimal design parameters were established.  Effective incorporation of these guidelines into our mol. design process resulted in the discovery of small mol. inhibitors such as GNE-7915 (18, I) and 19, which possess an ideal balance of LRRK2 cellular potency, broad kinase selectivity, metabolic stability, and brain penetration across multiple species.  Advancement of GNE-7915 into rodent and higher species toxicity studies enabled risk assessment for early development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptu1BnxYNJQrVg90H21EOLACvtfcHk0liHmSDFgLKAeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbfO&md5=9fc7ccca9c973a960e7393c79c1255fa</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Brain-Penetrable%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Small%2520Molecule%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433%26doi%3D10.1021%2Fjm301020q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayward, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jasti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatsis, P.</span><span> </span><span class="NLM_article-title">Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1021/jm5014055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5014055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVens7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=419-432&author=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=M.+M.+Haywardauthor=K.+J.+Coffmanauthor=J.+Jastiauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirstauthor=P.+Galatsis&title=Discovery+and+Preclinical+Profiling+of+3-%5B4-%28Morpholin-4-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidin-5-yl%5Dbenzonitrile+%28PF-06447475%29%2C+a+Highly+Potent%2C+Selective%2C+Brain+Penetrant%2C+and+in+Vivo+Active+LRRK2+Kinase+Inhibitor&doi=10.1021%2Fjm5014055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor</span></div><div class="casAuthors">Henderson, Jaclyn L.; Kormos, Bethany L.; Hayward, Matthew M.; Coffman, Karen J.; Jasti, Jayasankar; Kurumbail, Ravi G.; Wager, Travis T.; Verhoest, Patrick R.; Noell, G. Stephen; Chen, Yi; Needle, Elie; Berger, Zdenek; Steyn, Stefanus J.; Houle, Christopher; Hirst, Warren D.; Galatsis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">419-432</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Leucine rich repeat kinase 2 (LRRK2) has been genetically linked to Parkinson's disease (PD) by genome-wide assocn. studies (GWAS).  The most common LRRK2 mutation, G2019S, which is relatively rare in the total population, gives rise to increased kinase activity.  As such, LRRK2 kinase inhibitors are potentially useful in the treatment of PD.  We herein disclose the discovery and optimization of a novel series of potent LRRK2 inhibitors, focusing on improving kinome selectivity using a surrogate crystallog. approach.  This resulted in the identification of 14 (PF-06447475), a highly potent, brain penetrant and selective LRRK2 inhibitor which has been further profiled in in vivo safety and pharmacodynamic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndkJkbl5dB7Vg90H21EOLACvtfcHk0lh9cY73_RbbmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVens7%252FO&md5=d970c348ae4ec899b504e28060b21f13</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm5014055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5014055%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHayward%26aufirst%3DM.%2BM.%26aulast%3DCoffman%26aufirst%3DK.%2BJ.%26aulast%3DJasti%26aufirst%3DJ.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520Preclinical%2520Profiling%2520of%25203-%255B4-%2528Morpholin-4-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidin-5-yl%255Dbenzonitrile%2520%2528PF-06447475%2529%252C%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Brain%2520Penetrant%252C%2520and%2520in%2520Vivo%2520Active%2520LRRK2%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D419%26epage%3D432%26doi%3D10.1021%2Fjm5014055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=584-589&author=J.+M.+Hatcherauthor=J.+Zhangauthor=H.+G.+Choiauthor=G.+Itoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+a+Pyrrolopyrimidine+%28JH-II-127%29%2C+a+Highly+Potent%2C+Selective%2C+and+Brain+Penetrant+LRRK2+Inhibitor&doi=10.1021%2Facsmedchemlett.5b00064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00064%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DIto%26aufirst%3DG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520a%2520Pyrrolopyrimidine%2520%2528JH-II-127%2529%252C%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520and%2520Brain%2520Penetrant%2520LRRK2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D584%26epage%3D589%26doi%3D10.1021%2Facsmedchemlett.5b00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheewatrakoolpong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMong, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgraf, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span> </span><span class="NLM_article-title">MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span><span class="refDoi"> DOI: 10.1124/jpet.115.227587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1124%2Fjpet.115.227587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26407721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslamsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2015&pages=397-409&author=M.+J.+Fellauthor=C.+Mirescuauthor=K.+Basuauthor=B.+Cheewatrakoolpongauthor=D.+E.+DeMongauthor=J.+M.+Ellisauthor=L.+A.+Hydeauthor=Y.+Linauthor=C.+G.+Markgrafauthor=H.+Meiauthor=M.+Millerauthor=F.+M.+Pouletauthor=J.+D.+Scottauthor=M.+D.+Smithauthor=Z.+Yinauthor=X.+Zhouauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=J.+A.+Morrow&title=MLi-2%2C+a+Potent%2C+Selective%2C+and+Centrally+Active+Compound+for+Exploring+the+Therapeutic+Potential+and+Safety+of+LRRK2+Kinase+Inhibition&doi=10.1124%2Fjpet.115.227587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition</span></div><div class="casAuthors">Fell, Matthew J.; Mirescu, Christian; Basu, Kallol; Cheewatrakoolpong, Boonlert; DeMong, Duane E.; Ellis, J. Michael; Hyde, Lynn A.; Lin, Yinghui; Markgraf, Carrie G.; Mei, Hong; Miller, Michael; Poulet, Frederique M.; Scott, Jack D.; Smith, Michelle D.; Yin, Zhizhang; Zhou, Xiaoping; Parker, Eric M.; Kennedy, Matthew E.; Morrow, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-409</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of familial and sporadic Parkinson's disease (PD).  That the most prevalent mutation, G2019S, leads to increased kinase activity has led to a concerted effort to identify LRRK2 kinase inhibitors as a potential disease-modifying therapy for PD.  An internal medicinal chem. effort identified several potent and highly selective compds. with favorable drug-like properties.  Here, we characterize the pharmacol. properties of cis-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine (MLi-2), a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity.  MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 (IC50 = 1.4 nM), and a radioligand competition binding assay (IC50 = 3.4 nM).  MLi-2 has greater than 295-fold selectivity for over 300 kinases in addn. to a diverse panel of receptors and ion channels.  Acute oral and subchronic dosing in MLi-2 mice resulted in dose-dependent central and peripheral target inhibition over a 24-h period as measured by dephosphorylation of pSer935 LRRK2.  Treatment of MitoPark mice with MLi-2 was well tolerated over a 15-wk period at brain and plasma exposures >100× the in vivo plasma IC50 for LRRK2 kinase inhibition as measured by pSer935 dephosphorylation.  Morphol. changes in the lung, consistent with enlarged type II pneumocytes, were obsd. in MLi-2-treated MitoPark mice.  These data demonstrate the suitability of MLi-2 as a compd. to explore LRRK2 biol. in cellular and animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpot402TvUrkbVg90H21EOLACvtfcHk0lhPFlqLWovIIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslamsbk%253D&md5=83c68f7bb731bef2fa9db880196dbabe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.227587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.227587%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DMirescu%26aufirst%3DC.%26aulast%3DBasu%26aufirst%3DK.%26aulast%3DCheewatrakoolpong%26aufirst%3DB.%26aulast%3DDeMong%26aufirst%3DD.%2BE.%26aulast%3DEllis%26aufirst%3DJ.%2BM.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMarkgraf%26aufirst%3DC.%2BG.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMiller%26aufirst%3DM.%26aulast%3DPoulet%26aufirst%3DF.%2BM.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26atitle%3DMLi-2%252C%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Centrally%2520Active%2520Compound%2520for%2520Exploring%2520the%2520Therapeutic%2520Potential%2520and%2520Safety%2520of%2520LRRK2%2520Kinase%2520Inhibition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D355%26spage%3D397%26epage%3D409%26doi%3D10.1124%2Fjpet.115.227587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMong, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macala, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnihotri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Columbus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirescu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embrey, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiscia, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. W.</span><span> </span><span class="NLM_article-title">Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor That Reduces Brain Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2983</span><span class="NLM_x">–</span> <span class="NLM_lpage">2992</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00045</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFaltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2983-2992&author=J.+D.+Scottauthor=D.+E.+DeMongauthor=T.+J.+Greshockauthor=K.+Basuauthor=X.+Daiauthor=J.+Harrisauthor=A.+Hruzaauthor=S.+W.+Liauthor=S.-I.+Linauthor=H.+Liuauthor=M.+K.+Macalaauthor=Z.+Huauthor=H.+Meiauthor=H.+Zhangauthor=P.+Walshauthor=M.+Poirierauthor=Z.-C.+Shiauthor=L.+Xiaoauthor=G.+Agnihotriauthor=M.+A.+S.+Baptistaauthor=J.+Columbusauthor=M.+J.+Fellauthor=L.+A.+Hydeauthor=R.+Kuvelkarauthor=Y.+Linauthor=C.+Mirescuauthor=J.+A.+Morrowauthor=Z.+Yinauthor=X.+Zhangauthor=X.+Zhouauthor=R.+K.+Changauthor=M.+W.+Embreyauthor=J.+M.+Sandersauthor=H.+E.+Tisciaauthor=R.+E.+Droletauthor=J.+T.+Kernauthor=S.+M.+Surauthor=J.+J.+Rengerauthor=M.+T.+Bilodeauauthor=M.+E.+Kennedyauthor=E.+M.+Parkerauthor=A.+W.+Stamfordauthor=R.+P.+Nargundauthor=J.+A.+McCauleyauthor=M.+W.+Miller&title=Discovery+of+a+3-%284-Pyrimidinyl%29+Indazole+%28MLi-2%29%2C+an+Orally+Available+and+Selective+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Inhibitor+That+Reduces+Brain+Kinase+Activity&doi=10.1021%2Facs.jmedchem.7b00045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity</span></div><div class="casAuthors">Scott, Jack D.; DeMong, Duane E.; Greshock, Thomas J.; Basu, Kallol; Dai, Xing; Harris, Joel; Hruza, Alan; Li, Sarah W.; Lin, Sue-Ing; Liu, Hong; Macala, Megan K.; Hu, Zhiyong; Mei, Hong; Zhang, Honglu; Walsh, Paul; Poirier, Marc; Shi, Zhi-Cai; Xiao, Li; Agnihotri, Gautam; Baptista, Marco A. S.; Columbus, John; Fell, Matthew J.; Hyde, Lynn A.; Kuvelkar, Reshma; Lin, Yinghui; Mirescu, Christian; Morrow, John A.; Yin, Zhizhang; Zhang, Xiaoping; Zhou, Xiaoping; Chang, Ronald K.; Embrey, Mark W.; Sanders, John M.; Tiscia, Heather E.; Drolet, Robert E.; Kern, Jonathan T.; Sur, Sylvie M.; Renger, John J.; Bilodeau, Mark T.; Kennedy, Matthew E.; Parker, Eric M.; Stamford, Andrew W.; Nargund, Ravi; McCauley, John A.; Miller, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2983-2992</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Leucine-Rich Repeat Kinase 2 (LRRK2) is a large, multidomain protein which contains a kinase domain and GTPase domain among other regions.  Individuals possessing gain of function mutations in the kinase domain such as the most prevalent G2019S mutation have been assocd. with an increased risk for the development of Parkinson's Disease (PD).  Given this genetic validation for inhibition of LRRK2 kinase activity as a potential means of effecting disease progression, the team set out to develop LRRK2 inhibitors to test this hypothesis.  A high throughput screen of the compd. collection afforded a no. of promising indazole leads which were truncated in order to identify a min. pharmacophore.  Further optimization of these indazoles led to the development of MLi-2 I: a potent, highly selective, orally available, brain penetrant inhibitor of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbCbKjwmMvE7Vg90H21EOLACvtfcHk0lgMtYv9cvQZGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFaltL8%253D&md5=4d18d0d3288d0a9330c385776a9f0b7c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00045%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DDeMong%26aufirst%3DD.%2BE.%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DBasu%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DHruza%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DLin%26aufirst%3DS.-I.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMacala%26aufirst%3DM.%2BK.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWalsh%26aufirst%3DP.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DZ.-C.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DAgnihotri%26aufirst%3DG.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DColumbus%26aufirst%3DJ.%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMirescu%26aufirst%3DC.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DEmbrey%26aufirst%3DM.%2BW.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DTiscia%26aufirst%3DH.%2BE.%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMiller%26aufirst%3DM.%2BW.%26atitle%3DDiscovery%2520of%2520a%25203-%25284-Pyrimidinyl%2529%2520Indazole%2520%2528MLi-2%2529%252C%2520an%2520Orally%2520Available%2520and%2520Selective%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Inhibitor%2520That%2520Reduces%2520Brain%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2983%26epage%3D2992%26doi%3D10.1021%2Facs.jmedchem.7b00045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badolo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chell, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daechsel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span> </span><span class="NLM_article-title">The Design and SAR of a Novel Series of 2-Aminopyridine Based LRRK2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4500</span><span class="NLM_x">–</span> <span class="NLM_lpage">4505</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2017.07.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28802631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4500-4505&author=G.+P.+Smithauthor=L.+Badoloauthor=V.+Chellauthor=I.+Chenauthor=K.+V.+Christensenauthor=L.+Davidauthor=J.+A.+Daechselauthor=M.+Hentzerauthor=M.+C.+Herzigauthor=G.+K.+Mikkelsenauthor=S.+P.+Watsonauthor=D.+S.+Williamson&title=The+Design+and+SAR+of+a+Novel+Series+of+2-Aminopyridine+Based+LRRK2+Inhibitors&doi=10.1016%2Fj.bmcl.2017.07.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors</span></div><div class="casAuthors">Smith, Garrick P.; Badolo, Lassina; Chell, Victoria; Chen, I.-Jen; Christensen, Kenneth Vielsted; David, Laurent; Daechsel, Justus Alfred; Hentzer, Morten; Herzig, Martin Christian; Mikkelsen, Gitte Kobberoee; Watson, Stephen P.; Williamson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4500-4505</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase 2 (LRRK2) has attracted considerable interest as a therapeutic target for the treatment of Parkinson's disease.  Compds. derived from a 2-aminopyridine screening hit were optimized using a LRRK2 homol. model based on mixed lineage kinase 1 (MLK1), such that a 2-aminopyridine-based lead mol. 45 (I), with in vivo activity, was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBjU_w5MtzRrVg90H21EOLACvtfcHk0lgMtYv9cvQZGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrrN&md5=6d46e7e3ed4b977e9f083c45a1923f6f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.072%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DBadolo%26aufirst%3DL.%26aulast%3DChell%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26aulast%3DDavid%26aufirst%3DL.%26aulast%3DDaechsel%26aufirst%3DJ.%2BA.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DM.%2BC.%26aulast%3DMikkelsen%26aufirst%3DG.%2BK.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26atitle%3DThe%2520Design%2520and%2520SAR%2520of%2520a%2520Novel%2520Series%2520of%25202-Aminopyridine%2520Based%2520LRRK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4500%26epage%3D4505%26doi%3D10.1016%2Fj.bmcl.2017.07.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Fuji, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baca, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baptista, M. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodbeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiske, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honigberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jubb, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katavolos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin-Koh, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichelt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roose-Girma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urkowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warming, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaylaoglu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span> </span><span class="NLM_article-title">Effect of Selective LRRK2 Kinase Inhibition on Nonhuman Primate Lung</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">273ra15</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aaa3634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1126%2Fscitranslmed.aaa3634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=25653221" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=273ra15&author=R.+N.+Fujiauthor=M.+Flagellaauthor=M.+Bacaauthor=M.+A.+S.+Baptistaauthor=J.+Brodbeckauthor=B.+K.+Chanauthor=B.+K.+Fiskeauthor=L.+Honigbergauthor=A.+M.+Jubbauthor=P.+Katavolosauthor=D.+W.+Leeauthor=S.-C.+Lewin-Kohauthor=T.+Linauthor=X.+Liuauthor=S.+Liuauthor=J.+P.+Lyssikatosauthor=J.+O%E2%80%99Mahonyauthor=M.+Reicheltauthor=M.+Roose-Girmaauthor=Z.+Shengauthor=T.+Shererauthor=A.+Smithauthor=M.+Solonauthor=Z.+K.+Sweeneyauthor=J.+Tarrantauthor=A.+Urkowitzauthor=S.+Warmingauthor=M.+Yaylaogluauthor=S.+Zhangauthor=H.+Zhuauthor=A.+A.+Estradaauthor=R.+J.+Watts&title=Effect+of+Selective+LRRK2+Kinase+Inhibition+on+Nonhuman+Primate+Lung&doi=10.1126%2Fscitranslmed.aaa3634"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa3634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa3634%26sid%3Dliteratum%253Aachs%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DBaptista%26aufirst%3DM.%2BA.%2BS.%26aulast%3DBrodbeck%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DFiske%26aufirst%3DB.%2BK.%26aulast%3DHonigberg%26aufirst%3DL.%26aulast%3DJubb%26aufirst%3DA.%2BM.%26aulast%3DKatavolos%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLewin-Koh%26aufirst%3DS.-C.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DJ.%26aulast%3DReichelt%26aufirst%3DM.%26aulast%3DRoose-Girma%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DSherer%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSolon%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DUrkowitz%26aufirst%3DA.%26aulast%3DWarming%26aufirst%3DS.%26aulast%3DYaylaoglu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DEffect%2520of%2520Selective%2520LRRK2%2520Kinase%2520Inhibition%2520on%2520Nonhuman%2520Primate%2520Lung%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D273ra15%26doi%3D10.1126%2Fscitranslmed.aaa3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Taymans, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span> </span><span class="NLM_article-title">LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1570159X13666151030102847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.2174%2F1570159X13666151030102847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=26517051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCgu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=214-225&author=J.-M.+Taymansauthor=E.+Greggio&title=LRRK2+Kinase+Inhibition+as+a+Therapeutic+Strategy+for+Parkinson%E2%80%99s+Disease%2C+Where+Do+We+Stand%3F&doi=10.2174%2F1570159X13666151030102847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?</span></div><div class="casAuthors">Taymans, Jean-Marc; Greggio, Elisa</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">214-225</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">One of the most promising therapeutic targets for potential disease modifying treatment of Parkinson's disease (PD) is leucine-rich repeat kinase 2 (LRRK2).  Specifically, targeting LRRK2's kinase function has generated a lot of interest from both industry and academia.  This work has yielded several published studies showing the feasibility of developing potent, selective and brain permeable LRRK2 kinase inhibitors.  The availability of these exptl. drugs is contributing to filling in the gaps in our knowledge on the safety and efficacy of LRRK2 kinase inhibition.  Recent studies of LRRK2 kinase inhibition in preclin. models point to potential undesired effects in peripheral tissues such as lung and kidney.  Also, while strategies are now emerging to measure target engagement of LRRK2 inhibitors, there remains an important need to expand efficacy studies in preclin. models of progressive PD.  Future work in the LRRK2 inhibition field must therefore be directed towards developing mols. and treatment regimens which demonstrate efficacy in mammalian models of disease in conditions where safety liabilities are reduced to a min.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrE-1Rx3Jzh7Vg90H21EOLACvtfcHk0lh1E0--OZ45HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCgu74%253D&md5=f68fc6814e2add4836aefe53321d1199</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1570159X13666151030102847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X13666151030102847%26sid%3Dliteratum%253Aachs%26aulast%3DTaymans%26aufirst%3DJ.-M.%26aulast%3DGreggio%26aufirst%3DE.%26atitle%3DLRRK2%2520Kinase%2520Inhibition%2520as%2520a%2520Therapeutic%2520Strategy%2520for%2520Parkinson%25E2%2580%2599s%2520Disease%252C%2520Where%2520Do%2520We%2520Stand%253F%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2016%26volume%3D14%26spage%3D214%26epage%3D225%26doi%3D10.2174%2F1570159X13666151030102847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moehle, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli-Daley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLucas, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiyaveettil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moukha-Chafiq, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kezar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span> </span><span class="NLM_article-title">Unique Functional and Structural Properties of the LRRK2 Protein ATP-Binding Pocket</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">32937</span><span class="NLM_x">–</span> <span class="NLM_lpage">32951</span><span class="refDoi"> DOI: 10.1074/jbc.M114.602318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1074%2Fjbc.M114.602318" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=32937-32951&author=Z.+Liuauthor=R.+A.+Galemmoauthor=K.+B.+Fraserauthor=M.+S.+Moehleauthor=S.+Senauthor=L.+A.+Volpicelli-Daleyauthor=L.+J.+DeLucasauthor=L.+J.+Rossauthor=J.+Valiyaveettilauthor=O.+Moukha-Chafiqauthor=A.+K.+Pathakauthor=S.+Ananthanauthor=H.+Kezarauthor=E.+L.+Whiteauthor=V.+Guptaauthor=J.+A.+Maddryauthor=M.+J.+Sutoauthor=A.+B.+West&title=Unique+Functional+and+Structural+Properties+of+the+LRRK2+Protein+ATP-Binding+Pocket&doi=10.1074%2Fjbc.M114.602318"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.602318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.602318%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DFraser%26aufirst%3DK.%2BB.%26aulast%3DMoehle%26aufirst%3DM.%2BS.%26aulast%3DSen%26aufirst%3DS.%26aulast%3DVolpicelli-Daley%26aufirst%3DL.%2BA.%26aulast%3DDeLucas%26aufirst%3DL.%2BJ.%26aulast%3DRoss%26aufirst%3DL.%2BJ.%26aulast%3DValiyaveettil%26aufirst%3DJ.%26aulast%3DMoukha-Chafiq%26aufirst%3DO.%26aulast%3DPathak%26aufirst%3DA.%2BK.%26aulast%3DAnanthan%26aufirst%3DS.%26aulast%3DKezar%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DMaddry%26aufirst%3DJ.%2BA.%26aulast%3DSuto%26aufirst%3DM.%2BJ.%26aulast%3DWest%26aufirst%3DA.%2BB.%26atitle%3DUnique%2520Functional%2520and%2520Structural%2520Properties%2520of%2520the%2520LRRK2%2520Protein%2520ATP-Binding%2520Pocket%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D32937%26epage%3D32951%26doi%3D10.1074%2Fjbc.M114.602318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a Potent LRRK2 Kinase Inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2012.01.084" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+Potent+LRRK2+Kinase+Inhibitor&doi=10.1016%2Fj.bmcl.2012.01.084"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.084%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520Potent%2520LRRK2%2520Kinase%2520Inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869%26doi%3D10.1016%2Fj.bmcl.2012.01.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Brain Penetrant LRRK2 Inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span><span class="refDoi"> DOI: 10.1021/ml300123a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300123a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=658-662&author=H.+G.+Choiauthor=J.+Zhangauthor=X.+Dengauthor=J.+M.+Hatcherauthor=M.+P.+Patricelliauthor=Z.+Zhaoauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Brain+Penetrant+LRRK2+Inhibitor&doi=10.1021%2Fml300123a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300123a%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DHatcher%26aufirst%3DJ.%2BM.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DBrain%2520Penetrant%2520LRRK2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D658%26epage%3D662%26doi%3D10.1021%2Fml300123a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaitsev, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span> </span><span class="NLM_article-title">Kinetic, Mechanistic, and Structural Modeling Studies of Truncated Wild-Type LRRK2 and the G2019S Mutant</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">9399</span><span class="NLM_x">–</span> <span class="NLM_lpage">9408</span><span class="refDoi"> DOI: 10.1021/bi201173d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201173d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=9399-9408&author=M.+Liuauthor=S.+Kangauthor=S.+Rayauthor=J.+Jacksonauthor=A.+D.+Zaitsevauthor=S.+A.+Gerberauthor=G.+D.+Cunyauthor=M.+A.+Glicksman&title=Kinetic%2C+Mechanistic%2C+and+Structural+Modeling+Studies+of+Truncated+Wild-Type+LRRK2+and+the+G2019S+Mutant&doi=10.1021%2Fbi201173d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi201173d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201173d%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DZaitsev%26aufirst%3DA.%2BD.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26atitle%3DKinetic%252C%2520Mechanistic%252C%2520and%2520Structural%2520Modeling%2520Studies%2520of%2520Truncated%2520Wild-Type%2520LRRK2%2520and%2520the%2520G2019S%2520Mutant%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D9399%26epage%3D9408%26doi%3D10.1021%2Fbi201173d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Göring, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taymans, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Indolinone Based LRRK2 Kinase Inhibitors with a Key Hydrogen Bond</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4630</span><span class="NLM_x">–</span> <span class="NLM_lpage">4637</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2014.08.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4630-4637&author=S.+G%C3%B6ringauthor=J.-M.+Taymansauthor=V.+Baekelandtauthor=B.+Schmidt&title=Indolinone+Based+LRRK2+Kinase+Inhibitors+with+a+Key+Hydrogen+Bond&doi=10.1016%2Fj.bmcl.2014.08.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ring%26aufirst%3DS.%26aulast%3DTaymans%26aufirst%3DJ.-M.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DIndolinone%2520Based%2520LRRK2%2520Kinase%2520Inhibitors%2520with%2520a%2520Key%2520Hydrogen%2520Bond%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4630%26epage%3D4637%26doi%3D10.1016%2Fj.bmcl.2014.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S. S.</span><span> </span><span class="NLM_article-title">Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1725</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span><span class="refDoi"> DOI: 10.1021/bi3012077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi3012077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=1725-1736&author=M.+Liuauthor=S.+A.+Benderauthor=G.+D.+Cunyauthor=W.+Shermanauthor=M.+Glicksmanauthor=S.+S.+Ray&title=Type+II+Kinase+Inhibitors+Show+an+Unexpected+Inhibition+Mode+against+Parkinson%E2%80%99s+Disease-Linked+LRRK2+Mutant+G2019S&doi=10.1021%2Fbi3012077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi3012077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi3012077%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBender%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DGlicksman%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DS.%2BS.%26atitle%3DType%2520II%2520Kinase%2520Inhibitors%2520Show%2520an%2520Unexpected%2520Inhibition%2520Mode%2520against%2520Parkinson%25E2%2580%2599s%2520Disease-Linked%2520LRRK2%2520Mutant%2520G2019S%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D1725%26epage%3D1736%26doi%3D10.1021%2Fbi3012077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gancia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Groot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Discovery of LRRK2 Inhibitors by Using an Ensemble of Virtual Screening Methods</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2520</span><span class="NLM_x">–</span> <span class="NLM_lpage">2527</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2017.03.098" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2520-2527&author=E.+Ganciaauthor=M.+De+Grootauthor=B.+Burtonauthor=D.+E.+Clark&title=Discovery+of+LRRK2+Inhibitors+by+Using+an+Ensemble+of+Virtual+Screening+Methods&doi=10.1016%2Fj.bmcl.2017.03.098"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.098%26sid%3Dliteratum%253Aachs%26aulast%3DGancia%26aufirst%3DE.%26aulast%3DDe%2BGroot%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520of%2520LRRK2%2520Inhibitors%2520by%2520Using%2520an%2520Ensemble%2520of%2520Virtual%2520Screening%2520Methods%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2520%26epage%3D2527%26doi%3D10.1016%2Fj.bmcl.2017.03.098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span> </span><span class="NLM_article-title">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5545</span><span class="refDoi"> DOI: 10.1021/jm300452p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300452p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5536-5545&author=H.+Chenauthor=B.+K.+Chanauthor=J.+Drummondauthor=A.+A.+Estradaauthor=J.+Gunzner-Tosteauthor=X.+Liuauthor=Y.+Liuauthor=J.+Moffatauthor=D.+Shoreauthor=Z.+K.+Sweeneyauthor=T.+Tranauthor=S.+Wangauthor=G.+Zhaoauthor=H.+Zhuauthor=D.+J.+Burdick&title=Discovery+of+Selective+LRRK2+Inhibitors+Guided+by+Computational+Analysis+and+Molecular+Modeling&doi=10.1021%2Fjm300452p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></div><div class="casAuthors">Chen, Huifen; Chan, Bryan K.; Drummond, Jason; Estrada, Anthony A.; Gunzner-Toste, Janet; Liu, Xingrong; Liu, Yichin; Moffat, John; Shore, Daniel; Sweeney, Zachary K.; Tran, Thuy; Wang, Shumei; Zhao, Guiling; Zhu, Haitao; Burdick, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5536-5545</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson's disease (PD).  Potent and selective small mols. capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD.  In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homol. model was developed that provided robust guidance in the hit-to-lead optimization of small mol. LRRK2 inhibitors.  Through a combination of mol. modeling, sequence anal., and matched mol. pair (MMP) activity cliff anal., a potent and selective lead inhibitor was discovered.  The selectivity of this compd. could be understood using the LRRK2 homol. model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YrcBmeoRILVg90H21EOLACvtfcHk0lgTFEw5MQpMfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOlu7Y%253D&md5=fe4d3a709a35f94e3c092b73bdb09936</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DShore%26aufirst%3DD.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26atitle%3DDiscovery%2520of%2520Selective%2520LRRK2%2520Inhibitors%2520Guided%2520by%2520Computational%2520Analysis%2520and%2520Molecular%2520Modeling%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5536%26epage%3D5545%26doi%3D10.1021%2Fjm300452p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lang, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span> </span><span class="NLM_article-title">Discovery of LRRK2 Inhibitors Using Sequential in Silico Joint Pharmacophore Space (JPS) and Ensemble Docking</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2713</span><span class="NLM_x">–</span> <span class="NLM_lpage">2719</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2015.04.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2713-2719&author=C.+A.+Langauthor=S.+S.+Rayauthor=M.+Liuauthor=A.+K.+Singhauthor=G.+D.+Cuny&title=Discovery+of+LRRK2+Inhibitors+Using+Sequential+in+Silico+Joint+Pharmacophore+Space+%28JPS%29+and+Ensemble+Docking&doi=10.1016%2Fj.bmcl.2015.04.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.027%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DC.%2BA.%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DDiscovery%2520of%2520LRRK2%2520Inhibitors%2520Using%2520Sequential%2520in%2520Silico%2520Joint%2520Pharmacophore%2520Space%2520%2528JPS%2529%2520and%2520Ensemble%2520Docking%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2713%26epage%3D2719%26doi%3D10.1016%2Fj.bmcl.2015.04.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Poël, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1021/ml3003007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3003007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=85-90&author=B.+K.+Chanauthor=A.+A.+Estradaauthor=H.+Chenauthor=J.+Atherallauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=S.+L.+Dominguezauthor=J.+Drummondauthor=A.+Gillauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=A.+D.+Medhurstauthor=X.+Liuauthor=J.+G.+Moffatauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=H.+Van+de+Po%C3%ABlauthor=S.+Zhangauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+a+Highly+Selective%2C+Brain-Penetrant+Aminopyrazole+LRRK2+Inhibitor&doi=10.1021%2Fml3003007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3003007%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DAtherall%26aufirst%3DJ.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520Highly%2520Selective%252C%2520Brain-Penetrant%2520Aminopyrazole%2520LRRK2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D85%26epage%3D90%26doi%3D10.1021%2Fml3003007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Troxler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenidge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drückes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweizer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span> </span><span class="NLM_article-title">Discovery of Novel Indolinone-Based, Potent, Selective and Brain Penetrant Inhibitors of LRRK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4085</span><span class="NLM_x">–</span> <span class="NLM_lpage">4090</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2013.05.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4085-4090&author=T.+Troxlerauthor=P.+Greenidgeauthor=K.+Zimmermannauthor=S.+Desrayaudauthor=P.+Dr%C3%BCckesauthor=T.+Schweizerauthor=D.+Staufferauthor=G.+Rovelliauthor=D.+R.+Shimshek&title=Discovery+of+Novel+Indolinone-Based%2C+Potent%2C+Selective+and+Brain+Penetrant+Inhibitors+of+LRRK2&doi=10.1016%2Fj.bmcl.2013.05.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.054%26sid%3Dliteratum%253Aachs%26aulast%3DTroxler%26aufirst%3DT.%26aulast%3DGreenidge%26aufirst%3DP.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DSchweizer%26aufirst%3DT.%26aulast%3DStauffer%26aufirst%3DD.%26aulast%3DRovelli%26aufirst%3DG.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26atitle%3DDiscovery%2520of%2520Novel%2520Indolinone-Based%252C%2520Potent%252C%2520Selective%2520and%2520Brain%2520Penetrant%2520Inhibitors%2520of%2520LRRK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4085%26epage%3D4090%26doi%3D10.1016%2Fj.bmcl.2013.05.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Munoz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phoa, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doddareddy, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemin, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">Optimisation of LRRK2 Inhibitors and Assessment of Functional Efficacy in Cell-Based Models of Neuroinflammation</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.ejmech.2015.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=25791676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVCjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=29-34&author=L.+Munozauthor=M.+E.+Kavanaghauthor=A.+F.+Phoaauthor=B.+Hengauthor=N.+Dzamkoauthor=E.-J.+Chenauthor=M.+R.+Doddareddyauthor=G.+J.+Guilleminauthor=M.+Kassiou&title=Optimisation+of+LRRK2+Inhibitors+and+Assessment+of+Functional+Efficacy+in+Cell-Based+Models+of+Neuroinflammation&doi=10.1016%2Fj.ejmech.2015.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation</span></div><div class="casAuthors">Munoz, Lenka; Kavanagh, Madeline E.; Phoa, Athena F.; Heng, Benjamin; Dzamko, Nicolas; Chen, Ew-Jun; Doddareddy, Munikumar Reddy; Guillemin, Gilles J.; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-34</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">LRRK2IN1 is a highly potent inhibitor of leucine-rich repeat kinase 2 (LRRK2, IC50 = 7.9 nM), an established target for treatment of Parkinson's disease.  Two LRRK2IN1 analogs 2-[[4-[(1,4'-bipiperidine)-1'-carbonyl]-2-chlorophenyl]amino]-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one (1) and (1,4'-bipiperidin)-1'-yl[3-chloro-4-[[5,11-dimethyl-6,11-dihydro-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-2-yl]amino]phenyl]methanone (2) were synthesized which retained LRRK2 inhibitory activity (1: IC50 = 72 nM; 2: IC50 = 51 nM), were predicted to have improved bioavailability and were efficacious in cell-based models of neuroinflammation.  Analog (1) inhibited IL-6 secretion from LPS-stimulated primary human microglia with EC50 = 4.26 μM.  To further optimize the mol. properties of LRRK2IN1, a library of truncated analogs was designed based on docking studies.  Despite lacking LRRK2 inhibitory activity, these compds. show anti-neuroinflammatory efficacy at micromolar concn.  The compds. developed were valuable tools in establishing a cell-based assay for assessing anti-neuroinflammatory efficacy of LRRK2 inhibitors.  Herein, the authors present data that IL-1β stimulated U87 glioma cell line is a reliable model for neuroinflammation, as data obtained in this model were consistent with results obtained using primary human microglia and astrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdjPn76kjM8rVg90H21EOLACvtfcHk0lgTIHSPo-e3Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVCjt7w%253D&md5=d5a15af430d40594df5b071c5efebdc9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DKavanagh%26aufirst%3DM.%2BE.%26aulast%3DPhoa%26aufirst%3DA.%2BF.%26aulast%3DHeng%26aufirst%3DB.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DE.-J.%26aulast%3DDoddareddy%26aufirst%3DM.%2BR.%26aulast%3DGuillemin%26aufirst%3DG.%2BJ.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DOptimisation%2520of%2520LRRK2%2520Inhibitors%2520and%2520Assessment%2520of%2520Functional%2520Efficacy%2520in%2520Cell-Based%2520Models%2520of%2520Neuroinflammation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D95%26spage%3D29%26epage%3D34%26doi%3D10.1016%2Fj.ejmech.2015.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Discovery of 4-Alkylamino-7-Aryl-3-Cyanoquinoline LRRK2 Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1974</span><span class="NLM_x">–</span> <span class="NLM_lpage">1977</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2013.02.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1974-1977&author=A.+W.+Garofaloauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=E.+F.+Brighamauthor=D.+Chianauthor=M.+Franziniauthor=E.+Goldbachauthor=G.+T.+Kwongauthor=R.+Motterauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=L.+Ruslimauthor=H.+L.+Shamauthor=D.+Tamauthor=P.+Tanakaauthor=A.+P.+Truongauthor=X.+M.+Yeauthor=Z.+Ren&title=Discovery+of+4-Alkylamino-7-Aryl-3-Cyanoquinoline+LRRK2+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2013.02.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.041%26sid%3Dliteratum%253Aachs%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChian%26aufirst%3DD.%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DKwong%26aufirst%3DG.%2BT.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTanaka%26aufirst%3DP.%26aulast%3DTruong%26aufirst%3DA.%2BP.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DDiscovery%2520of%25204-Alkylamino-7-Aryl-3-Cyanoquinoline%2520LRRK2%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1974%26epage%3D1977%26doi%3D10.1016%2Fj.bmcl.2013.02.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Franzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aubele, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldbach, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiago, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span> </span><span class="NLM_article-title">Triazolopyridazine LRRK2 Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1967</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.02.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2013.02.043" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1967-1973&author=M.+Franziniauthor=X.+M.+Yeauthor=M.+Adlerauthor=D.+L.+Aubeleauthor=A.+W.+Garofaloauthor=S.+Gaubyauthor=E.+Goldbachauthor=G.+D.+Probstauthor=K.+P.+Quinnauthor=P.+Santiagoauthor=H.+L.+Shamauthor=D.+Tamauthor=A.+Truongauthor=Z.+Ren&title=Triazolopyridazine+LRRK2+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2013.02.043"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.02.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.02.043%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DM.%26aulast%3DYe%26aufirst%3DX.%2BM.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DAubele%26aufirst%3DD.%2BL.%26aulast%3DGarofalo%26aufirst%3DA.%2BW.%26aulast%3DGauby%26aufirst%3DS.%26aulast%3DGoldbach%26aufirst%3DE.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSantiago%26aufirst%3DP.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DTruong%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DZ.%26atitle%3DTriazolopyridazine%2520LRRK2%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1967%26epage%3D1973%26doi%3D10.1016%2Fj.bmcl.2013.02.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eatherton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edge, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jandu, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philps, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dossang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, F.</span><span> </span><span class="NLM_article-title">Discovery of 5-Substituent-<i>N</i>-Arylbenzamide Derivatives as Potent, Selective and Orally Bioavailable LRRK2 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4034</span><span class="NLM_x">–</span> <span class="NLM_lpage">4038</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2017.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4034-4038&author=X.+Dingauthor=X.+Daiauthor=K.+Longauthor=C.+Pengauthor=D.+Andreottiauthor=P.+Bamboroughauthor=A.+J.+Eathertonauthor=C.+Edgeauthor=K.+S.+Janduauthor=P.+L.+Nicholsauthor=O.+J.+Philpsauthor=L.+P.+Stasiauthor=Z.+Wanauthor=J.-N.+Xiangauthor=K.+Dongauthor=P.+Dossangauthor=M.-H.+Hoauthor=Y.+Liauthor=L.+Mensahauthor=X.+Guanauthor=A.+D.+Reithauthor=F.+Ren&title=Discovery+of+5-Substituent-N-Arylbenzamide+Derivatives+as+Potent%2C+Selective+and+Orally+Bioavailable+LRRK2+Inhibitors&doi=10.1016%2Fj.bmcl.2017.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DX.%26aulast%3DLong%26aufirst%3DK.%26aulast%3DPeng%26aufirst%3DC.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DEatherton%26aufirst%3DA.%2BJ.%26aulast%3DEdge%26aufirst%3DC.%26aulast%3DJandu%26aufirst%3DK.%2BS.%26aulast%3DNichols%26aufirst%3DP.%2BL.%26aulast%3DPhilps%26aufirst%3DO.%2BJ.%26aulast%3DStasi%26aufirst%3DL.%2BP.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DDossang%26aufirst%3DP.%26aulast%3DHo%26aufirst%3DM.-H.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMensah%26aufirst%3DL.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DDiscovery%2520of%25205-Substituent-N-Arylbenzamide%2520Derivatives%2520as%2520Potent%252C%2520Selective%2520and%2520Orally%2520Bioavailable%2520LRRK2%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4034%26epage%3D4038%26doi%3D10.1016%2Fj.bmcl.2017.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Substrate Specificity and Inhibitors of LRRK2, a Protein Kinase Mutated in Parkinson’s Disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.1042/BJ20091035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1042%2FBJ20091035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2009&pages=47-60&author=R.+J.+Nicholsauthor=N.+Dzamkoauthor=J.+E.+Huttiauthor=L.+C.+Cantleyauthor=M.+Deakauthor=J.+Moranauthor=P.+Bamboroughauthor=A.+D.+Reithauthor=D.+R.+Alessi&title=Substrate+Specificity+and+Inhibitors+of+LRRK2%2C+a+Protein+Kinase+Mutated+in+Parkinson%E2%80%99s+Disease&doi=10.1042%2FBJ20091035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1042%2FBJ20091035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20091035%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHutti%26aufirst%3DJ.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSubstrate%2520Specificity%2520and%2520Inhibitors%2520of%2520LRRK2%252C%2520a%2520Protein%2520Kinase%2520Mutated%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D424%26spage%3D47%26epage%3D60%26doi%3D10.1042%2FBJ20091035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Yun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heo, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DooKim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seol, W.</span><span> </span><span class="NLM_article-title">Identification of Chemicals to Inhibit the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2), a Parkinson’s Disease-Associated Protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2953</span><span class="NLM_x">–</span> <span class="NLM_lpage">2957</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2011.03.061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2953-2957&author=H.+Yunauthor=H.+Y.+Heoauthor=H.+H.+Kimauthor=N.+DooKimauthor=W.+Seol&title=Identification+of+Chemicals+to+Inhibit+the+Kinase+Activity+of+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29%2C+a+Parkinson%E2%80%99s+Disease-Associated+Protein&doi=10.1016%2Fj.bmcl.2011.03.061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.061%26sid%3Dliteratum%253Aachs%26aulast%3DYun%26aufirst%3DH.%26aulast%3DHeo%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BH.%26aulast%3DDooKim%26aufirst%3DN.%26aulast%3DSeol%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520Chemicals%2520to%2520Inhibit%2520the%2520Kinase%2520Activity%2520of%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%252C%2520a%2520Parkinson%25E2%2580%2599s%2520Disease-Associated%2520Protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2953%26epage%3D2957%26doi%3D10.1016%2Fj.bmcl.2011.03.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Greshock, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajapakse, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiscia, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renger, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Potent, Selective and Orally Bioavailable Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2631</span><span class="NLM_x">–</span> <span class="NLM_lpage">2635</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2016.04.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=27106707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsFynsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2631-2635&author=T.+J.+Greshockauthor=J.+M.+Sandersauthor=R.+E.+Droletauthor=H.+A.+Rajapakseauthor=R.+K.+Changauthor=B.+Kimauthor=V.+L.+Radaauthor=H.+E.+Tisciaauthor=H.+Suauthor=M.-T.+Laiauthor=S.+M.+Surauthor=R.+I.+Sanchezauthor=M.+T.+Bilodeauauthor=J.+J.+Rengerauthor=J.+T.+Kernauthor=J.+A.+McCauley&title=Potent%2C+Selective+and+Orally+Bioavailable+Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29+Inhibitors&doi=10.1016%2Fj.bmcl.2016.04.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors</span></div><div class="casAuthors">Greshock, Thomas J.; Sanders, John M.; Drolet, Robert E.; Rajapakse, Hemaka A.; Chang, Ronald K.; Kim, Boyoung; Rada, Vanessa L.; Tiscia, Heather E.; Su, Hua; Lai, Ming-Tain; Sur, Sylvie M.; Sanchez, Rosa I.; Bilodeau, Mark T.; Renger, John J.; Kern, Jonathan T.; McCauley, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2631-2635</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Familial Parkinson's disease cases have recently been assocd. with the leucine rich repeat kinase 2 (LRRK2) gene.  It has been hypothesized that inhibition of the LRRK2 protein may have the potential to alter disease pathogenesis.  A dihydrobenzothiophene series of potent, selective, orally bioavailable LRRK2 inhibitors were identified from a high-throughput screen of the internal Merck sample collection.  Initial SAR studies around the core established the series as a tractable small mol. lead series of LRRK2 inhibitors for potential treatment of Parkinson's disease.  It was also found that incorporation of a lactam into the core drastically improved the CNS and DMPK properties of these small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLXQXzXljjB7Vg90H21EOLACvtfcHk0ljsj89MF3dflQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsFynsLc%253D&md5=50dcf355189aba4facaba45fd0aac592</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.021%26sid%3Dliteratum%253Aachs%26aulast%3DGreshock%26aufirst%3DT.%2BJ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DChang%26aufirst%3DR.%2BK.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DRada%26aufirst%3DV.%2BL.%26aulast%3DTiscia%26aufirst%3DH.%2BE.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DSanchez%26aufirst%3DR.%2BI.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DPotent%252C%2520Selective%2520and%2520Orally%2520Bioavailable%2520Leucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2631%26epage%3D2635%26doi%3D10.1016%2Fj.bmcl.2016.04.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Galatsis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormos, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, W. D.</span><span> </span><span class="NLM_article-title">Kinase Domain Inhibition of Leucine Rich Repeat Kinase 2 (LRRK2) Using a [1,2,4]triazolo[4,3-<i>b</i>]pyridazine Scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4132</span><span class="NLM_x">–</span> <span class="NLM_lpage">4140</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.bmcl.2014.07.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4132-4140&author=P.+Galatsisauthor=J.+L.+Hendersonauthor=B.+L.+Kormosauthor=S.+Hanauthor=R.+G.+Kurumbailauthor=T.+T.+Wagerauthor=P.+R.+Verhoestauthor=G.+S.+Noellauthor=Y.+Chenauthor=E.+Needleauthor=Z.+Bergerauthor=S.+J.+Steynauthor=C.+Houleauthor=W.+D.+Hirst&title=Kinase+Domain+Inhibition+of+Leucine+Rich+Repeat+Kinase+2+%28LRRK2%29+Using+a+%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazine+Scaffold&doi=10.1016%2Fj.bmcl.2014.07.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DNoell%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DNeedle%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DZ.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DHirst%26aufirst%3DW.%2BD.%26atitle%3DKinase%2520Domain%2520Inhibition%2520of%2520Leucine%2520Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%2520Using%2520a%2520%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazine%2520Scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4132%26epage%3D4140%26doi%3D10.1016%2Fj.bmcl.2014.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetter, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Haastert, P. J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Roco Kinase Structures Give Insights into the Mechanism of Parkinson Disease-Related Leucine-Rich-Repeat Kinase 2 Mutations</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">10322</span><span class="NLM_x">–</span> <span class="NLM_lpage">10327</span><span class="refDoi"> DOI: 10.1073/pnas.1203223109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1073%2Fpnas.1203223109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22689969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWgt7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=10322-10327&author=B.+K.+Gilsbachauthor=F.+Y.+Hoauthor=I.+R.+Vetterauthor=P.+J.+M.+van+Haastertauthor=A.+Wittinghoferauthor=A.+Kortholt&title=Roco+Kinase+Structures+Give+Insights+into+the+Mechanism+of+Parkinson+Disease-Related+Leucine-Rich-Repeat+Kinase+2+Mutations&doi=10.1073%2Fpnas.1203223109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations</span></div><div class="casAuthors">Gilsbach, Bernd K.; Ho, Franz Y.; Vetter, Ingrid R.; van Haastert, Peter J. M.; Wittinghofer, Alfred; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10322-10327, S10322/1-S10322/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in human leucine-rich-repeat kinase 2 (LRRK2) have been found to be the most frequent cause of late-onset Parkinson disease.  Here we show that Dictyostelium discoideum Roco4 is a suitable model to study the structural and biochem. characteristics of the LRRK2 kinase and can be used for optimization of current and identification of new LRRK2 inhibitors.  We have solved the structure of Roco4 kinase wild-type, Parkinson disease-related mutants G1179S and L1180T (G2019S and 12020T in LRRK2) and the structure of Roco4 kinase in complex with the LRRK2 inhibitor H1 152.  Taken together, our data give important insight in the LRRK2 activation mechanism and, most importantly, explain the G2019S- related increase in LRRK2 kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGop9QBSj5K0PrVg90H21EOLACvtfcHk0lhS1q7sxTTRpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWgt7rO&md5=9434ba22e421025a17e354f66402f194</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1203223109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1203223109%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DHo%26aufirst%3DF.%2BY.%26aulast%3DVetter%26aufirst%3DI.%2BR.%26aulast%3Dvan%2BHaastert%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DRoco%2520Kinase%2520Structures%2520Give%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Parkinson%2520Disease-Related%2520Leucine-Rich-Repeat%2520Kinase%25202%2520Mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D10322%26epage%3D10327%26doi%3D10.1073%2Fpnas.1203223109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Gilsbach, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messias, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittinghofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kortholt, A.</span><span> </span><span class="NLM_article-title">Structural Characterization of LRRK2 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3751</span><span class="NLM_x">–</span> <span class="NLM_lpage">3756</span><span class="refDoi"> DOI: 10.1021/jm5018779</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5018779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3751-3756&author=B.+K.+Gilsbachauthor=A.+C.+Messiasauthor=G.+Itoauthor=M.+Sattlerauthor=D.+R.+Alessiauthor=A.+Wittinghoferauthor=A.+Kortholt&title=Structural+Characterization+of+LRRK2+Inhibitors&doi=10.1021%2Fjm5018779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Characterization of LRRK2 Inhibitors</span></div><div class="casAuthors">Gilsbach, Bernd K.; Messias, Ana C.; Ito, Genta; Sattler, Michael; Alessi, Dario R.; Wittinghofer, Alfred; Kortholt, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3751-3756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase inhibition is considered to be an important therapeutic target for LRRK2 mediated Parkinson's disease (PD).  Many LRRK2 kinase inhibitors have been reported but have yet to be optimized in order to qualify as drug candidates for the treatment of the disease.  In order to start a structure-function anal. of such inhibitors, we mutated the active site of Dictyostelium Roco4 kinase to resemble LRRK2.  Here, we show satn. transfer difference (STD) NMR and the first cocrystal structures of two potent in vitro inhibitors, LRRK2-IN-1 and compd. 19, with mutated Roco4.  Our data demonstrate that this system can serve as an excellent tool for the structural characterization and optimization of LRRK2 inhibitors using X-ray crystallog. and NMR spectroscopy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC3zihwkAhp7Vg90H21EOLACvtfcHk0li7waPFkBU2yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOitbc%253D&md5=48a13492467bdad081fede8662764285</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm5018779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018779%26sid%3Dliteratum%253Aachs%26aulast%3DGilsbach%26aufirst%3DB.%2BK.%26aulast%3DMessias%26aufirst%3DA.%2BC.%26aulast%3DIto%26aufirst%3DG.%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DWittinghofer%26aufirst%3DA.%26aulast%3DKortholt%26aufirst%3DA.%26atitle%3DStructural%2520Characterization%2520of%2520LRRK2%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3751%26epage%3D3756%26doi%3D10.1021%2Fjm5018779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Berman, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westbrook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shindyalov, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, P. E.</span><span> </span><span class="NLM_article-title">The Protein Data Bank</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.+M.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0li7waPFkBU2yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>Molecular Operating Environment (MOE), version <span class="NLM_edition">2016.0802</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc</span>: <span class="NLM_publisher-loc">Montreal, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+version+2016.0802%3B+Chemical+Computing+Group+Inc%3A+Montreal%2C+Canada%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Massey, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiumana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scrace, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallowfield, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedford, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span> </span><span class="NLM_article-title">Identification of Novel, in Vivo Active Chk1 Inhibitors Utilizing Structure Guided Drug Design</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">35797</span><span class="NLM_x">–</span> <span class="NLM_lpage">35812</span><span class="refDoi"> DOI: 10.18632/oncotarget.5929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.18632%2Foncotarget.5929" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=35797-35812&author=A.+J.+Masseyauthor=S.+Stokesauthor=H.+Browneauthor=N.+Foloppeauthor=A.+Fiumanaauthor=S.+Scraceauthor=M.+Fallowfieldauthor=S.+Bedfordauthor=P.+Webbauthor=L.+Bakerauthor=M.+Christieauthor=M.+J.+Drysdaleauthor=M.+Wood&title=Identification+of+Novel%2C+in+Vivo+Active+Chk1+Inhibitors+Utilizing+Structure+Guided+Drug+Design&doi=10.18632%2Foncotarget.5929"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5929%26sid%3Dliteratum%253Aachs%26aulast%3DMassey%26aufirst%3DA.%2BJ.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DBrowne%26aufirst%3DH.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFiumana%26aufirst%3DA.%26aulast%3DScrace%26aufirst%3DS.%26aulast%3DFallowfield%26aufirst%3DM.%26aulast%3DBedford%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DBaker%26aufirst%3DL.%26aulast%3DChristie%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Novel%252C%2520in%2520Vivo%2520Active%2520Chk1%2520Inhibitors%2520Utilizing%2520Structure%2520Guided%2520Drug%2520Design%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D35797%26epage%3D35812%26doi%3D10.18632%2Foncotarget.5929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span> </span><span class="NLM_article-title">Structure-Based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">–</span> <span class="NLM_lpage">4345</span><span class="refDoi"> DOI: 10.1021/jm049022c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049022c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVWrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4332-4345&author=N.+Foloppeauthor=L.+M.+Fisherauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potterauthor=A.+G.+S.+Robertsonauthor=A.+E.+Surgenor&title=Structure-Based+Design+of+Novel+Chk1+Inhibitors%3A+Insights+into+Hydrogen+Bonding+and+Protein-Ligand+Affinity&doi=10.1021%2Fjm049022c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-Ligand Affinity</span></div><div class="casAuthors">Foloppe, Nicolas; Fisher, Lisa M.; Howes, Rob; Kierstan, Peter; Potter, Andrew; Robertson, Alan G. S.; Surgenor, Allan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4332-4345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery, synthesis, and crystallog. binding mode of novel furopyrimidine and pyrrolopyrimidine inhibitors I (X = O, NH; R1 = H, R2 = HOCH2CH2, HO2CCH2, MeOCH2CH2, etc.; R1 = Me, R2 = HOCH2CH2) of the Chk1 kinase, an oncol. target, are reported.  These inhibitors are synthetically tractable and inhibit Chk1 by competing for its ATP site.  A chronol. account allows an objective comparison of modeled compd. docking modes to the subsequently obtained crystal structures.  The comparison provides insights regarding the interpretation of modeling results, in relationship to the multiple reasonable docking modes which may be obtained in a kinase-ATP site.  The crystal structures were used to guide medicinal chem. efforts.  This led to a thorough characterization of a pair of ligand-protein complexes which differ by a single hydrogen bond.  An anal. indicates that this hydrogen bond is expected to contribute a fraction of the 10-fold change in binding affinity, adding a valuable observation to the debate about the energetic role of hydrogen bonding in mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFPaHpTfrMgLVg90H21EOLACvtfcHk0liKmYTsRUDDig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVWrsbo%253D&md5=a7a8b8b210d73096f09e82990c6191a7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm049022c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049022c%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%2BS.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26atitle%3DStructure-Based%2520Design%2520of%2520Novel%2520Chk1%2520Inhibitors%253A%2520Insights%2520into%2520Hydrogen%2520Bonding%2520and%2520Protein-Ligand%2520Affinity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4332%26epage%3D4345%26doi%3D10.1021%2Fjm049022c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Hermanson, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, K.</span><span> </span><span class="NLM_article-title">Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e43580</span><span class="refDoi"> DOI: 10.1371/journal.pone.0043580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1371%2Fjournal.pone.0043580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=22952710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yktb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e43580&author=S.+B.+Hermansonauthor=C.+B.+Carlsonauthor=S.+M.+Riddleauthor=J.+Zhaoauthor=K.+W.+Vogelauthor=R.+J.+Nicholsauthor=K.+Bi&title=Screening+for+Novel+LRRK2+Inhibitors+Using+a+High-Throughput+TR-FRET+Cellular+Assay+for+LRRK2+Ser935+Phosphorylation&doi=10.1371%2Fjournal.pone.0043580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation</span></div><div class="casAuthors">Hermanson, Spencer B.; Carlson, Coby B.; Riddle, Steven M.; Zhao, Jing; Vogel, Kurt W.; Nichols, R. Jeremy; Bi, Kun</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e43580</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Mutations in the leucine-rich repeat kinase-2 (LRRK2) have been linked to Parkinson's disease.  Recent studies show that inhibition of LRRK2 kinase activity decreased the level of phosphorylation at its own Ser910 and Ser935, indicating that these sites are prime targets for cellular readouts of LRRK2 inhibition.  Methodol./Principal Findings: Using Time-Resolved Forster Resonance Energy Transfer (TR-FRET) technol., we developed a high-throughput cellular assay for monitoring LRRK2 phosphorylation at Ser935.  LRRK2-Green Fluorescence Protein (GFP) fusions were expressed in cells via BacMam.  Phosphorylation at Ser935 in these cells is detected using a terbium labeled anti-phospho-Ser935 antibody that generates a TR-FRET signal between terbium and GFP.  LRRK2 wild-type and G2019S are constitutively phosphorylated at Ser935 in cells as measured by TR-FRET.  The phosphorylation level is reduced for the R1441C mutant and little could be detected for the kinase-dead mutant D1994A.  The TR-FRET cellular assay was further validated using reported LRRK2 inhibitors including LRRK2-IN-1 and our results confirmed that inhibition of LRRK2 can reduce the phosphorylation level at Ser935.  To demonstrate the utility of this assay for screening, we profiled a small library of 1120 compds.  Three known LRRK2 inhibitors were identified and 16 hits were followed up in the TR-FRET and a cytotoxicity assay.  Interestingly, out of the top 16 hits, five are known inhibitors of IκB phosphorylation, two CHK1 and two CDC25 inhibitors.  Thirteen hits were further tested in a biochem. LRRK2 kinase activity assay and Western blot anal. for their effects on the phosphorylation of Ser910, Ser935, Ser955 and Ser973.  Conclusions/Significance: We developed a TR-FRET cellular assay for LRRK2 Ser935 phosphorylation that can be applied to the screening for LRRK2 inhibitors.  We report for the first time that several compds. such as IKK16, CHK1 inhibitors and GW441756 can inhibit LRRK2 Ser935 phosphorylation in cells and LRRK2 kinase activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_56Cqq9eWnbVg90H21EOLACvtfcHk0liKmYTsRUDDig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yktb7I&md5=adbdb9b8d5812e3d908646240541921b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0043580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0043580%26sid%3Dliteratum%253Aachs%26aulast%3DHermanson%26aufirst%3DS.%2BB.%26aulast%3DCarlson%26aufirst%3DC.%2BB.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DVogel%26aufirst%3DK.%2BW.%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DBi%26aufirst%3DK.%26atitle%3DScreening%2520for%2520Novel%2520LRRK2%2520Inhibitors%2520Using%2520a%2520High-Throughput%2520TR-FRET%2520Cellular%2520Assay%2520for%2520LRRK2%2520Ser935%2520Phosphorylation%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De43580%26doi%3D10.1371%2Fjournal.pone.0043580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDevitt, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johanson, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concha, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B. S.</span><span> </span><span class="NLM_article-title">Structural Basis for Chk1 Inhibition by UCN-01</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">46609</span><span class="NLM_x">–</span> <span class="NLM_lpage">46615</span><span class="refDoi"> DOI: 10.1074/jbc.M201233200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1074%2Fjbc.M201233200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=12244092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46609-46615&author=B.+Zhaoauthor=M.+J.+Bowerauthor=P.+J.+McDevittauthor=H.+Zhaoauthor=S.+T.+Davisauthor=K.+O.+Johansonauthor=S.+M.+Greenauthor=N.+O.+Conchaauthor=B.+S.+Zhou&title=Structural+Basis+for+Chk1+Inhibition+by+UCN-01&doi=10.1074%2Fjbc.M201233200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Chk1 Inhibition by UCN-01</span></div><div class="casAuthors">Zhao, Baoguang; Bower, Michael J.; McDevitt, Patrick J.; Zhao, Huizhen; Davis, Stephen T.; Johanson, Kyung O.; Green, Susan M.; Concha, Nestor O.; Zhou, Bin-Bing S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46609-46615</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Chk1 is a serine-threonine kinase that plays an important role in the DNA damage response, including G2/M cell cycle control.  UCN-01 (7-hydroxystaurosporine), currently in clin. trials, has recently been shown to be a potent Chk1 inhibitor that abrogates the G2/M checkpoint induced by DNA-damaging agents.  To understand the structural basis of Chk1 inhibition by UCN-01, we detd. the crystal structure of the Chk1 kinase domain in complex with UCN-01.  Chk1 structures with staurosporine and its analog SB-218078 were also detd.  All three compds. bind in the ATP-binding pocket of Chk1, producing only slight changes in the protein conformation.  Selectivity of UCN-01 toward Chk1 over cyclin-dependent kinases can be explained by the presence of a hydroxyl group in the lactam moiety interacting with the ATP-binding pocket.  Hydrophobic interactions and hydrogen-bonding interactions were obsd. in the structures between UCN-01 and the Chk1 kinase domain.  The high structural complementarity of these interactions is consistent with the potency and selectivity of UCN-01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6biZWQjRI0rVg90H21EOLACvtfcHk0lgII_9kTVUAZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKgs7g%253D&md5=bc5ab22df94aa4f458f752a808d49a92</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M201233200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M201233200%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DBower%26aufirst%3DM.%2BJ.%26aulast%3DMcDevitt%26aufirst%3DP.%2BJ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DDavis%26aufirst%3DS.%2BT.%26aulast%3DJohanson%26aufirst%3DK.%2BO.%26aulast%3DGreen%26aufirst%3DS.%2BM.%26aulast%3DConcha%26aufirst%3DN.%2BO.%26aulast%3DZhou%26aufirst%3DB.%2BS.%26atitle%3DStructural%2520Basis%2520for%2520Chk1%2520Inhibition%2520by%2520UCN-01%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46609%26epage%3D46615%26doi%3D10.1074%2Fjbc.M201233200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">DeLano, W. L.</span>The PyMOL Molecular Graphics System, version <span class="NLM_edition">1.8.6.0</span>; <span class="NLM_publisher-name">Schrödinger LLC</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+L.+DeLano&title=The+PyMOL+Molecular+Graphics+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26jtitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Nichols, P. L.; Eatherton, A. J.; Bamborough, P.; Jandu, K. S.; Philps, O. J.; Andreotti, D.</span><span> </span><span class="NLM_article-title">Novel Compounds</span>. WO 2011/038572,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+L.+Nichols&author=A.+J.+Eatherton&author=P.+Bamborough&author=K.+S.+Jandu&author=O.+J.+Philps&author=D.+Andreotti&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Afsari, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nippe, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, C. J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, A. R.</span><span> </span><span class="NLM_article-title">Abnormal Visual Gain Control in a Parkinson’s Disease Model</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4465</span><span class="NLM_x">–</span> <span class="NLM_lpage">4478</span><span class="refDoi"> DOI: 10.1093/hmg/ddu159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1093%2Fhmg%2Fddu159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=24718285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=4465-4478&author=F.+Afsariauthor=K.+V.+Christensenauthor=G.+P.+Smithauthor=M.+Hentzerauthor=O.+M.+Nippeauthor=C.+J.+H.+Elliottauthor=A.+R.+Wade&title=Abnormal+Visual+Gain+Control+in+a+Parkinson%E2%80%99s+Disease+Model&doi=10.1093%2Fhmg%2Fddu159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal visual gain control in a Parkinson's disease model</span></div><div class="casAuthors">Afsari, Farinaz; Christensen, Kenneth V.; Smith, Garrick Paul; Hentzer, Morten; Nippe, Olivia M.; Elliott, Christopher J. H.; Wade, Alex R.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4465-4478</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Our understanding of Parkinson's disease (PD) has been revolutionized by the discovery of disease-causing genetic mutations.  The most common of these is the G2019S mutation in the LRRK2 kinase gene, which leads to increased kinase activity.  However, the link between increased kinase activity and PD is unclear.  Previously, we showed that dopaminergic expression of the human LRRK2-G2019S transgene in flies led to an activity-dependent loss of vision in older animals and we hypothesized that this may have been preceded by a failure to regulate neuronal activity correctly in younger animals.  To test this hypothesis, we used a sensitive measure of visual function based on frequency-tagged steady-state visually evoked potentials.  Spectral anal. allowed us to identify signals from multiple levels of the fly visual system and wild-type visual response curves were qual. similar to those from human cortex.  Dopaminergic expression of hLRRK2-G2019S increased contrast sensitivity throughout the retinal network.  To test whether this was due to increased kinase activity, we fed Drosophila with kinase inhibitors targeted at LRRK2.  Contrast sensitivity in both day 1 and day 14 flies was normalized by a novel LRRK2 kinase inhibitor 'BMPPB-32'.  Biochem. and cellular assays suggested that BMPPB-32 would be a more specific kinase inhibitor than LRRK2-IN-1.  We confirmed this in vivo, finding that dLRRK- null flies show large off-target effects with LRRK2-IN-1 but not BMPPB-32.  Our data link the increased Kinase activity of the G2019S-LRRK2 mutation to neuronal dysfunction and demonstrate the power of the Drosophila visual system in assaying the neurol. effects of genetic diseases and therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa_glJRmFOqrVg90H21EOLACvtfcHk0lgII_9kTVUAZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OrsbzF&md5=8804121c354a2d548151649497b52bdb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu159%26sid%3Dliteratum%253Aachs%26aulast%3DAfsari%26aufirst%3DF.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DHentzer%26aufirst%3DM.%26aulast%3DNippe%26aufirst%3DO.%2BM.%26aulast%3DElliott%26aufirst%3DC.%2BJ.%2BH.%26aulast%3DWade%26aufirst%3DA.%2BR.%26atitle%3DAbnormal%2520Visual%2520Gain%2520Control%2520in%2520a%2520Parkinson%25E2%2580%2599s%2520Disease%2520Model%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D4465%26epage%3D4478%26doi%3D10.1093%2Fhmg%2Fddu159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Ding, X.; Liu, Q.; Sang, Y.; Stasi, L. P.; Wan, Z.; Zhao, B.; Edge, C. M.</span><span> </span><span class="NLM_article-title">Compounds</span>. WO 2015/113452,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=X.+Ding&author=Q.+Liu&author=Y.+Sang&author=L.+P.+Stasi&author=Z.+Wan&author=B.+Zhao&author=C.+M.+Edge&title=Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DX.%26atitle%3DCompounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Augelli-Szafran, C. E.; Suto, M.; Galemmo, R.; Moukha-Chafiq, O.; Gupta, V.; Ananthan, S.</span><span> </span><span class="NLM_article-title">Pyrrolopyrimdine Compounds, Use as Inhibitors of the Kinase LRRK2, and Methods for Preparation Thereof</span>. US 2017/0174694,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+E.+Augelli-Szafran&author=M.+Suto&author=R.+Galemmo&author=O.+Moukha-Chafiq&author=V.+Gupta&author=S.+Ananthan&title=Pyrrolopyrimdine+Compounds%2C+Use+as+Inhibitors+of+the+Kinase+LRRK2%2C+and+Methods+for+Preparation+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAugelli-Szafran%26aufirst%3DC.%2BE.%26atitle%3DPyrrolopyrimdine%2520Compounds%252C%2520Use%2520as%2520Inhibitors%2520of%2520the%2520Kinase%2520LRRK2%252C%2520and%2520Methods%2520for%2520Preparation%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Estrada, A. A.; Feng, J. A.; Lyssikatos, J. P.; Sweeney, Z. K.; De Vicente Fidalgo, J.</span><span> </span><span class="NLM_article-title">Compound, Compositions and Methods</span>. WO 2017/087905,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+A.+Estrada&author=J.+A.+Feng&author=J.+P.+Lyssikatos&author=Z.+K.+Sweeney&author=J.+De+Vicente+Fidalgo&title=Compound%2C+Compositions+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26atitle%3DCompound%252C%2520Compositions%2520and%2520Methods%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Galatsis, P.; Hayward, M. M.; Kormos, B. L.; Wager, T. T.; Zhang, L.; Henderson, J. L.; Kurumbail, R. G.; Verhoest, P. R.; Stepan, A. F.</span><span> </span><span class="NLM_article-title">Novel 3,4-Disubstituted 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridines and 4,5-Disubstituted-7<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridazines as LRRK2 Inhibitors</span>. WO 2015/092592,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+Galatsis&author=M.+M.+Hayward&author=B.+L.+Kormos&author=T.+T.+Wager&author=L.+Zhang&author=J.+L.+Henderson&author=R.+G.+Kurumbail&author=P.+R.+Verhoest&author=A.+F.+Stepan&title=Novel+3%2C4-Disubstituted+1H-Pyrrolo%5B2%2C3-b%5Dpyridines+and+4%2C5-Disubstituted-7H-pyrrolo%5B2%2C3-c%5Dpyridazines+as+LRRK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGalatsis%26aufirst%3DP.%26atitle%3DNovel%25203%252C4-Disubstituted%25201H-Pyrrolo%255B2%252C3-b%255Dpyridines%2520and%25204%252C5-Disubstituted-7H-pyrrolo%255B2%252C3-c%255Dpyridazines%2520as%2520LRRK2%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Brough, P.; Drysdale, M.</span><span> </span><span class="NLM_article-title">1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine Derivatives Useful as Hsp90 Inhibitors</span>. WO 2008/025947,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Brough&author=M.+Drysdale&title=1H-Pyrrolo%5B2%2C3-b%5Dpyridine+Derivatives+Useful+as+Hsp90+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%26atitle%3D1H-Pyrrolo%255B2%252C3-b%255Dpyridine%2520Derivatives%2520Useful%2520as%2520Hsp90%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Development and Optimization of a Binding Assay for the XIAP BIR3 Domain Using Fluorescence Polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span><span class="refDoi"> DOI: 10.1016/j.ab.2004.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.ab.2004.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15325294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=261-273&author=Z.+Nikolovska-Coleskaauthor=R.+Wangauthor=X.+Fangauthor=H.+Panauthor=Y.+Tomitaauthor=P.+Liauthor=P.+P.+Rollerauthor=K.+Krajewskiauthor=N.+G.+Saitoauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Development+and+Optimization+of+a+Binding+Assay+for+the+XIAP+BIR3+Domain+Using+Fluorescence+Polarization&doi=10.1016%2Fj.ab.2004.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang; Pan, Hongguang; Tomita, York; Li, Peng; Roller, Peter P.; Krajewski, Krzysztof; Saito, Naoyuki G.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The X-linked inhibitor of apoptosis protein (XIAP) is a potent cellular inhibitor of apoptosis.  Designing small-mol. inhibitors that target the BIR3 domain of XIAP, where Smac/DIABLO (second mitochondria-derived activator of caspase/direct IAP-binding protein with low pI) and caspase-9 bind, is a promising strategy for inhibiting the antiapoptotic activity of XIAP and for overcoming apoptosis resistance of cancer cells mediated by XIAP.  Herein, we report the development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-mol. inhibitors to the BIR3 domain of XIAP.  Among four fluorescent probes tested, a mutated N-terminal Smac peptide (AbuRPFK-(5-Fam)-NH2) showed the highest affinity (Kd = 17.92 nM) and a large dynamic range (ΔmP=231±0.9), and was selected as the most suitable probe for the binding assay.  The binding conditions (DMSO tolerance and stability) have been investigated.  Under optimized conditions, a Z' factor of 0.88 was achieved in a 96-well format for high-throughput screening.  It was found that the popular Cheng-Prusoff equation is invalid for the calcn. of the competitive inhibition consts. (Ki values) for inhibitors in the FP-based competitive binding assay conditions, and accordingly, a new math. equation was developed, validated, and used to compute the Ki values.  An assocd. Web-based computer program was also developed for this task.  Several known Smac peptides with high and low affinities have been evaluated under the assay conditions and the results obtained indicated that the FP-based competitive binding assay performs correctly as designed: it can quant. and accurately det. the binding affinities of Smac-based peptide inhibitors with a wide range of affinities, and is suitable for high-throughput screening of inhibitors binding to the XIAP BIR3 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWjEsqtWsZRbVg90H21EOLACvtfcHk0lgU2N8NvlRKYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFeltL0%253D&md5=23cade47a4996c7ca4c01278d3e0d3a6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DN.%2BG.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDevelopment%2520and%2520Optimization%2520of%2520a%2520Binding%2520Assay%2520for%2520the%2520XIAP%2520BIR3%2520Domain%2520Using%2520Fluorescence%2520Polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ab.2004.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand Efficiency: A Useful Metric for Lead Selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03069-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+Efficiency%3A+A+Useful+Metric+for+Lead+Selection&doi=10.1016%2FS1359-6446%2804%2903069-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eaNoGsyKS-dR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520Efficiency%253A%2520A%2520Useful%2520Metric%2520for%2520Lead%2520Selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431%26doi%3D10.1016%2FS1359-6446%2804%2903069-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Bedford, S. T.; Chen, I.; Wang, Y.; Williamson, D. S.</span><span> </span><span class="NLM_article-title">Arylpyrrolopyridine Derived Compounds as LRRK2 Inhibitors</span>. US 2017/0020850,<span class="NLM_x"> </span><span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+T.+Bedford&author=I.+Chen&author=Y.+Wang&author=D.+S.+Williamson&title=Arylpyrrolopyridine+Derived+Compounds+as+LRRK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBedford%26aufirst%3DS.%2BT.%26atitle%3DArylpyrrolopyridine%2520Derived%2520Compounds%2520as%2520LRRK2%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanoy, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">164ra161</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3004485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1126%2Fscitranslmed.3004485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=23241745" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=164ra161&author=Z.+Shengauthor=S.+Zhangauthor=D.+Bustosauthor=T.+Kleinheinzauthor=C.+E.+Le+Pichonauthor=S.+L.+Dominguezauthor=H.+O.+Solanoyauthor=J.+Drummondauthor=X.+Zhangauthor=X.+Dingauthor=F.+Caiauthor=Q.+Songauthor=X.+Liauthor=Z.+Yueauthor=M.+P.+van+der+Brugauthor=D.+J.+Burdickauthor=J.+Gunzner-Tosteauthor=H.+Chenauthor=X.+Liuauthor=A.+A.+Estradaauthor=Z.+K.+Sweeneyauthor=K.+Scearce-Levieauthor=J.+G.+Moffatauthor=D.+S.+Kirkpatrickauthor=H.+Zhu&title=Ser1292+Autophosphorylation+Is+an+Indicator+of+LRRK2+Kinase+Activity+and+Contributes+to+the+Cellular+Effects+of+PD+Mutations&doi=10.1126%2Fscitranslmed.3004485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004485%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DBustos%26aufirst%3DD.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DSolanoy%26aufirst%3DH.%2BO.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DKirkpatrick%26aufirst%3DD.%2BS.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DSer1292%2520Autophosphorylation%2520Is%2520an%2520Indicator%2520of%2520LRRK2%2520Kinase%2520Activity%2520and%2520Contributes%2520to%2520the%2520Cellular%2520Effects%2520of%2520PD%2520Mutations%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D164ra161%26doi%3D10.1126%2Fscitranslmed.3004485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span> </span><span class="NLM_article-title">LRRK2 Phosphorylation</span>. In  <span class="citation_source-book">Leucine-Rich Repeat Kinase 2 (LRRK2)</span>; <span class="NLM_contrib-group">Rideout, H. J.</span>, Ed.; , Advances in Neurobiology; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span>, DOI: <span class="refDoi"> DOI: 10.1007/978-3-319-49969-7_3</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1007%2F978-3-319-49969-7_3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=51-70&author=R.+J.+Nicholsauthor=H.+J.+Rideout&title=Leucine-Rich+Repeat+Kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-49969-7_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-319-49969-7_3%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26atitle%3DLRRK2%2520Phosphorylation%26btitle%3DLeucine-Rich%2520Repeat%2520Kinase%25202%2520%2528LRRK2%2529%26aulast%3DRideout%26aufirst%3DH.%2BJ.%26pub%3DSpringer%26date%3D2017%26spage%3D51%26epage%3D70%26doi%3D10.1007%2F978-3-319-49969-7_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Graves, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litchfield, D. W.</span><span> </span><span class="NLM_article-title">“Going KiNativ”: Probing the Native Kinome</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1016%2Fj.chembiol.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21700204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=683-684&author=L.+M.+Gravesauthor=D.+W.+Litchfield&title=%E2%80%9CGoing+KiNativ%E2%80%9D%3A+Probing+the+Native+Kinome&doi=10.1016%2Fj.chembiol.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">"Going KiNativ": Probing the Native Kinome</span></div><div class="casAuthors">Graves, Lee M.; Litchfield, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">683-684</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  In this issue, Patricelli et al. describe an in situ chemoproteomics approach (KiNativ) for profiling the kinome and kinome response to specific kinase inhibitors that enables characterization of inhibitor interactions with endogenously expressed kinases in native conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUFZGjHhjv7Vg90H21EOLACvtfcHk0liTR9Qu4pigiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbw%253D&md5=268621add2030f7201c8b7933c2b7780</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DGraves%26aufirst%3DL.%2BM.%26aulast%3DLitchfield%26aufirst%3DD.%2BW.%26atitle%3D%25E2%2580%259CGoing%2520KiNativ%25E2%2580%259D%253A%2520Probing%2520the%2520Native%2520Kinome%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D683%26epage%3D684%26doi%3D10.1016%2Fj.chembiol.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Thirstrup, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dächsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppermann, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fog, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, K. V.</span><span> </span><span class="NLM_article-title">Selective LRRK2 Kinase Inhibition Reduces Phosphorylation of Endogenous Rab10 and Rab12 in Human Peripheral Mononuclear Blood Cells</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">10300</span><span class="refDoi"> DOI: 10.1038/s41598-017-10501-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1038%2Fs41598-017-10501-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=28860483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A280%3ADC%252BC1cbjsFyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=10300&author=K.+Thirstrupauthor=J.+C.+D%C3%A4chselauthor=F.+S.+Oppermannauthor=D.+S.+Williamsonauthor=G.+P.+Smithauthor=K.+Fogauthor=K.+V.+Christensen&title=Selective+LRRK2+Kinase+Inhibition+Reduces+Phosphorylation+of+Endogenous+Rab10+and+Rab12+in+Human+Peripheral+Mononuclear+Blood+Cells&doi=10.1038%2Fs41598-017-10501-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells</span></div><div class="casAuthors">Thirstrup Kenneth; Dachsel Justus C; Fog Karina; Christensen Kenneth V; Oppermann Felix S; Williamson Douglas S; Smith Garrick P</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10300</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Genetic variation in the leucine-rich repeat kinase 2 (LRRK2) gene is associated with risk of familial and sporadic Parkinson's disease (PD).  To support clinical development of LRRK2 inhibitors as disease-modifying treatment in PD biomarkers for kinase activity, target engagement and kinase inhibition are prerequisite tools.  In a combined proteomics and phosphoproteomics study on human peripheral mononuclear blood cells (PBMCs) treated with the LRRK2 inhibitor Lu AF58786 a number of putative biomarkers were identified.  Among the phospho-site hits were known LRRK2 sites as well as two phospho-sites on human Rab10 and Rab12.  LRRK2 dependent phosphorylation of human Rab10 and human Rab12 at positions Thr73 and Ser106, respectively, was confirmed in HEK293 and, more importantly, Rab10-pThr73 inhibition was validated in immune stimulated human PBMCs using two distinct LRRK2 inhibitors.  In addition, in non-stimulated human PBMCs acute inhibition of LRRK2 with two distinct LRRK2 inhibitor compounds reduced Rab10-Thr73 phosphorylation in a concentration-dependent manner with apparent IC50's equivalent to IC50's on LRRK2-pSer935.  The identification of Rab10 phosphorylated at Thr73 as a LRRK2 inhibition marker in human PBMCs strongly support inclusion of assays quantifying Rab10-pThr73 levels in upcoming clinical trials evaluating LRRK2 kinase inhibition as a disease-modifying treatment principle in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAuKrO7n1L5z0O18WR3iAofW6udTcc2eZhXiYcjZ4G9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cbjsFyjug%253D%253D&md5=31bb02a9c7dd8dc8d765c08351e4714f</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-10501-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-10501-z%26sid%3Dliteratum%253Aachs%26aulast%3DThirstrup%26aufirst%3DK.%26aulast%3DD%25C3%25A4chsel%26aufirst%3DJ.%2BC.%26aulast%3DOppermann%26aufirst%3DF.%2BS.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DSmith%26aufirst%3DG.%2BP.%26aulast%3DFog%26aufirst%3DK.%26aulast%3DChristensen%26aufirst%3DK.%2BV.%26atitle%3DSelective%2520LRRK2%2520Kinase%2520Inhibition%2520Reduces%2520Phosphorylation%2520of%2520Endogenous%2520Rab10%2520and%2520Rab12%2520in%2520Human%2520Peripheral%2520Mononuclear%2520Blood%2520Cells%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D10300%26doi%3D10.1038%2Fs41598-017-10501-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Software XDS for Image Rotation, Recognition and Crystal Symmetry Assignment</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Software+XDS+for+Image+Rotation%2C+Recognition+and+Crystal+Symmetry+Assignment&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0likKeQ_a24Cyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DSoftware%2520XDS%2520for%2520Image%2520Rotation%252C%2520Recognition%2520and%2520Crystal%2520Symmetry%2520Assignment%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span>SAINT; <span class="NLM_publisher-name">Bruker AXS</span>: <span class="NLM_publisher-loc">Madison, WI</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SAINT%3B+Bruker+AXS%3A+Madison%2C+WI%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSAINT%26pub%3DBruker%2520AXS%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21460441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+W.+Leslieauthor=A.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0likKeQ_a24Cyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Vagin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplyakov, A.</span><span> </span><span class="NLM_article-title">MOLREP: An Automated Program for Molecular Replacement</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1025</span><span class="refDoi"> DOI: 10.1107/S0021889897006766</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0021889897006766" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1997&pages=1022-1025&author=A.+Vaginauthor=A.+Teplyakov&title=MOLREP%3A+An+Automated+Program+for+Molecular+Replacement&doi=10.1107%2FS0021889897006766"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">MOLREP: an automated program for molecular replacement</span></div><div class="casAuthors">Vagin, Alexei; Teplyakov, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1022-1025</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">MOLREP is an automated program for mol. replacement which uses effective new approaches in data processing and rotational and translational searching.  These include an automatic choice of all parameters, scaling by Patterson origin peaks and soft resoln. cutoff.  One of the cornerstones of the program is an original full-symmetry translation function combined with a packing function.  Information from the model already placed in the cell is incorporated in both translation and packing functions.  A no. of tests using exptl. data proved the ability of the program to find the correct soln. in difficult cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkGXdZ-nTKxLVg90H21EOLACvtfcHk0likKeQ_a24Cyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhslehu7Y%253D&md5=96af64aedd8a8f018c3c18b57a6b4b21</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1107%2FS0021889897006766&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889897006766%26sid%3Dliteratum%253Aachs%26aulast%3DVagin%26aufirst%3DA.%26aulast%3DTeplyakov%26aufirst%3DA.%26atitle%3DMOLREP%253A%2520An%2520Automated%2520Program%2520for%2520Molecular%2520Replacement%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1997%26volume%3D30%26spage%3D1022%26epage%3D1025%26doi%3D10.1107%2FS0021889897006766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skubák, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebedev, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span> </span><span class="NLM_article-title">REFMAC5 for the Refinement of Macromolecular Crystal Structures</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+Refinement+of+Macromolecular+Crystal+Structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lgulOt0fHTtTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520Refinement%2520of%2520Macromolecular%2520Crystal%2520Structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgulOt0fHTtTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Schüttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M. F.</span><span> </span><span class="NLM_article-title">PRODRG: A Tool for High-Throughput Crystallography of Protein-Ligand Complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Sch%C3%BCttelkopfauthor=D.+M.+F.+van+Aalten&title=PRODRG%3A+A+Tool+for+High-Throughput+Crystallography+of+Protein-Ligand+Complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuettelkopf, Alexander W.; van Aalten, Daan M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1355-1363</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The small-mol. topol. generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and mol. topologies suitable for x-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compds. from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the std. libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallog. R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbflrch0bs97Vg90H21EOLACvtfcHk0lgulOt0fHTtTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D&md5=f9bfdb14be7b04ea5c0db67feb39f72a</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26atitle%3DPRODRG%253A%2520A%2520Tool%2520for%2520High-Throughput%2520Crystallography%2520of%2520Protein-Ligand%2520Complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gražulis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaitkus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span> </span><span class="NLM_article-title">AceDRG: A Stereochemical Description Generator for Ligands</span> <span class="citation_source-journal">Acta Crystallogr. Sect. D Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1107/S2059798317000067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=10.1107%2FS2059798317000067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2017&pages=112-122&author=F.+Longauthor=R.+A.+Nichollsauthor=P.+Emsleyauthor=S.+Gra%C5%BEulisauthor=A.+Merkysauthor=A.+Vaitkusauthor=G.+N.+Murshudov&title=AceDRG%3A+A+Stereochemical+Description+Generator+for+Ligands&doi=10.1107%2FS2059798317000067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">AceDRG: a stereochemical description generator for ligands</span></div><div class="casAuthors">Long, Fei; Nicholls, Robert A.; Emsley, Paul; Grazulis, Saulius; Merkys, Andrius; Vaitkus, Antanas; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The program AceDRG is designed for the derivation of stereochem. information about small mols.  It uses local chem. and topol. environment-based atom typing to derive and organize bond lengths and angles from a small-mol. database: the Crystallog. Open Database (COD).  Information about the hybridization states of atoms, whether they belong to small rings (up to seven-membered rings), ring aromaticity and nearest-neighbor information is encoded in the atom types.  All atoms from the COD have been classified according to the generated atom types.  All bonds and angles have also been classified according to the atom types and, in a certain sense, bond types.  Derived data are tabulated in a machine-readable form that is freely available from CCP4.  AceDRG can also generate stereochem. information, provided that the basic bonding pattern of a ligand is known.  The basic bonding pattern is perceived from one of the computational chem. file formats, including SMILES, mmCIF, SDF MOL and SYBYL MOL2 files.  Using the bonding chem., atom types, and bond and angle tables generated from the COD, AceDRG derives the 'ideal' bond lengths, angles, plane groups, arom. rings and chirality information, and writes them to an mmCIF file that can be used by the refinement program REFMAC5 and the model-building program Coot.  Other refinement and model-building programs such as PHENIX and BUSTER can also use these files.  AceDRG also generates one or more coordinate sets corresponding to the most favorable conformation(s) of a given ligand.  AceDRG employs RDKit for chem. perception and for initial conformation generation, as well as for the interpretation of SMILES strings, SDF MOL and SYBYL MOL2 files.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0LaF0rLfdLVg90H21EOLACvtfcHk0lhdvvtuMUak4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGgu78%253D&md5=0a581d62dd3b00004e37be490ee71fe8</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1107%2FS2059798317000067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798317000067%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DF.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DGra%25C5%25BEulis%26aufirst%3DS.%26aulast%3DMerkys%26aufirst%3DA.%26aulast%3DVaitkus%26aufirst%3DA.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DAceDRG%253A%2520A%2520Stereochemical%2520Description%2520Generator%2520for%2520Ligands%26jtitle%3DActa%2520Crystallogr.%2520Sect.%2520D%2520Struct.%2520Biol.%26date%3D2017%26volume%3D73%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS2059798317000067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+Substructure+Filters+for+Removal+of+Pan+Assay+Interference+Compounds+%28PAINS%29+from+Screening+Libraries+and+for+Their+Exclusion+in+Bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lhdvvtuMUak4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520Substructure%2520Filters%2520for%2520Removal%2520of%2520Pan%2520Assay%2520Interference%2520Compounds%2520%2528PAINS%2529%2520from%2520Screening%2520Libraries%2520and%2520for%2520Their%2520Exclusion%2520in%2520Bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1NVR','PDB','1NVR'); return false;">PDB: 1NVR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR','PDB','5OOR'); return false;">PDB: 5OOR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOP','PDB','5OOP'); return false;">PDB: 5OOP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZM','PDB','4YZM'); return false;">PDB: 4YZM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOT','PDB','5OOT'); return false;">PDB: 5OOT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ6','PDB','5OQ6'); return false;">PDB: 5OQ6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ5','PDB','5OQ5'); return false;">PDB: 5OQ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP2','PDB','5OP2'); return false;">PDB: 5OP2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ7','PDB','5OQ7'); return false;">PDB: 5OQ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ8','PDB','5OQ8'); return false;">PDB: 5OQ8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP4','PDB','5OP4'); return false;">PDB: 5OP4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YZN','PDB','4YZN'); return false;">PDB: 4YZN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPB','PDB','5OPB'); return false;">PDB: 5OPB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPR','PDB','5OPR'); return false;">PDB: 5OPR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4U8Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4U8Z','PDB','4U8Z'); return false;">PDB: 4U8Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP5','PDB','5OP5'); return false;">PDB: 5OP5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP7','PDB','5OP7'); return false;">PDB: 5OP7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPS','PDB','5OPS'); return false;">PDB: 5OPS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPU','PDB','5OPU'); return false;">PDB: 5OPU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPV','PDB','5OPV'); return false;">PDB: 5OPV</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01186">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_76121"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01186">10.1021/acs.jmedchem.7b01186</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental details for compounds <b>12</b>–<b>21</b> and <b>24</b>–<b>34</b>, sequence alignment of LRRK2, CHK1, and Roco4 surrogates, tables of X-ray data collection and refinement statistics, electron density maps, details of CHK1 WT and 8-, 10-, and 12-point mutant kinase binding assays, tables of LRRK2 G2019S and WT activity and CHK1 WT and 8-, 10-, and 12-point mutant kinase binding assay data, kinase selectivity data for compounds <b>22</b> and <b>23</b>, broad in vitro pharmacology profiling data for compound <b>23</b> and comparative LRRK2 G2019S and WT enzyme activity and pSer935 HEK293 data for compounds <b>22</b> and <b>23</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings, LRRK2 G2019S and WT IC<sub>50</sub>, cK<sub>i</sub>, p(cK<sub>i</sub>) and LE, LRRK2 G2019S and WT pSer935 HEK293 (384-well) IC<sub>50</sub>, HLM CL, <i>P</i><sub>app</sub> (MDR1-MDCK), CHK1 WT and 8-, 10-, and 12-point mutant IC<sub>50</sub> and p(cK<sub>i</sub>), PDB codes for complexes with CHK1 8-, 10- and 12-point mutants (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_001.pdf">jm7b01186_si_001.pdf (2.31 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01186/suppl_file/jm7b01186_si_002.csv">jm7b01186_si_002.csv (7.65 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for ligand bound structures with CHK1 10-point mutant: AMP-PNP (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOP">5OOP</a>), <b>1</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOR">5OOR</a>), <b>2</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OOT">5OOT</a>), <b>3b</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP2">5OP2</a>), <b>4a</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP4">5OP4</a>), <b>5</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP5">5OP5</a>), <b>6</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OP7">5OP7</a>), <b>7</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPB">5OPB</a>), <b>8</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPR">5OPR</a>), <b>9</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPS">5OPS</a>), <b>22</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPU">5OPU</a>), and <b>23</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OPV">5OPV</a>). PDB codes for ligand bound structures with CHK1 8-point mutant: <b>2</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ5">5OQ5</a>) and <b>3b</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ7">5OQ7</a>). PDB codes for ligand bound structures with CHK1 12-point mutant: <b>2</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ6">5OQ6</a>) and <b>3b</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5OQ8">5OQ8</a>). Authors will release the atomic coordinates upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01186&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01186%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01186" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679945604dec3d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
